The information
contained in this preliminary prospectus supplement is not
complete and may be changed. This preliminary prospectus
supplement and the accompanying prospectus are not an offer to
sell these securities and are not soliciting an offer to buy
these securities in any state where the offer or sale is not
permitted.
|
CALCULATION
OF REGISTRATION FEE CHART
|
|
|
|
|
|
|
|
|
|
Amount to be
|
|
|
|
|
|
|
Registered/Maximum
|
|
|
|
|
|
|
Offering Price per
|
|
|
|
|
|
|
Unit/Maximum
|
|
|
|
Title of Each Class of
|
|
|
Aggregate Offering
|
|
|
Amount of
|
Securities to be Registered
|
|
|
Price
|
|
|
Registration Fee
|
Convertible Notes due 2013
|
|
|
$258,750,000
|
|
|
$10,168.88(1)
|
Common stock, par value $0.01 per share
|
|
|
(2)
|
|
|
(2)
|
|
|
|
|
|
|
|
|
|
|
(1)
|
|
The filing fee of $10,168.88 is calculated in accordance with
Rule 457(o) and Rule 457(r) of the Securities Act of
1933, as amended (the Securities Act) and relates to
the registration statement on
Form S-3
(File No.
333-131886)
filed by Energy Conversion Devices, Inc.
|
|
(2)
|
|
There are also being registered hereby an indeterminate number
of shares of common stock into which the notes may be converted.
Pursuant to Rule 457(i), no separate registration fee is payable
where securities and securities into which conversion is offered
are registered at the same time and no additional consideration
is payable upon conversion.
|
Filed
Pursuant to Rule 424(b)(5)
Registration
No. 333-131886
SUBJECT TO COMPLETION, DATED
JUNE 12, 2008
PRELIMINARY PROSPECTUS
SUPPLEMENT TO PROSPECTUS DATED FEBRUARY 15, 2006
Energy Conversion Devices,
Inc.
$225,000,000
% Convertible
Senior Notes due 2013
We are offering $225,000,000 aggregate principal amount of
our % Convertible Senior Notes
due 2013, or the notes. The notes will bear interest
at a rate of % per year. Interest
on the notes will be payable semi-annually in arrears on June 15
and December 15 of each year, beginning December 15, 2008. The
notes will mature on June 15, 2013.
Holders may convert their notes, at their option, under certain
circumstances described herein prior to the close of business on
the business day immediately preceding the maturity date. Upon
conversion, we will deliver cash and a number of shares of our
common stock determined as described in this prospectus
supplement. The conversion rate for the notes will
be shares of our
common stock per $1,000 principal amount of notes, equivalent to
a conversion price of approximately
$ per share of our common stock.
The conversion rate will be subject to adjustment in certain
events as described in this prospectus supplement, including
following certain corporate transactions.
If we undergo a fundamental change, as defined in this
prospectus supplement, holders may require us to purchase all or
a portion of their notes for cash at a price equal to 100% of
the principal amount of the notes to be purchased plus any
accrued and unpaid interest.
The notes will be senior unsecured obligations, will rank equal
in right of payment with any of our other existing and future
senior unsecured debt, and will rank senior to all of our debt
that is subordinated to the notes. The notes will be effectively
subordinated to any of our secured indebtedness to the extent of
the assets securing such indebtedness. The notes also will be
structurally subordinated to any existing and future
indebtedness and other liabilities and commitments (including
trade payables and lease obligations) of our subsidiaries.
For a more detailed description of the notes, see
Description of the Notes beginning on
page S-40.
Concurrently with this offering of notes, we are offering, by
means of a separate prospectus supplement and accompanying
prospectus, 4,708,500 shares of our common stock,
3,438,500 of which are being borrowed by an affiliate of
Credit Suisse Securities (USA) LLC, a managing underwriter in
this offering, and 1,270,000 of which are being
underwritten by the underwriters of this offering and offered to
the public at a price of $ per
share. We refer to the portion of the common stock offering for
which we will receive cash proceeds as the underwritten
equity offering and the shares sold in the underwritten
equity offering as the underwritten shares. We
estimate that the net proceeds from the sale of the underwritten
shares, after deducting estimated underwriting discounts and
commissions and estimated offering expenses payable by us, will
be approximately $ million,
assuming the underwriters over-allotment option in that
offering is not exercised. We refer to the borrowed shares
portion of the common stock offering as the borrowed
shares. We will not receive any proceeds from the
borrowing of the borrowed shares by the affiliate of Credit
Suisse Securities (USA) LLC, but we will receive from that
affiliate a nominal lending fee for the use of those shares. See
Description of the Share Lending Agreement and
Underwriting. This affiliate has agreed to use the
borrowed shares to facilitate the establishment by investors in
the notes, and certain other of our securities, of hedge
positions in such securities. Up
to of the borrowed
shares may be used to facilitate such transactions on a delayed
basis at any time prior to the termination of the agreement
relating to the borrowed shares.
Our common stock is listed on the Nasdaq Global Select Market
under the symbol ENER. On June 11, 2008, the
last reported sale price of our common stock on the Nasdaq
Global Select Market was $64.24 per share.
We do not intend to apply for listing of the notes on any
securities exchange or for inclusion of the notes in any
automated quotation system.
Investing in the notes involves
risks. See Risk Factors on
page S-12
of this prospectus supplement.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Underwriting
|
|
|
|
|
|
|
Discounts and
|
|
|
|
|
Price to
Public
(1)
|
|
Commissions
|
|
Proceeds to
ECD
(1)
|
Per note
|
|
|
100
|
%
|
|
|
|
%
|
|
|
|
%
|
Total
|
|
$
|
225,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
|
Plus accrued interest, if any, from
June , 2008, if settlement occurs after that
date.
|
The underwriters have a
30-day
option to purchase a maximum of $33,750,000 additional principal
amount of the notes solely to cover over-allotments, if any.
Neither the Securities and Exchange Commission nor any state
securities commission has approved or disapproved of these
securities or determined if this prospectus supplement or the
related prospectus is truthful or complete. Any representation
to the contrary is a criminal offense.
Delivery of the notes will be made in book-entry form on or
about June , 2008.
|
|
CREDIT
SUISSE
|
UBS INVESTMENT BANK
|
JPMORGAN
|
|
DEUTSCHE
BANK SECURITIES
|
LAZARD CAPITAL MARKETS
|
June , 2008
Energy Conversion Devices, Inc.
®
Building-integrated and commercial rooftop photovoltaics
|
TABLE OF
CONTENTS
|
|
|
|
|
Prospectus Supplement
|
|
Page
|
|
|
|
|
S-ii
|
|
|
|
|
S-iii
|
|
|
|
|
S-1
|
|
|
|
|
S-12
|
|
|
|
|
S-32
|
|
|
|
|
S-33
|
|
|
|
|
S-34
|
|
|
|
|
S-35
|
|
|
|
|
S-36
|
|
|
|
|
S-40
|
|
|
|
|
S-63
|
|
|
|
|
S-66
|
|
|
|
|
S-68
|
|
|
|
|
S-69
|
|
|
|
|
S-74
|
|
|
|
|
S-78
|
|
|
|
|
S-79
|
|
|
|
|
S-79
|
|
|
|
|
S-79
|
|
|
|
|
|
|
Prospectus
|
|
Page
|
|
|
|
|
1
|
|
|
|
|
1
|
|
|
|
|
2
|
|
|
|
|
2
|
|
|
|
|
12
|
|
|
|
|
12
|
|
|
|
|
12
|
|
|
|
|
12
|
|
|
|
|
13
|
|
|
|
|
13
|
|
|
|
|
13
|
|
About
This Prospectus Supplement
This document is in two parts. The first part is this prospectus
supplement, which describes the specific terms of this offering,
risks related to an investment in the notes and a discussion of
risks our business faces. The second part, the accompanying
prospectus, gives more general information, some of which may
not apply to this offering. If any statement in this prospectus
supplement varies between this prospectus supplement and the
accompanying prospectus, you should rely only on the information
contained or incorporated by reference in this prospectus
supplement.
You should rely only on the information contained or
incorporated by reference in this prospectus supplement, the
accompanying prospectus and any free writing prospectus prepared
by or on behalf of us. We have not, and the underwriters have
not, authorized any other person to provide you with different
information. If anyone provides you with different or
inconsistent information, you should not rely on it. We are not,
and the underwriters are not, making an offer to sell these
securities in any jurisdiction where the offer or sale is not
permitted.
You should assume that the information appearing in this
prospectus supplement, the accompanying prospectus and the
documents incorporated by reference is accurate only as of the
respective dates of those documents in which the information is
contained. Our business, financial condition, results of
operations and prospects may have changed since any of those
respective dates. You should read this entire prospectus
supplement, as well as the accompanying prospectus and the
documents incorporated by reference that are described under
Where You Can Find More Information in this
prospectus supplement and the accompanying prospectus before
making your investment decision. Unless otherwise indicated
herein, the information in this prospectus supplement assumes no
exercise of the underwriters option to purchase additional
notes described herein.
In this prospectus supplement, we rely on and refer to
information regarding the market in which we operate and compete
and other related markets. We obtained this information from
various third-party sources, including industry publications,
surveys and forecasts that we believe to be reasonable. We also
make statements in this prospectus supplement regarding the
performance, characteristics or properties of our products.
Unless indicated otherwise, these statements are based on our
own studies, internal data and information obtained from our
customers.
S-ii
Cautionary
Note Regarding Forward-Looking Statements
This prospectus supplement includes forward-looking
statements that involve risks and uncertainties. These
forward-looking statements are made pursuant to safe harbor
provisions of the Private Securities Litigation Reform Act of
1995. Forward-looking statements include statements concerning
our plans, objectives, goals, strategies, future events, future
sales or performance, capital expenditures, financing needs,
plans or intentions relating to acquisitions, business trends
and other information that is not historical information. When
used in this prospectus, the words estimates,
expects, anticipates,
projects, plans, intends,
believes, forecasts,
foresees, likely, may,
should, goal, target and
variations of such words or similar expressions are intended to
identify forward-looking statements. All forward-looking
statements are based upon information available to us on the
date of this prospectus supplement.
These forward-looking statements are subject to risks,
uncertainties and other factors, many of which are outside of
our control, that could cause actual results to differ
materially from the results discussed in the forward-looking
statements, including, among other things, the matters discussed
in this prospectus supplement in the section captioned
Risk Factors. Factors you should consider that could
cause these differences are:
|
|
|
|
|
the worldwide demand for electricity and the market for
renewable energy, including solar energy;
|
|
|
|
the ability or inability of conventional fossil fuel-based
generation technologies to meet the worldwide demand for
electricity;
|
|
|
|
government subsidies and policies supporting renewable energy,
including solar energy;
|
|
|
|
our expenses, sources of sales and international sales and
operations;
|
|
|
|
future pricing of, and demand for, our solar laminates;
|
|
|
|
the performance, features and benefits of our solar laminates
and plans for the enhancement of solar laminates;
|
|
|
|
the supply and price of components and raw materials;
|
|
|
|
our ability to expand our manufacturing capacity in a timely and
cost-effective manner;
|
|
|
|
our ability to retain our current key executives, integrate new
key executives and attract and retain other skilled managerial,
engineering and sales marketing personnel;
|
|
|
|
the viability of our intellectual property and our continued
investment in research and development;
|
|
|
|
payments and other obligations resulting from the unfavorable
resolution of legal proceedings;
|
|
|
|
changes in, or the failure to comply with, government
regulations and environmental, health and safety requirements;
|
|
|
|
interest rate fluctuations and both our and our end-users
ability to secure financing on commercially reasonable terms or
at all; and
|
|
|
|
general economic and business conditions, including those
influenced by international and geopolitical events such as the
war in Iraq and any future terrorist attacks.
|
There may be other factors that could cause our actual results
to differ materially from the results referred to in the
forward-looking statements. We undertake no obligation to
publicly update or revise forward-looking statements to reflect
events or circumstances after the date made or to reflect the
occurrence of unanticipated events, except as required by law.
S-iii
Prospectus
Supplement Summary
This summary highlights information contained elsewhere in
this prospectus supplement, the accompanying prospectus and the
documents incorporated by reference. This summary does not
contain all of the information that you may consider to be
important in deciding whether to invest in our notes. You should
read this entire prospectus supplement, the accompanying
prospectus and the documents incorporated by reference
carefully, including the Risk Factors section
beginning on
page S-12
of this prospectus supplement, as well as our consolidated
financial statements and the related notes incorporated by
reference.
Unless otherwise specified or unless the context requires
otherwise, all references in this prospectus supplement to
ECD, we, us, our
or similar references mean Energy Conversion Devices, Inc. and
its subsidiaries.
Our
Company
We design, manufacture and sell photovoltaic (PV)
products, commonly referred to as solar cells, solar modules or
solar laminates, that provide clean, renewable energy by
converting sunlight into electricity. Our solar laminates have
unique characteristics that differentiate them from conventional
crystalline solar modules, including physical flexibility, low
weight, high durability and ease of installation. These
characteristics make our products particularly suitable for
rooftop applications, which is our target market. We manufacture
our solar laminates using a proprietary process and technology
that we developed through nearly 30 years of research.
Demand for our solar laminates, which we market under the brand
name
UNI-SOLAR
®
,
currently exceeds our ability to manufacture these products, and
we believe this trend will continue for some time. To meet the
increasing demand for our products, we are actively expanding
our production capacity and have embarked on an expansion plan
to reach 1 GW of annual production capacity by 2012. Solar
laminate sales represent more than 90% of our revenues. We also
receive fees and royalties from licensees of our nickel metal
hydride (NiMH) battery technology and sell high
performance nickel hydroxide used in NiMH batteries.
We appointed a new President and Chief Executive Officer in
September of 2007, who is leading a new management team, all of
whom have been appointed since June 2006, including our Chief
Financial Officer, Vice President of Operations, Senior Vice
President and Chief Administration Officer, Vice President of
Strategic Marketing, Vice President of Systems Engineering and
Vice President of Global Sales. Over the past several months,
this new leadership team has implemented a series of strategic
initiatives designed to strengthen our competitive position and
improve our financial performance, including:
|
|
|
|
|
Focusing our efforts on expanding our solar
business.
We have made a strategic decision to
focus our business on the production and sale of our solar
laminates. We believe this concentration will enable us to
capitalize on global PV market growth opportunities and position
us for increased profitability.
|
|
|
|
Implementing best practices to improve ramp times, increase
production yields and lower costs.
We have
developed and implemented techniques to reduce our ramp
time. The phrase ramp time refers to the
amount of time it takes to bring a new production line to
nameplate capacity, which is the amount of annual
production of solar laminates measured in watts that a plant
initially is designed to produce. Shorter ramp times reduce our
costs and enable us to accelerate the availability of our
finished products for sale. We have also developed and
implemented improved manufacturing practices in our facilities
that are resulting in higher production yields and lower
production costs, thereby increasing our gross margins.
|
|
|
|
Restructuring our operations to reduce costs related to
non-solar related activities and streamlining our organization
and reporting structure.
In April 2007, we began
implementing a restructuring plan to reduce costs in our
non-manufacturing activities. This plan includes the elimination
of over 100 employees and other changes, which we expect to
result in approximately $23.0 million of annualized cost
savings (as implemented through June 30, 2008). We expect
to realize further savings primarily through facility
rationalization programs related to non-manufacturing
activities. In June 2007, we also realigned our organizational
structure into two segments and began a process of consolidating
support functions within our businesses. These actions have
streamlined our decision-making processes and reduced our costs.
|
S-1
|
|
|
|
|
Reviewing strategic alternatives with respect to our non-core
businesses.
In connection with concentrating our
efforts on our solar business, we are performing ongoing reviews
of our other business activities. These reviews are designed to
identify activities where we can realize greater value for our
stockholders through a variety of mechanisms, including
potential exits of these activities. For example, in May 2008,
we announced that we were engaged in discussions to sell our
ownership interest in Cobasys LLC (Cobasys), a joint
venture with Chevron Technology Ventures, LLC (CTV)
that manufactures hybrid vehicle batteries and battery systems.
|
Our
Market Opportunity
Solar power technology has been used to generate electricity in
space program applications for several decades and in commercial
applications over the last 30 years. Increasingly,
government incentive programs are accelerating the adoption of
solar power. According to Solarbuzz, a research and consulting
firm, the global PV market grew to an estimated 2,826 MW in
2007, as measured by total PV modules delivered to installation
sites during that year, representing a compound annual growth
rate of 47.4% since 2003. Solarbuzz estimates that PV industry
revenues were approximately $17.2 billion in 2007 and
projects under one of its forecast scenarios that the global PV
market and PV industry revenues will reach 9,917 MW and
$39.5 billion, respectively, in 2012.
Today, the cost per kilowatt hour for solar power is higher than
electricity delivered through the power grid. However, the cost
for electricity delivered through the power grid has been
increasing steadily while the cost of solar power has been
decreasing. Some industry and government publications have
indicated that the cost of solar power may become as economical
as electricity delivered through the power grid by 2015.
Thin-film technologies, such as our solar laminates, are being
developed as a means of substantially reducing the cost of PV
systems as they are cheaper to manufacture than traditional PV
systems due to their reduced material, energy, handling and
capital costs. Growth in thin-film demand is expected to be
driven by rising conversion efficiency and increased demand for
building-integrated photovoltaics (BIPV), such as
grid-connected roof-mounted PV systems. According to one of
Solarbuzzs forecast scenarios, grid-connected roof-mounted
PV systems are expected to grow from approximately 56% of the
total PV market in 2007 to 66% of the market by 2012. Within the
overall roof-mounted market, many commercial buildings can be
powered by less than 5
watts/ft
2
.
We believe the installed solar capacity on commercial rooftops
could reach 5 GW by 2012.
Our
Competitive Strengths
We have several competitive strengths, including:
|
|
|
|
|
Our products are well-suited for rooftop applications and
possess several unique attributes.
Our PV
laminates possess several unique attributes that make them ideal
for both rooftop and building integrated applications, including:
|
|
|
|
|
|
Ability to be integrated with roofing materials and to
qualify for special BIPV incentives.
Unlike
conventional solar modules, our products are physically
flexible, do not require a metal frame and can be integrated
directly with roofing materials during production to create a
seamless appearance. France and Italy, which are among the most
significant markets for solar products, have recently instituted
higher incentives for BIPV than for ground mount installations.
These governments typically define BIPV products as those that
represent an essential component of the roofing materials
themselves. We believe our PV laminates are one of only a few
products available today that qualify as BIPV under this
definition.
|
|
|
|
Low weight.
Our PV laminates weigh less than
one pound per square foot. This compares with between two and
five pounds per square foot for conventional solar modules. The
relatively low weight of our products allows them to be used on
most rooftops without the need for reinforcement which can add
significant cost to the installation.
|
|
|
|
Superior resistance to wind lift.
Our PV
laminates have a low profile and are bonded to, or integrated
with, the roof as opposed to being mounted on a raised support
structure like many conventional solar modules. This gives our
products superior resistance to wind lift, which can loosen and
even dislodge conventional solar modules in storm prone areas.
|
S-2
|
|
|
|
|
No roof penetration.
Our PV laminates are
bonded to roofing materials during production or to existing
roof surfaces by their adhesive backing and do not require
penetrating the roof with bolts or other fasteners like many
conventional solar modules. We believe that end-users prefer
systems that do not result in roof penetrations as such
installations may lead to leaks, damages to the structural
integrity of the roof or invalidation of the roof
manufacturers warranty.
|
|
|
|
High durability and impact resistance.
Our PV
laminates are flexible and can be walked on or dropped with
minimal risk of damaging the product. Dropping a conventional
solar module, which generally is enclosed in glass, can often
destroy the entire product.
|
|
|
|
Ease of installation.
Our PV laminates can be
shipped in rolls directly to the installation site in addition
to being integrated with the roofing materials. Installers
remove a release paper from the back of our products as they
unfurl the roll on the roof. The release paper reveals an
adhesive backing that allows the product to be bonded directly
to the roof. We believe the installation process for our
products is significantly less time consuming than the
installation process for conventional glass-based solar modules,
which typically involves building a support structure and
mounting each module individually. This simplified installation
process results in cost savings to our customers.
|
|
|
|
|
|
Effective research and development activities supporting
innovation in our solar business
. Our research
and development group is a leader in the development of
thin-film solar technology and has been recognized for achieving
high efficiency solar cells using this technology. For example,
we developed the first commercial flexible PV product. We
continue to develop new innovative technologies to reduce
production cost, improve light-to-electricity conversion
efficiency, and identify new commercial applications for our
products.
|
|
|
|
Our products do not use polysilicon, which is currently in
short supply
. Conventional solar modules are made
from crystalline silicon wafers. These wafers are made from
polysilicon, which is also used to produce semiconductor chips.
Rising demand for solar modules has led to a significant
increase in the price of polysilicon. From December 2004 to the
second half of 2007, the average spot price of polysilicon
increased from $32 per kilogram to nearly $400 per kilogram and
several polysilicon manufacturers have reported that their
capacity is sold out for the next two to three years. Our
production process uses silane gas to deposit a thin film of
amorphous silicon on a sheet of stainless steel. Silane gas is
widely available and we have agreements in place with multiple
suppliers. We believe that our use of silane gas as opposed to
polysilicon allows us to control our material costs and deliver
our product more reliably than our competitors who manufacture
conventional solar modules based on crystalline silicon.
|
|
|
|
Our roll-to-roll manufacturing process and equipment are
proprietary.
Most conventional crystalline solar
modules are produced using well-known processes and widely
available equipment. We believe the availability of conventional
crystalline technology has contributed to the proliferation of a
large number of solar companies that produce similar products.
We design, develop and manufacture our automated production
equipment based on proprietary process technologies, including
vacuum deposition of amorphous silicon and large-scale,
roll-to-roll
manufacturing processes. We believe that our access to these
technologies poses a significant barrier to entry for
competitors who may seek to produce products similar to our own.
|
|
|
|
Our products generate more electricity in real world
conditions than many competing products, resulting in higher
returns on investment for our customers.
Solar
modules are typically priced by their rated power output
measured in watt peak determined in standard test conditions,
and most solar module manufacturers sell their products for a
similar price per watt. We believe our solar laminates generate
electricity earlier in the day and later into the evening and
perform better in diffuse light and at high temperatures than
conventional crystalline products. Our internal studies (based
on prevailing European climate conditions) have shown that our
solar laminates produce 8-20% more kilowatt hours of electricity
per rated kilowatt of power output on an annual basis than
similarly priced conventional solar modules. Higher
kilowatt-hours
per rated kilowatt of output increases our customers
return on investment, which we believe should result in greater
demand for our products relative to conventional solar modules
over time.
|
S-3
|
|
|
|
|
We have developed multiple sales channels for our solar
laminates.
Most conventional solar modules are
distributed through a relatively small number of specialty PV
distributors and installers. We sell our solar laminates through
this channel as well as through commercial roofing companies and
building contractors, which we believe gives us greater access
to end-users in our target markets.
|
|
|
|
Our management team has significant experience scaling and
optimizing manufacturing operations.
Our current
management team possesses significant manufacturing expertise,
which we believe will become increasingly critical to our
success as we continue to grow and improve the productivity and
efficiency of our operations. Our President and Chief Executive
Officer has held a variety of positions in manufacturing
environments over a
15-year
period in which he has demonstrated the ability to improve
profitability, lead team-building and reorganization efforts and
integrate businesses of a global scale. Our Vice President of
Operations has held progressive manufacturing leadership roles
within the automotive industry for more than 21 years. Our
second tier of operations management also possesses many years
of relevant manufacturing experience and its members have been
integrated in the development and implementation of our current
growth and efficiency programs. We believe our current team has
the necessary skills and experience to successfully scale and
optimize our business as we move forward. For more information
about our directors, executive officers and key employees,
please see Management, beginning on page S-36.
|
Our
Strategy
Our key strategies include:
|
|
|
|
|
Focus on customers where our products have a competitive
advantage, particularly within the BIPV
market.
The physical flexibility, durability and
lightweight nature of our solar laminates makes them an
attractive value proposition for the BIPV market, particularly
commercial rooftop applications, where our solar laminates can
be integrated with roofing materials and other building
products. Our solar laminates produce over 5.8
watts/ft
2
,
whereas many commercial buildings can be powered by less than
5 watts/ft
2
,
which represents a significant market opportunity for us.
Additionally, the BIPV market is attractive due to the
favorable incentives offered by France and Italy, two of the
largest solar markets, for BIPV products. Since BIPV products
are integrated into the buildings that ultimately consume the
power produced, they do not take the land space or use the
transmission infrastructure required by other solar products.
France and Italy are rewarding this factor in the form of higher
incentives. We believe the BIPV market, including commercial
roof top applications, represents the most attractive
opportunity for our solar laminates and we believe we will
continue to increase our sales within this market.
|
|
|
|
Expand our manufacturing capacity to meet growing
demand
. We have embarked on an expansion plan to
reach 1 GW of nameplate capacity by 2012. We believe this
expansion is necessary to meet the rapidly growing demand for
our products. We currently have agreements in place to sell 94%
and 48% of our FY 2009 and FY 2010, respectively,
forecasted production volumes, each of which exceeds our current
nameplate capacity, and we have agreements totaling
approximately 600 MW through 2013. We currently operate two
manufacturing lines in Auburn Hills, Michigan totaling
58 MW of nameplate capacity and are ramping up production
at two new manufacturing lines in Greenville, Michigan with
additional nameplate capacity of 60 MW. We expect these new
lines to be operating at nameplate capacity by December 2008. We
also are installing two additional manufacturing lines at a
second location in Greenville, Michigan that will bring our
nameplate capacity to 178 MW. We expect these lines to be
operating at nameplate capacity before the end of FY 2009. We
will continue our manufacturing expansion to 300 MW of
nameplate capacity and then to 1 GW of nameplate capacity by
carefully evaluating sites globally based on analysis of
proximity to end markets, local cost-structure (including
incentives) and access to an appropriately skilled workforce. As
we plan for capacity expansion, we believe that our
differentiated technology and processes can be replicated
successfully.
|
|
|
|
Increase the percentage of our sales from take or
pay agreements.
Historically we entered
into long-term supply agreements with our customers that did not
include minimum purchase requirements. These orders were
completed on a current basis through purchase orders issued by
the customers as they required our PV laminates. In order to
increase visibility and certainty, and to plan our operations
accordingly, we
|
S-4
|
|
|
|
|
have recently focused our efforts on long-term take or
pay agreements that require the customer to purchase a
specified minimum amount of our products. We have and will
continue to increase the percentage of our products that are
sold under take or pay agreements as we continue to pursue our
strategy of demand-driven expansion.
|
|
|
|
|
|
Reduce the cost and increase conversion efficiency of our
products.
Although significant progress has been
made to date in reducing the cost and increasing the conversion
efficiency of our products, we continue to believe that
additional cost improvements and higher efficiency can be
achieved through:
|
|
|
|
|
|
Lowering raw material costs.
We already have
qualified suppliers, and are in the process of qualifying
additional suppliers, for certain commodity materials such as
stainless steel, grid wire and polymers. We will continue to
transition our supply chain to include multiple suppliers. We
believe that using a broader pool of suppliers will help lower
costs by mitigating the impact of an increase of prices by our
suppliers and possibly creating more competition among such
suppliers. As we significantly increase our volume, we should
also benefit from more competitive pricing which will help us
reduce our cost per watt.
|
|
|
|
Increasing manufacturing throughput and
yield.
We are continually improving the
manufacturing process to increase the productivity and
efficiency of our machines. We will continue to implement
manufacturing best practices to increase manufacturing
throughput and yield, which will enable us to achieve scale
benefits.
|
|
|
|
Increasing the conversion efficiency of our laminate
products.
We are continually improving the
conversion efficiency of our solar laminates. Higher conversion
efficiency allows the same amount of power to be produced with
less material, which translates into lower costs and higher
margins for our product. We will continue to review our product
designs and manufacturing processes to identify opportunities to
improve the conversion efficiency of our solar laminates.
|
|
|
|
|
|
Increase our sales presence in key solar
markets.
We have identified several markets where
we believe there are significant growth opportunities for our
solar laminates, including France, Spain, Italy and South Korea.
In several of these target countries, government incentives
favoring BIPV continue to drive the increased adoption of solar
power generated by BIPV systems. We are in the process of
establishing relationships with appropriate channel partners and
deploying additional sales resources to exploit these
opportunities.
|
|
|
|
Continue to improve our financial
performance.
We have historically generated
operating losses. However, our business achieved operating
profitability during our third fiscal quarter ended
March 31, 2008. This profitability delivered by our new
management team resulted from adoption of a focused product
strategy, growth in our manufacturing capacity, continued
technological advancements, cost cutting and sourcing
initiatives and a focus on manufacturing efficiency. We will
continue implementing cost saving initiatives and executing the
programs we have started, with a long range goal of raising our
gross margin to in excess of 40%.
|
|
|
|
Continue to innovate, and realize value from our technology
portfolio.
While our innovation and technological
advancement in solar power is most prominent, we also have
developed proprietary technologies outside of our core solar
business that we believe have substantial value. These include
technologies for NiMH batteries, solid hydrogen storage, metal
hydride fuel cells, biofuel reformation and phase-change random
access memory. We are currently reviewing strategic alternatives
to determine the best way to maximize value for each of these
technologies. We have in the past licensed several of our
technologies to third parties under royalty bearing agreements.
We have also partnered with third parties to commercialize
certain other technologies. We expect to consider licenses,
joint ventures and sales as means to realize value from our
technology portfolio in the future.
|
Description
of Concurrent Offering
Concurrently with this offering, we are offering an aggregate of
4,708,500 shares of our common stock by means of a separate
prospectus supplement for an aggregate purchase price of
$ million.
S-5
1,270,000 of the shares being offered by that prospectus
supplement are being underwritten by the underwriters of this
offering and are being offered to the public at a price of
$ per share. We refer to this
portion of the concurrent offering as the underwritten
equity offering. We have also granted a
30-day
option to the underwriters of the underwritten equity offering
to purchase up to an additional 190,500 shares of our
common stock.
The remaining shares of common stock being offered by that
prospectus supplement and accompanying prospectus are shares
that we will loan to an affiliate of Credit Suisse Securities
(USA) LLC, a managing underwriter in this offering, pursuant to
a share lending agreement among us, Credit Suisse Securities
(USA) LLC and such affiliate. These shares are referred to in
this prospectus supplement as the borrowed shares.
Under the share lending agreement, the affiliate of Credit
Suisse Securities (USA) LLC has agreed to use such borrowed
shares to facilitate transactions by which investors in the
notes offered hereby and, with our consent, other securities
that we may issue in the future, will hedge their respective
investments through short sales or privately negotiated
transactions and will be entitled to sell such shares pursuant
to our registration statement.
This affiliate of Credit Suisse Securities (USA) LLC will
receive all of the proceeds from the sale of the borrowed shares
pursuant to the share lending agreement and we will not receive
any of those proceeds, but we will receive a nominal lending fee
for the use of those shares from that affiliate. See
Description of the Share Lending Agreement. Because
the shares borrowed pursuant to that agreement must be returned
to us, we believe that under U.S. GAAP the borrowed shares
will not be considered outstanding for the purpose of computing
and reporting our earnings per share.
The delivery of shares of common stock being offered pursuant to
the share lending agreement is contingent on the closing of this
offering. We expect that delivery of the shares of our common
stock in that portion of the common stock offering will be made
concurrently with the closing of this offering.
Recent
Developments
On June 6, 2008 we reached a settlement agreement with
International Acquisitions Services, Inc. (IAS),
Innovative Transportation Systems AG (ITS) and
Neville Chamberlain (together with IAS and ITS, the
InnoVan Plaintiffs). The settlement agreement
resolves a lawsuit instituted by the InnoVan Plaintiffs where
they claimed, among other things, that we made fraudulent
statements relating to the supply of battery products by Cobasys
to ITS, an entity created to manufacture and sell an electric
delivery vehicle known as the InnoVan. The net costs to us of
the litigation and settlement, including attorneys fees
and after certain third party reimbursements, is estimated to be
approximately $500,000.
Our
Corporate Information
We incorporated in the State of Delaware in 1964. Our principal
executive offices are located at 2956 Waterview Drive, Rochester
Hills, Michigan 48309. Our telephone number is
(248) 293-0440.
We maintain an Internet website at www.ovonic.com. We have not
incorporated by reference into this prospectus supplement the
information in, or that can be accessed through, our website,
and you should not consider it to be a part of this prospectus
supplement or the accompanying prospectus.
S-6
The
Offering
The following summary contains basic information about this
offering and the notes and is not intended to be complete. It
does not contain all of the information that may be important to
you. For a more complete understanding of all of the terms and
provisions of the notes, please refer to the section of this
prospectus supplement entitled Description of the
Notes.
|
|
|
Issuer
|
|
Energy Conversion Devices, Inc., a Delaware corporation.
|
|
Securities
|
|
$225,000,000 aggregate principal amount
of % Convertible Senior Notes
due 2013, or the notes. We have also granted the
underwriters a
30-day
option to purchase a maximum of $33,750,000 additional principal
amount of the notes solely to cover over-allotments, if any.
|
|
Maturity
|
|
The notes will mature on June 15, 2013, subject to earlier
repurchase or conversion.
|
|
Interest
|
|
% per year on the principal amount
from June , 2008, payable semi-annually in arrears on
June 15 and December 15 of each year, beginning December 15,
2008.
|
|
Conversion Rights
|
|
Under the circumstances discussed below, you will be able to
surrender your notes for conversion, in whole or in part, into
cash and, if applicable, shares of our common stock at any time
prior to the close of business (
i.e.
5:00 p.m. New York City time) on the business day
immediately preceding June 15, 2013, unless the notes have been
previously repurchased. Prior to March 15, 2013, you may,
subject to your compliance with the procedures described under
Description of the Notes Conversion
Rights, convert your notes only in the following
circumstances:
|
|
|
|
at any time during any calendar quarter commencing
after June 30, 2008, if the last reported sale price of our
common stock for at least 20 trading days during the period of
30 consecutive trading days ending on the last trading day of
the immediately preceding calendar quarter (subject to
adjustment in certain circumstances as described under
Description of the Notes Conversion
Rights Conversion Upon Satisfaction of Common Stock
Price Condition) is greater than 130% of the conversion
price on such last trading day;
|
|
|
|
during the five
business-day
period following any ten consecutive
trading-day
period (after a qualifying request for determination) in which
the trading price for the notes was less than 97% of the product
of the last reported sale price of our common stock and the
conversion rate on such day;
|
|
|
|
upon the occurrence of specified corporate
transactions described under Description of the
Notes Conversion Rights Conversion Upon
Specified Corporate Transactions.
|
|
|
|
On or after March 15, 2013, notes may be converted until
the close of business on the business day preceding maturity
without regard to the foregoing conditions.
|
|
|
|
The
conversion price
is a dollar amount
(initially, approximately $ )
determined by dividing $1,000 by the conversion rate.
|
S-7
|
|
|
|
|
The
conversion rate
is
initially shares
of our common stock, subject to adjustment as described under
Description of the Notes Conversion Rate
Adjustments.
|
|
Conversion Payment
|
|
Subject to certain exceptions, we will deliver to holders in
respect of each $1,000 principal amount of notes surrendered for
conversion a
settlement amount
equal to the
sum of the daily settlement amounts for each of the 20
consecutive trading days during the applicable cash settlement
averaging period.
|
|
|
|
The
daily settlement amount
, for each of the
20 consecutive trading days during a cash settlement averaging
period, shall consist of:
|
|
|
|
cash equal to $50 or, if less, the daily conversion
value; and
|
|
|
|
to the extent the daily conversion value exceeds
$50, a number of shares equal to (A) the difference between
the daily conversion value and $50, divided by (B) the
applicable stock price (as defined under Description of
the Notes Conversion Rights
General) of our common stock for such day.
|
|
|
|
The
daily conversion value
means, for each of
the 20 consecutive trading days during a cash settlement
averaging period, 1/20th of the product of (1) the
conversion rate and (2) the applicable stock price of our
common stock on such day.
|
|
|
|
The
cash settlement averaging period
with
respect to any note being converted means the 20 consecutive
trading-day
period beginning on and including the second trading day after a
conversion date (as defined under Description of the
Notes Conversion Rights Conversion
Procedures), except that with respect to any conversion
date that is on or after the 24th scheduled trading day
immediately preceding the maturity date, the cash settlement
averaging period means the 20 consecutive trading days beginning
on and including the 22nd scheduled trading day prior to the
maturity date.
|
|
|
|
You will not receive any additional cash payment, including any
accrued but unpaid interest, upon conversion of a note except in
circumstances described in Description of the
Notes Interest. Instead, interest will be
deemed paid by the shares of common stock delivered to you upon
conversion of a note.
|
|
Increase of Conversion Rate upon Certain Fundamental Changes
|
|
If a make-whole fundamental change (as defined under
Description of the Notes Conversion
Rights Increase of Conversion Rate Upon Conversion
Upon Make-Whole Fundamental Change) occurs, we may be
required in certain circumstances to increase the conversion
rate for any notes converted in connection with such fundamental
change. A description of how the conversion rate will be
increased and a table showing the increase in conversion rate
that would apply at various stock prices and effective dates of
the fundamental change are set forth under Description of
the Notes Conversion Rights Increase of
Conversion Rate Upon Conversion Upon Make-Whole Fundamental
Change.
|
|
Sinking Fund
|
|
None.
|
S-8
|
|
|
Repurchase of Notes upon a Fundamental Change
|
|
If we undergo a fundamental change (as defined under
Description of the Notes Fundamental Change
Permits Holders to Require Us to Purchase Notes), you will
have the option to require us to purchase all or any portion of
your notes for cash. The fundamental change purchase price will
be 100% of the principal amount of the notes to be purchased
plus any accrued and unpaid interest to, but excluding, the
fundamental change repurchase date.
|
|
Ranking
|
|
The notes will rank equally in right of payment with all our
existing and future unsecured senior debt and senior in right of
payment to any of our debt that is subordinated to the notes.
The indenture pursuant to which the notes are issued does not
limit the amount of debt that we or our subsidiaries may incur.
The notes will be effectively subordinated to any of our secured
indebtedness to the extent of the value of the assets securing
such indebtedness. The notes will also be structurally
subordinated to any existing and future indebtedness and other
liabilities and commitments (including trade payables and lease
obligations) of our subsidiaries.
|
|
Use of Proceeds
|
|
We intend to use the net proceeds from the offering for
expansion of our production capacity in connection with the 1 GW
plan and for general corporate purposes.
|
|
|
|
See Use of Proceeds.
|
|
Concurrent Offering
|
|
Concurrently with this offering, we are offering an aggregate of
4,708,500 shares of our common stock by means of a separate
prospectus supplement. 1,270,000 of the shares being offered by
that prospectus supplement are being underwritten by the
underwriters of this offering and are being offered to the
public at a price of $ per share.
We have also granted a
30-day
option to the underwriters of the underwritten equity offering
to purchase up to an additional 190,500 shares of our
common stock. The remaining shares of common stock being offered
by that prospectus supplement and accompanying prospectus are
shares that we will loan to an affiliate of Credit Suisse
Securities (USA) LLC, a managing underwriter in this offering,
pursuant to a share lending agreement among us, Credit Suisse
Securities (USA) LLC and such affiliate, and also are offered to
the public at a price of $ per
share. Under the share lending agreement, the affiliate of
Credit Suisse Securities (USA) LLC has agreed to use the
borrowed shares to facilitate transactions by which investors in
the notes offered hereby and, with our consent, other securities
that we may issue in the future, will hedge their respective
investments through short sales or privately negotiated
transactions, and such affiliate will be entitled to sell such
shares pursuant to our registration statement. Up
to of the borrowed shares may be
used to facilitate such transactions on a delayed basis at any
time prior to the termination of the agreement.
|
|
|
|
This affiliate of Credit Suisse Securities (USA) LLC will
receive all of the proceeds from the sale of the borrowed shares
pursuant to the share lending agreement and we will not receive
any of those proceeds, but we will receive a nominal lending fee
for the use of those shares from that affiliate. See
Description of the Share Lending Agreement.
|
S-9
|
|
|
|
|
Because the shares borrowed must be returned to us prior to
June 15, 2013, we believe that under U.S. GAAP the borrowed
shares will not be considered outstanding for the purpose of
computing and reporting our earnings per share.
|
|
|
|
For a discussion of the potential impact of any market or other
activity by the share borrower in connection with the share
lending agreement, see Risk Factors Risks
Relating to the Common Stock The effect of the
concurrent issuance of our shares of common stock, which
issuance is being made to facilitate sales of our common stock
in short sale transactions by purchasers of certain of our
securities, may be to lower the market price of our common
stock.
|
|
|
|
The delivery of shares of common stock being offered pursuant to
the share lending agreement is contingent on the closing of this
offering. We expect that delivery of the shares of our common
stock in the common stock offering will be made concurrently
with the closing of this offering.
|
|
Trustee and Paying Agent
|
|
The Bank of New York Trust Company, N.A.
|
|
Governing Law
|
|
The indenture and the notes provide that they will be governed
by, and construed in accordance with, the laws of the State of
New York.
|
|
Book-Entry Form
|
|
The notes will be issued in book-entry form and will be
represented by permanent global certificates deposited with, or
on behalf of, The Depository Trust Company, which we refer
to as DTC, and registered in the name of a nominee
of DTC. Beneficial interests in any of the notes will be shown
on, and transfers will be effected only through, records
maintained by DTC or its nominee and any such interest may not
be exchanged for certificated securities, except in limited
circumstances.
|
|
Absence of a Public Market for the Notes
|
|
The notes are new securities, and there is currently no
established market for the notes. The underwriters have advised
us that they currently intend to make a market in the notes.
However, they are not obligated to do so, and may discontinue
any market making with respect to the notes without notice. We
do not intend to apply for a listing of the notes on any
national securities exchange or any automated dealer quotation
system. Accordingly, we cannot assure you as to the development
or liquidity of any market for the notes.
|
|
Nasdaq Symbol for Our Common Stock
|
|
Our common stock is listed on the Nasdaq Global Select Market
under the symbol ENER.
|
|
Material U.S. Federal Income Tax Considerations
|
|
Holders are urged to consult their own tax advisors with respect
to the federal, state, local and foreign tax consequences of
purchasing, owning and disposing of the notes and the common
stock issuable upon conversion of the notes. See Material
U.S. Federal Income Tax Considerations.
|
|
Risk Factors
|
|
Investment in the notes involves risk. You should carefully
consider the information under the section titled Risk
Factors and all other information included in this
prospectus supplement, the accompanying prospectus and the
documents incorporated by reference before investing in the
notes.
|
S-10
Summary
Historical Consolidated Financial Data
The following summary consolidated financial information as of
and for the three years ended June 30, 2007, is derived
from our audited financial statements. The summary consolidated
financial information as of and for the nine months ended
March 31, 2008, and March 31, 2007 is derived from our
unaudited financial statements. Such financial information is
only a summary and should be read in conjunction with our
audited and unaudited financial statements, including the notes
thereto, and the Managements Discussion and Analysis
of Financial Condition and Results of Operations
incorporated by reference in this prospectus supplement. Figures
in the table below are in thousands, except share and per share
data.
Consolidated
Statements of Operations Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended March 31,
|
|
|
|
Year Ended June 30,
|
|
|
|
2008
|
|
|
2007
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
REVENUES
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Product sales
|
|
$
|
159,391
|
|
|
$
|
64,731
|
|
|
|
$
|
96,014
|
|
|
$
|
84,431
|
|
|
$
|
51,944
|
|
Revenues from product development agreements
|
|
|
8,490
|
|
|
|
8,750
|
|
|
|
|
11,934
|
|
|
|
10,046
|
|
|
|
17,653
|
|
Other revenues
|
|
|
5,592
|
|
|
|
4,078
|
|
|
|
|
5,619
|
|
|
|
7,942
|
|
|
|
86,973
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL REVENUES
|
|
|
173,473
|
|
|
|
77,559
|
|
|
|
|
113,567
|
|
|
|
102,419
|
|
|
|
156,570
|
|
EXPENSES
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of product sales
|
|
|
122,109
|
|
|
|
54,122
|
|
|
|
|
81,241
|
|
|
|
67,271
|
|
|
|
51,409
|
|
Cost of revenues from product development agreements
|
|
|
5,391
|
|
|
|
5,726
|
|
|
|
|
7,684
|
|
|
|
7,710
|
|
|
|
14,012
|
|
Product development and research
|
|
|
7,699
|
|
|
|
15,338
|
|
|
|
|
19,745
|
|
|
|
19,909
|
|
|
|
16,529
|
|
Operating, selling, general and administrative (net)
|
|
|
35,730
|
|
|
|
24,611
|
|
|
|
|
35,179
|
|
|
|
31,535
|
|
|
|
28,652
|
|
Restructuring charges
|
|
|
7,457
|
|
|
|
|
|
|
|
|
5,385
|
|
|
|
|
|
|
|
|
|
Other
|
|
|
6,925
|
|
|
|
3,961
|
|
|
|
|
6,835
|
|
|
|
3,215
|
|
|
|
2,585
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL EXPENSES
|
|
|
185,311
|
|
|
|
103,758
|
|
|
|
|
156,069
|
|
|
|
129,640
|
|
|
|
113,187
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
INCOME (LOSS) FROM OPERATIONS
|
|
|
(11,838
|
)
|
|
|
(26,199
|
)
|
|
|
|
(42,502
|
)
|
|
|
(27,221
|
)
|
|
|
43,383
|
|
Interest income (expense)
|
|
|
5,971
|
|
|
|
14,374
|
|
|
|
|
17,540
|
|
|
|
8,474
|
|
|
|
624
|
|
Other non-operating income (expense)
|
|
|
(57
|
)
|
|
|
(261
|
)
|
|
|
|
(269
|
)
|
|
|
(163
|
)
|
|
|
6,280
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NET INCOME (LOSS) BEFORE INCOME TAXES
|
|
|
(5,924
|
)
|
|
|
(12,086
|
)
|
|
|
|
(25,231
|
)
|
|
|
(18,910
|
)
|
|
|
50,287
|
|
Income taxes
|
|
|
95
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
825
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NET INCOME (LOSS) FROM CONTINUING OPERATIONS BEFORE
EXTRAORDINARY ITEM
|
|
$
|
(6,019
|
)
|
|
$
|
(12,086
|
)
|
|
|
$
|
(25,231
|
)
|
|
$
|
(18,910
|
)
|
|
$
|
49,462
|
|
Discontinued operations
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
314
|
|
|
|
(1,393
|
)
|
Extraordinary item
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,263
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NET INCOME (LOSS)
|
|
$
|
(6,019
|
)
|
|
$
|
(12,086
|
)
|
|
|
$
|
(25,231
|
)
|
|
$
|
(18,596
|
)
|
|
$
|
50,332
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic net income (loss) per share
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Continuing operations
|
|
$
|
(0.15
|
)
|
|
$
|
(0.31
|
)
|
|
|
$
|
(0.64
|
)
|
|
$
|
(0.58
|
)
|
|
$
|
1.80
|
|
Discontinued operations
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.01
|
|
|
|
(0.05
|
)
|
Extraordinary item
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.08
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
(0.15
|
)
|
|
$
|
(0.31
|
)
|
|
|
$
|
(0.64
|
)
|
|
$
|
(0.57
|
)
|
|
$
|
1.83
|
|
Diluted net income (loss) per share
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Continuing operations
|
|
$
|
(0.15
|
)
|
|
$
|
(0.31
|
)
|
|
|
$
|
(0.64
|
)
|
|
$
|
(0.58
|
)
|
|
$
|
1.67
|
|
Discontinued operations
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.01
|
|
|
|
(0.05
|
)
|
Extraordinary item
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.08
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
(0.15
|
)
|
|
$
|
(0.31
|
)
|
|
|
$
|
(0.64
|
)
|
|
$
|
(0.57
|
)
|
|
$
|
1.70
|
|
Weighted average shares
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
40,099,639
|
|
|
|
39,294,971
|
|
|
|
|
39,389,401
|
|
|
|
32,495,709
|
|
|
|
27,465,767
|
|
Diluted
|
|
|
40,099,639
|
|
|
|
39,294,971
|
|
|
|
|
39,389,401
|
|
|
|
32,495,709
|
|
|
|
29,661,847
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
OTHER FINANCIAL INFORMATION
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used in) operating activities
|
|
$
|
12,669
|
|
|
$
|
(1,332
|
)
|
|
|
$
|
(21,814
|
)
|
|
$
|
(21,419
|
)
|
|
$
|
(16,864
|
)
|
Capital expenditures
|
|
|
88,768
|
|
|
|
139,421
|
|
|
|
|
186,990
|
|
|
|
69,020
|
|
|
|
3,120
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
BALANCE SHEET INFORMATION
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash, cash equivalents and marketable
securities
(1)
|
|
$
|
95,653
|
|
|
$
|
271,922
|
|
|
|
$
|
205,774
|
|
|
$
|
404,467
|
|
|
$
|
96,136
|
|
Property, plant & equipment, net
|
|
|
271,549
|
|
|
|
139,204
|
|
|
|
|
136,984
|
|
|
|
70,343
|
|
|
|
58,879
|
|
Total assets
|
|
|
605,144
|
|
|
|
612,688
|
|
|
|
|
600,679
|
|
|
|
596,342
|
|
|
|
198,063
|
|
Capital leases
|
|
|
23,717
|
|
|
|
24,376
|
|
|
|
|
24,252
|
|
|
|
24,728
|
|
|
|
8,964
|
|
Total liabilities
|
|
|
78,665
|
|
|
|
77,262
|
|
|
|
|
75,172
|
|
|
|
59,321
|
|
|
|
42,343
|
|
Total stockholders equity
|
|
|
526,479
|
|
|
|
535,427
|
|
|
|
|
525,507
|
|
|
|
537,021
|
|
|
|
155,720
|
|
|
|
|
(1)
|
|
Excludes restricted
investments
|
S-11
Risk
Factors
Investing in the notes involves risks. In addition to the
risks of owning the notes, as a result of the conditional
conversion feature of the notes, a holder also will be exposed
to the risks of owning ECDs common stock, and the value of
notes may fluctuate with the value of our common stock. You
should consider carefully the risks described below and the
other information contained or incorporated by reference in this
prospectus supplement or the accompanying prospectus, before
making an investment decision. The risks and uncertainties
described below and in our other filings with the SEC
incorporated by reference herein are not the only ones facing
ECD. Additional risks and uncertainties not presently known to
us or that we currently consider immaterial may also adversely
affect us. If any of the following risks occur, our business,
financial condition or results of operations could be materially
harmed. In any such case, the value of the notes could decline
and you could lose part or all of your investment.
Risks
Relating to Us and Our Business
We
have a history of losses and our future profitability is
uncertain; the failure to achieve sustainable profitability
could have a material adverse effect on our business, results of
operations, financial condition and cash flows.
Since our inception, we have incurred significant net losses,
including a net loss of $25.2 million for the fiscal year
ended June 30, 2007. Principally as a result of ongoing
operating losses, we had an accumulated deficit of
$329.0 million as of June 30, 2007. And for the nine
months ended March 31, 2008, we incurred an additional net
loss of $6.0 million resulting in an accumulated deficit of
$335.0 million as of March 31, 2008. However, we
generated net income of $7.0 million for the quarter ended
March 31, 2008, and our goal is to operate our business in
such a way that such profitability is sustainable over the long
term. Nonetheless, we may be unable to sustain or increase our
profitability in the future, which in turn could materially and
adversely impact our ability to repay the notes and could
materially decrease the market value of our common stock (and as
a result, the value of our notes). We expect to continue to make
significant capital expenditures and anticipate that our
expenses will increase as we seek to:
|
|
|
|
|
expand our manufacturing operations, whether domestically or
internationally;
|
|
|
|
service our debt obligations;
|
|
|
|
develop our distribution network;
|
|
|
|
continue to research and develop our products and manufacturing
technologies;
|
|
|
|
implement internal systems and infrastructure to support our
growth; and
|
|
|
|
retain key members of management, retain other personnel and
hire additional personnel.
|
We do not know whether our revenue will grow at all or grow
rapidly enough to absorb these costs, and our limited operating
history under our current business strategy and new management
team makes it difficult to assess the extent of these expenses
or their impact on our operating results. If we fail to sustain
profitability, our business, results of operations, financial
condition and cash flows could be materially adversely affected.
We
rely on a relatively small number of customers for a significant
portion of our sales, and the loss of, or material reduction in,
sales to any of these customers could have a material adverse
effect on our business, results of operations, financial
condition and cash flows.
During the year ended June 30, 2007, and for the nine
months ended March 31, 2008, our top five customers
accounted for 40% and 49% of our total revenue, respectively,
and our top customer, Solar Integrated Technologies, accounted
for 8% and 21% of our total revenue, respectively, in such
periods. We expect that these customers will continue to
represent a significant portion of our total revenue in the
future. Any loss of or material reduction in sales to any of our
top customers, especially Solar Integrated Technologies, would
be difficult to recapture, and could have a material adverse
effect on our business, results of operations, financial
condition and cash flows.
S-12
We
sell a substantial portion of our products to customers who are
not subject to minimum purchase obligations, and as a result, we
face uncertainty as to future sales and inventory
levels.
Although we have entered into long-term supply agreements with
our customers, only a portion of these agreements contain
take or pay provisions that require the customer to
purchase a specified minimum amount of our products. The
remainder of these agreements generally do not include minimum
purchase requirements that obligate our customers to purchase
our products, but rather are completed in response to orders
issued by the customers when they require our PV products. We
are seeking to increase the percentage of our products that are
sold under take or pay agreements. For example, our top
customer, Solar Integrated Technologies, recently entered into a
take or pay agreement extending to the end of 2012. However,
there is no assurance that we will be successful or that take or
pay provisions in such agreements will be enforceable. If any of
our significant customers experiences a significant downturn in
its business, or fails to remain committed to our products, such
customer may reduce or discontinue purchases from us, especially
any customer who is not party to a take or pay agreement. If
such actions occur, our business, results of operations and
financial condition will likely be adversely affected.
We
face intense competition from other companies producing solar
energy and other renewable energy products; if we are unable to
compete successfully, our business, financial condition, results
of operations and prospects could be adversely
affected.
The solar energy market is intensely competitive and rapidly
evolving. The number of solar energy product manufacturers is
rapidly increasing due to the growth of actual and forecast
demand for solar energy products and the relatively low barriers
to entry. If we fail to attract and retain customers in our
target markets for our current and future core products, namely
solar laminates, we will be unable to increase our revenue and
market share. Some of our competitors have established more
prominent market positions, and if we fail to attract and retain
customers and establish successful distribution networks in our
target markets for our products, we will be unable to increase
our sales. Our competitors include Sharp Corporation, Q-Cells
AG, Kyocera Corporation, Sanyo Electric Co., Ltd., Sunpower
Corporation, Mitsubishi Electric Corporation and Suntech Power
Holdings Co., Ltd., all of which currently manufacture
predominantly crystalline or polycrystalline silicon solar
energy modules, and First Solar, Inc., which currently
manufactures thin film, cadmium telluride solar energy modules
on glass substrates.
We may also face competition from new entrants to the solar
energy market, including those that offer advanced technological
solutions or that have greater financial resources. A
significant number of our competitors are developing or
currently producing products based on advanced solar energy
technologies, including amorphous silicon, string ribbon and
nano technologies, which may eventually offer cost advantages
over the technologies currently used by us. A widespread
adoption of any of these technologies could result in a rapid
decline in our position in the solar energy market and our
revenue if we fail to adopt such technologies or develop
competitive technologies. Furthermore, the entire solar energy
industry also faces competition from conventional energy and
non-solar renewable energy providers.
Many of our existing and potential competitors have
substantially greater financial, technical, manufacturing and
other resources than we do. Our competitors greater size
in some cases provides them with a competitive advantage with
respect to manufacturing costs because of their economies of
scale and their ability to purchase raw materials at lower
prices. As a result, those competitors may have stronger
bargaining power with their suppliers and may have an advantage
over us in negotiating favorable pricing, as well as securing
supplies in times of shortages. Many of our competitors also
have greater brand name recognition, more established
distribution networks and larger customer bases. In addition,
many of our competitors have well-established relationships with
our current and potential customers and have extensive knowledge
of our target markets. As a result, they may be able to devote
more resources to the research, development, promotion and sale
of their products or respond more quickly to evolving industry
standards and changes in market conditions than we can. Our
failure to adapt to changing market conditions and to compete
successfully with existing or new competitors may materially and
adversely affect our financial condition and results of
operations.
S-13
If we
are unable to develop and market new and innovative products,
our business, financial condition and results of operations and
prospects could be adversely affected.
Our financial performance depends in part on our ability to
enhance our existing solar laminates, develop new and innovative
products and product applications, and adopt or develop new
technologies that continue to differentiate our products from
those of our competitors. The continued demand for our solar
laminates is premised in part on the features of our solar
laminates that distinguish them from the solar modules of our
competitors and the resulting unique product applications. These
features include physical flexibility, the ability of our
laminates to be integrated with roofing materials, low weight,
superior resistance to wind lift, durability, no roof
penetration and ease of installation. There are companies using
similar or competitive technologies that have introduced or
announced plans to introduce solar modules incorporating some or
all of these features. In addition, all solar modules compete
based on efficiency, and significant advances in the efficiency
of the solar modules of our competitors also could provide them
with a competitive advantage. If we fail to enhance our existing
solar laminates, develop new and innovative products and product
applications, or adopt or develop new technologies that continue
to differentiate our products from those of our competitors, our
business, financial condition and results of operations and
prospects could be adversely affected.
We
have focused our business strategy on, and invested significant
financial resources in, the BIPV segment of the PV market; if
demand for BIPV systems does not develop as we anticipate or
takes longer to develop than we anticipate, we may experience
difficulties in implementing our business
strategies.
Our current business strategy rests on increasing demand for
BIPV systems. We believe that there has been an increase in
demand for BIPV systems based in part on increasing interest and
customer support from the building industry, solar customers and
governments. As a result, we have invested, and will continue to
invest, significant financial resources in the production and
commercialization of our solar laminates for BIPV systems. If
the BIPV segment does not develop as we anticipate, or takes
longer to develop than we anticipate, we may experience
difficulties implementing our growth and business strategies.
This in turn, could adversely impact our business, financial
condition and results of operations and prospects.
Our
expansion plans require substantial capital expenditures,
significant engineering efforts, timely delivery of
manufacturing equipment and dedicated management attention, and
our failure to complete these plans could have a material
adverse effect on the growth of our sales and
earnings.
Our future success depends, to a large extent, on our ability to
expand our production capacity. If we are unable to do so, we
will not be able to attain the desired level of economies of
scale in our operations or cut the marginal production cost to
the level necessary to effectively maintain our pricing and
other competitive advantages. We expect that we will make
substantial capital expenditures for our future growth. This
expansion has required, and will continue to require,
substantial capital expenditures, significant engineering
efforts, timely delivery of manufacturing equipment and
dedicated management attention, and is subject to significant
risks and uncertainties, including:
|
|
|
|
|
We may experience cost overruns, construction delays, equipment
problems, including delays in manufacturing equipment deliveries
or deliveries of equipment that is damaged or does not meet our
specifications, and other operating difficulties;
|
|
|
|
We will be required to obtain governmental approvals, permits or
documents of similar nature with respect to any new expansion
projects, but it is uncertain whether such approvals, permits or
documents will be obtained in a timely manner or at all;
|
|
|
|
We may need to issue additional equity or debt securities in
order to finance the costs of developing the new facilities, the
timing and availability of which may be uncertain, and the terms
of which could be dilutive to our existing stockholders; and
|
|
|
|
We may not have sufficient management resources to properly
oversee capacity expansion as currently planned.
|
S-14
Any of these or similar difficulties could significantly delay
or otherwise constrain our ability to undertake our capacity
expansion plans as currently planned, which in turn would limit
our ability to increase sales, reduce marginal manufacturing
costs or otherwise improve our prospects and profitability.
We
rapidly are expanding our manufacturing capacity for solar
laminates in order to meet expected demand, and our revenue and
profits will depend upon our ability to successfully complete
this expansion and then to sell our solar laminates at higher
volumes to match our expanded capacity.
We plan to continue the expansion of our nameplate capacity from
the current 178 MW to an expected capacity exceeding
300 MW by 2010 and reaching 1 GW by 2012. This expansion
plan includes adding new facilities in Greenville, Michigan, and
Tijuana, Mexico and other locations to be determined. Our
facilities are comprised of solar laminate production systems
that we are designing, developing, manufacturing, installing and
testing the equipment for this expansion internally and through
third parties. We may experience delays, additional or
unexpected costs, technology limitations and other adverse
events in connection with our capacity expansion projects,
including those associated with the equipment we are providing.
For example, we source some of the equipment that we use in our
manufacturing process from single source suppliers.
Additionally, there can be no assurance that market demand will
align with our expanding manufacturing capacity or that our
marketing capabilities at the expanded manufacturing volumes
will be successful. As a result, we may not be able to realize
revenue and profits based upon the expected additional capacity,
or we may experience delays or reductions in these revenue and
profits, and our business could be materially adversely affected.
We
expect that we will need to obtain additional financing to
continue to operate our business, including significant capital
expenditures to increase our production capacity, and financing
may be unavailable or available only on disadvantageous
terms.
We have in the past experienced substantial losses and negative
cash flow from operations and have required financing in order
to pursue the commercialization of products based on our
technologies. We expect that we will continue to need financing
to operate our business, possibly including for capital
expenditures to expand our production capacity. There can be no
assurance that the proceeds from the sale of notes and the
concurrent equity offering will be sufficient to fund our
manufacturing capacity expansion in our United Solar Ovonic
segment from the current 178 MW to 300 MW by 2010 and
1 GW by 2012. If additional financing is required, there can be
no assurance that such additional financing will be available or
that the terms of such additional financing, if available, will
be acceptable to us. If adequate capital is not available or is
not available on acceptable terms, our ability to fund our
operations, further develop and expand our manufacturing
operations and distribution network, or otherwise respond to
competitive pressures would be significantly limited and our
ability to repay the notes could be materially and adversely
affected.
Demand
for our products may be adversely affected by the current
economic and credit environment, which could have an adverse
impact on our business, results of operations, financial
condition and cash flows.
The United States and international economies recently have
experienced (and continue to experience) a period of slow
economic growth. A near-term economic recovery is uncertain. In
particular, the current credit and housing crises, the increase
in U.S. sub-prime mortgage defaults, terrorist acts and
similar events, continued turmoil in the Middle East or war in
general could contribute to a slowdown of the market demand for
products that require significant initial capital expenditures,
including demand for solar modules and new residential and
commercial buildings. If the economic recovery slows down as a
result of the recent economic, political and social turmoil, or
if there are further terrorist attacks in the United States or
elsewhere, we may experience decreases in the demand for our
solar laminates, which may harm our operating results.
For example, we have benefited from historically low interest
rates that have made it more attractive for our customers to use
credit to purchase our products. Interest rates have fluctuated
recently and may eventually rise, which likely will increase the
cost of financing these purchases and may reduce our
customers profits and investors expected returns on
investment. Given the current credit environment, particularly
the tightening of the credit markets, there can be no assurance
that our customers will be able to borrow money on a timely
basis or on
S-15
reasonable terms, which could have a negative impact on their
demand for our products. Our sales are affected by interest rate
fluctuations and the availability of liquidity, and would be
adversely affected by increases in interest rates or liquidity
constraints. Rising interest rates may also make certain
alternative investments more attractive to investors, and
therefore lead to a decline in demand for our solar laminates,
which could have a material adverse effect on our business,
results of operations, financial condition and cash flows.
We are
vulnerable to risks associated with doing business in foreign
countries, the realization of which could have a material
adverse effect on our business, results of operations, financial
condition and cash flows.
We have a solar laminate manufacturing facility in Tijuana,
Mexico, and have established a joint venture in Tianjin, China,
to manufacture solar laminates. We expect that we will have to
expend significant management attention and financial resources
in order to successfully manage these and other international
operations. In addition, the marketing, distribution and sale of
our solar laminates outside the United States expose us to a
number of markets in which we have limited experience. These
operations subject us to a number of risks, including:
|
|
|
|
|
the potential that we may be forced to forfeit, voluntarily or
involuntarily, foreign assets due to economic or political
instability in the countries in which we choose to locate our
manufacturing facilities;
|
|
|
|
difficult and expensive compliance with the commercial and legal
requirements of international markets;
|
|
|
|
difficulty in interpreting and enforcing contracts governed by
foreign law, which may be subject to multiple, conflicting and
changing laws, regulations and tax systems;
|
|
|
|
inability to obtain, maintain or enforce intellectual property
rights;
|
|
|
|
encountering trade barriers such as export requirements,
tariffs, currency exchange controls, taxes and other
restrictions and expenses, which could affect the competitive
pricing of our solar laminates and reduce our market share in
some countries;
|
|
|
|
being subjected to additional withholding taxes or other tax on
our foreign income or tariffs and other restrictions on foreign
trade and investment, including currency exchange controls;
|
|
|
|
being subjected to fluctuations in exchange rates which may
affect product demand and may affect our profitability in
U.S. dollars to the extent the price of our solar laminates
and cost of raw materials, labor and equipment is denominated in
a foreign currency;
|
|
|
|
limitations on dividends or restrictions against repatriation of
earnings;
|
|
|
|
difficulty in recruiting and retaining individuals skilled in
international business operations; and
|
|
|
|
increased costs associated with maintaining international
marketing efforts.
|
The realization of any of these risks may require that we devote
significant management time and financial resources to resolve
such risks. Further, such risks and the efforts to address such
risks may impede our ability to operate our business and to
achieve our strategic goals, either of which could have a
material adverse effect on our business, results of operations,
financial condition and cash flows.
If we
are unable to obtain key raw materials that meet our quality,
quantity and cost requirements, our business, financial
condition, results of operations and prospects could be
adversely affected.
The key raw materials used in our business are stainless steel,
resin-based polymers, nickel and high purity industrial gases,
primarily argon, nitrogen, hydrogen, silane and germane. Most of
our key raw materials are readily available from numerous
sources, however we have, in certain instances, selected
single-source suppliers for certain key raw materials and
components for efficiency, cost and quality. Our supply chain
and operations could be adversely impacted by the failure of the
suppliers of the single-sourced materials to provide us with the
raw materials that meet our quality, quantity and cost
requirements. In addition, significant shortages or price
increases in raw materials that are not single-sourced may
adversely impact our business. For example, the operations of
many of our competitors that produce conventional solar energy
products have been adversely impacted by the
S-16
current shortage of polysilicon (a key raw material for
conventional solar energy products), which has caused prices for
those materials to rise and limited availability of materials
for manufacturing needs. Similarly, the cost of certain raw
materials, in particular stainless steel and resin-based polymer
materials, has risen over the last several years, which has
impacted and may continue to impact our operations. Any
constraint on our production may cause us to be unable to meet
our obligations under customer purchase orders, and any increase
in the price of raw materials could constrain our margins,
either of which would adversely impact on our financial results.
We actively manage our raw materials and other supply costs
through purchasing strategies and product design and operating
improvements, however our management may not always be
effective, which could adversely impact our supply chain and
financial condition. Some of our suppliers may be unable to
supply our increasing demand for raw materials and components as
we implement our planned increase in production capacity. In
such event, we may be unable to identify new suppliers or
qualify their products for use on our production lines in a
timely manner and on commercially reasonable terms. Raw
materials and components from new suppliers also may be less
suited for our technology and yield solar laminates with lower
conversion efficiencies, higher failure rates and higher rates
of degradation than solar laminates manufactured with the raw
materials from our current suppliers. Our failure to obtain raw
materials and components that meet our quality, quantity and
cost requirements in a timely manner could interrupt or impair
our ability to manufacture our solar laminates or increase our
manufacturing cost.
Significant
warranty and product liability claims could adversely affect our
business and results of operations.
We may be subject to warranty and product liability claims in
the event that our solar laminates fail to perform as expected
or if a failure of our solar laminates results, or is alleged to
result, in bodily injury, property damage or other damages.
Since our solar laminates are electricity producing devices, it
is possible that our products could result in injury, whether by
product malfunctions, defects, improper installation or other
causes. In addition, because the products we are developing
incorporate new technologies and use new installation methods,
we cannot predict whether or not product liability claims will
be brought against us in the future or the effect of any
resulting negative publicity on our business. Moreover, we may
not have adequate resources in the event of a successful claim
against us.
Our current standard product warranty for our solar laminates
includes a
20-year
warranty. We believe our warranty periods are competitive with
industry practice. Due to the long warranty period and our
proprietary technology, we bear the risk of extensive warranty
claims long after we have shipped product and recognized
revenue. Although we test our solar power products for
reliability and durability, we cannot ensure that we effectively
simulate
20-year
warranty period. Any increase in the defect rate of our products
would cause us to increase the amount of warranty reserves and
have a corresponding negative impact on our results.
A successful warranty or product liability claim against us that
is not covered by insurance or is in excess of our available
insurance limits could require us to make significant payments
of damages. In addition, quality issues can have various other
ramifications, including delays in the recognition of revenue,
loss of revenue, loss of future sales opportunities, increased
costs associated with repairing or replacing products, and a
negative impact on our goodwill and reputation. The possibility
of future product failures could cause us to incur substantial
expenses to repair or replace defective products. Furthermore,
widespread product failures may damage our market reputation and
reduce our market share and cause sales to decline.
If we
lose key personnel or are unable to attract and retain qualified
personnel to maintain and expand our business, our business,
financial condition, results of operations and prospects could
be adversely affected.
Our efforts to transform from a multi-faceted research and
development company to a solar power-focused commercial
enterprise is being led by our recently reorganized management
team, including Mark Morelli, Joseph Conroy, Mike Fetcenko,
Subhendu Guha, Jay Knoll, Sanjeev Kumar, Arthur Rogers,
Marcelino Susas, Tom Toner and Corby Whitaker. Our success is
highly dependent on the continued services of these individuals
and of a limited number of skilled managers, scientists and
technicians. The loss of any of these individuals could have a
material adverse effect on us. In addition, our success will
depend upon, among other factors, the recruitment and retention
S-17
of additional highly skilled and experienced management and
technical personnel. There can be no assurance that we will be
able to retain existing employees or to attract and retain
additional personnel on acceptable terms given the competition
for such personnel in industrial, academic and nonprofit
research sectors.
If
governments reduce or eliminate government incentives related to
solar power, our business, financial condition, results of
operations and prospects could be adversely
affected.
Today, the cost of solar power exceeds the cost of power
furnished by the electric utility grid in most locations. As a
result, federal, state and local government bodies in many
countries, most notably Germany, Japan, Italy, Spain, France,
Greece and the United States (at the national level and at the
state and local level), have provided incentives in the form of
rebates, tax credits and other incentives to end users,
distributors, system integrators and manufacturers of solar
power products to promote the use of solar energy to reduce
dependency on other forms of energy. These government economic
incentives could be reduced or eliminated. In particular,
political changes in a particular country could result in
significant reductions or eliminations of subsidies or economic
incentives. Also, electric utility companies or other energy
producers that have significant political lobbying powers may
seek changes in the relevant legislation in their markets (or in
the country as a whole) that may adversely affect the
development and commercial acceptance of solar energy. A
significant reduction in the scope or discontinuation of
government incentive programs, especially those in our target
markets, could cause demand for our products and our revenue to
decline, and have a material adverse effect on our business,
financial condition, results of operations and prospects.
Our
government product development and research contracts may result
in rights to inventions being assigned to the government, may be
terminated by unilateral government action, or we may be
unsuccessful in obtaining new government contracts to replace
those that have been terminated or completed.
We have several government product development and research
contracts. Any revenue or profits that may be derived by us from
these contracts will be substantially dependent upon the
government agencies willingness to continue to devote
their financial resources to our research and development
efforts. There can be no assurance that such financial resources
will be available or that such research and development efforts
will be successful. Our government contracts may be terminated
for the convenience of the government at any time, even if we
have fully performed our obligations under the contracts. Upon a
termination for convenience, we would generally only be entitled
to recover certain eligible costs and expenses we had incurred
prior to termination and would not be entitled to any other
payments or damages. Therefore, if government product
development and research contracts are terminated or completed
and we are unsuccessful in obtaining replacement government
contracts, our revenue and profits may decline and our business
may be adversely affected. In July 2007, we entered into a
three-year cooperative agreement with the Department of Energy
to increase the efficiency of our photovoltaic products, lower
material costs and reduce installation costs. The terms of this
agreement requires us to assign to the government inventions
conceived or reduced to practice during the course of the
agreement unless the government grants a waiver to such
requirement, in which case the government would retain, at a
minimum, a nonexclusive, paid-up license and so called
march-in rights to such inventions. We have applied
for, but have not yet received, a waiver of this requirement. If
the government does not grant a waiver, we would receive
nonexclusive, royalty-free license to such inventions.
Demand
for our products is affected by existing regulations concerning
the electrical utility industry; changes to such regulations may
present technical, regulatory and economic barriers to the
purchase and use of solar power products, which may
significantly reduce demand for our products.
The market for electricity generation products is influenced
heavily by foreign, federal, state and local government
regulations and policies concerning the electric utility
industry, as well as internal policies and regulations
promulgated by electric utilities. These regulations and
policies often relate to electricity pricing and technical
interconnection of customer-owned electricity generation. In the
United States (at both the national level and the state and
local level) and in a number of other countries, these
regulations and policies are being modified and may continue to
be modified.
S-18
Customer purchases of, or further investment in the research and
development of, alternative energy sources, including solar
power technology, could be deterred by these regulations and
policies, which could result in a significant reduction in the
potential demand for our solar laminates. For example, utility
companies commonly charge fees to larger, industrial customers
for disconnecting from the electric grid or for having the
capacity to use power from the electric grid for
back-up
purposes. These fees could increase the cost to our customers of
using our solar laminates and make them less desirable, thereby
harming our business, prospects, results of operations and
financial condition.
We anticipate that our solar laminates and their installation
will be subject to oversight and regulation in accordance with
national, state and local laws and ordinances relating to
building codes, safety, environmental protection, utility
interconnection and metering and related matters. There is also
a burden in having to track the requirements of individual
countries and states and design equipment to comply with the
varying standards. Any new government regulations or utility
policies pertaining to our solar laminates may result in
significant additional expenses to us and our resellers and
their customers and, as a result, could cause a significant
reduction in demand for our solar laminates.
The
expansion of our business into new markets, such as residential,
may increase our exposure to certain risks, including class
action claims.
We are developing new applications of our solar technology,
including solar laminates to be integrated into residential
roofing materials. Our new solar technology applications may not
gain market acceptance and we may not otherwise be successful in
entering new markets, including the market for residential
applications. Moreover, entry into new markets may increase our
exposure to certain risks that we currently face or expose us to
new risks. For example, the residential construction market for
solar energy systems is exposed to different risks than the
commercial construction markets, including more acute
seasonality, sensitivity to interest rates and other
macroeconomic conditions, as well as enhanced legal exposure. In
particular, new home developments can result in class action
litigation when one or more homes in a development experiences
problems with roofing or power systems. If we enter the
residential market and experience product failures that create
property damage or personal injury, we may be exposed to greater
liability of a different nature than with respect to product
failures in commercial building applications.
We
have entered into joint ventures and licensing agreements to
develop and commercialize products based on our technologies; if
we fail to manage such joint ventures and licensing agreements
successfully, such failure could have a material adverse effect
on our business, results of operations, financial condition and
cash flows.
We have entered into licensing and joint venture agreements in
order to develop and commercialize certain products based on our
technologies. Any revenue or profits that may be derived by us
from these agreements will be substantially dependent upon our
ability to agree with our joint venture partners and licensees
about the management and operation of the joint ventures and
license agreements. In addition, any revenue or profits from
such agreements will be substantially dependent on the
willingness and ability of our joint venture partners and
licensees to devote their financial resources and manufacturing
and marketing capabilities to commercialize products based on
our technologies. There can be no assurance that we will agree
regarding the operation of such joint ventures and licensing
agreements, that required financial resources will be available
on mutually agreeable terms, or that commercialization efforts
will be successful. If we and our joint venture partners and
licensees are unable to agree with respect to the operation of
our joint ventures and licensing agreements, are unwilling or
unable to devote financial resources or are unable to
commercialize products based on our technologies, we may not be
able to realize revenue and profits based on our technologies
and our business could be materially adversely affected.
If we
are unsuccessful in our efforts to license or manufacture and
commercially sell products based on our Ovonic Materials segment
technologies, our business, results of operations, financial
condition and cash flows will be adversely
affected.
Our Ovonic Materials segment invents, designs and develops
materials and products based on our pioneering materials science
technology, principally amorphous and disordered materials. The
commercialization of products
S-19
based on our technologies depends upon consumer acceptance and
the achievement and verification of the overall performance,
cost, reliability, efficiency and safety of the products. There
can be no assurance that our research and development efforts
will be successful or that we, our licensees or our joint
ventures will be able to develop commercial applications for our
products and technologies. Further, the areas in which we are
developing technologies and products are characterized by rapid
and significant technological change. Rapid technological
development may result in our products becoming obsolete or
noncompetitive. If future products based on our technologies
cannot be developed for manufacture and sold commercially or our
products become obsolete or noncompetitive, we may be unable to
recover our investments. Although our joint venture partners and
licensees may have experience in commercial-scale manufacturing,
we have little such experience, other than with respect to
producing our solar laminates, and there can be no assurance
that we or our joint ventures and licensees will expand or
establish capabilities for manufacturing products beyond those
presently in existence. In order to produce products on a
commercial scale, we and our joint ventures and licensees will
be required to establish or significantly increase manufacturing
capabilities currently being used to produce certain of our
products. In addition, the commercialization schedule may be
delayed if we, our licensees or our joint ventures experience
delays in meeting development goals, if products based on our
technologies exhibit technical defects, or if we, our licensees
or our joint ventures are unable to meet cost or performance
goals. In this event, potential purchasers of products based on
our technologies may choose alternative technologies and any
delays could allow potential competitors to gain market
advantages. Either of these events could adversely affect our
business, results of operations, financial condition and cash
flows.
We may
become subject to legal or regulatory proceedings that may reach
unfavorable resolutions.
We are involved in legal proceedings arising in the normal
course of business. Due to the inherent uncertainties of legal
proceedings, the outcome of any such proceeding could be
unfavorable, and we may choose to make payments or enter into
other arrangements to settle such proceedings. Failure to settle
such proceedings could require us to pay damages or other
expenses, which could have a material adverse effect on our
financial condition or results of operations. We have been
subject to legal proceedings in the past involving the validity
and enforceability of certain of our patents. While such
patent-related legal proceedings have been resolved, such
proceedings can require the expenditure of substantial
management time and financial resources and can adversely affect
our financial performance. There can be no assurance that we
will not be a party to other legal proceedings in the future.
Compliance
with environmental regulations can be expensive, and
noncompliance with these regulations may require us to pay
substantial fines, suspend production or cease
operations.
The operation of our manufacturing facilities entails the use
and handling of potentially harmful substances, including toxic
and combustible gases that pose inherent risks of environmental
damage or personal injury. Although we believe that we are in
material compliance with environmental laws, rules and
regulations, there can be no assurance that we will not incur
material costs and liabilities in the future because of an
accident or other event resulting in personal injury or
unauthorized release of such substances to the environment. We
may be liable, irrespective of fault, for material cleanup costs
or other liabilities incurred at these facilities in the event
of a release of hazardous substances into the environment by our
operations.
For example, our manufacturing process involves the controlled
storage and use of silane and germane, both of which are toxic
and combustible. Although we have rigorous safety procedures for
handling these materials, the risk of accidental injury from
such hazardous materials cannot be completely eliminated. If we
have an accident at one of our facilities involving a release of
these substances, we may be subject to civil
and/or
criminal penalties, including financial penalties and damages,
and possibly injunctions preventing us from continuing our
operations.
In addition, it is possible that increasingly strict
requirements imposed by environmental laws and enforcement
policies could require us to make significant capital
expenditures. To date such laws and regulations have not had a
significant impact on our operations, and we believe that we
have all necessary permits to conduct operations as they are
presently conducted. If more stringent laws and regulations are
adopted in the future, the costs of compliance with these new
laws and regulations could be substantial. The failure to comply
with present or future regulations could result in fines, third
party lawsuits, suspension of production or cessation of
operations.
S-20
Our
Cobasys affiliate faces uncertain prospects and is the subject
of a pending arbitration the outcome of which is uncertain but
may expose us to material liability if not settled or resolved
favorably.
Cobasys, our joint venture formed to commercialize our NiMH
battery technology, has generated losses since its formation.
Cobasys had losses of approximately $76.0 million and
obtained funding of approximately $84.0 million in 2007,
and in January 2008 Cobasys management forecast losses of
approximately $82.0-86.0 million and funding requirements
of approximately $92.0-94.0 million for 2008. The two
members of Cobasys our 91% owned subsidiary Ovonic
Battery Company (OBC) and CTV have not
approved a 2008 business plan and budget nor have been able to
agree on a solution to Cobasys business issues or whether
Cobasys should continue as a going concern if it cannot be sold
in the near future. Until September 2007, CTV historically
funded Cobasys loss-generating operations through the
purchase of preferred interests cumulating in excess of
$168.0 million. From October 2007 through January 2008, CTV
declined to purchase preferred interests and funded Cobasys in a
manner that in our view violated the December 2, 2004
agreement among us, OBC and CTV that governs Cobasys (the
Operating Agreement) and applicable Michigan law.
Since February 2008, Cobasys has received funding support from a
customer in the form of a loan for capital equipment purchases
and a price increase on products sold to the customer. There is
no assurance that this customer funding support will continue on
these or other terms, what the future funding requirements may
be or that the support, if provided, will otherwise be
sufficient to permit Cobasys to continue as a going concern.
On September 10, 2007, CTV issued a notice of dispute and
filed claims in arbitration against us and OBC relating to
Cobasys. CTVs original arbitration claim asserted damages
in the amount of $162.0 million and sought injunctive and
other relief and alleged that we and OBC breached and
anticipatorily repudiated obligations to provide certain funding
to Cobasys under the Operating Agreement. CTV subsequently filed
a supplemental notice of dispute amending its claims to assert
that we and OBC had dishonored CTVs preferred interest in
Cobasys and that OBC had breached its obligation to use diligent
efforts to approve a 2008 annual budget for Cobasys. At a
hearing on January
28-29,
2008,
CTV requested that the arbitrator declare that we and OBC be
obligated to fund our share of Cobasys necessary costs and
expenses through capital contributions favored by CTV but
opposed by OBC. We and OBC requested that the arbitrator declare
that under the Operating Agreement neither Cobasys member is
required to make any capital contribution absent a unanimously
approved annual budget and an agreement by the members that a
capital contribution must be made. Since the operating costs and
expenses of Cobasys are uncertain, we are unable to assess the
magnitude of our liability if CTVs request is granted,
however such liability could be material.
However, prior to any ruling by the arbitrator on these
competing claims, the parties suspended the arbitration pursuant
to an interim settlement agreement among us, OBC and CTV in
order to pursue the potential sale of Cobasys to a third party.
Sale negotiations have been ongoing during which the parties to
the arbitration have on nine occasions amended the interim
settlement agreement to extend the deadline for timely
consummation. There is no assurance that the sale will be
completed by June 30, 2008, the current deadline, and, if
not completed, that the parties will again extend the interim
settlement agreement. If the sale of Cobasys does not close by
that date and any of we, OBC or CTV determine not to further
extend our interim settlement agreement, we, OBC or CTV could
resume the arbitration and receive a ruling from the arbitrator.
We cannot assure you that a sale will be timely consummated or
consummated at all. If not timely consummated and the
arbitration is resumed, we cannot assure you that we and OBC
would prevail or otherwise avoid material liability.
If we
are unable to protect our intellectual property and our
proprietary technology including our trade secrets and other
confidential information, our operating results, financial
condition and future growth prospects may be adversely
impacted.
Our success depends in part on our ability to obtain and
maintain intellectual property protection for products based on
our technologies. Our policy is to seek to protect our products
and technologies by, among other methods, filing United States
and foreign patent applications related to our proprietary
technology, inventions and improvements. We maintain an
extensive patent portfolio presently consisting of over 300
U.S. patents and over 500 foreign counterparts (including
patents assigned to a custodial owner to support the Cobasys
business). The patent positions of companies like ours generally
are uncertain and involve complex legal and factual questions.
Our ability to maintain our proprietary position for our
technology will depend on our success in obtaining effective
patent claims
S-21
and enforcing those claims once granted. We do not know whether
any of our patent applications will result in the issuance of
any patents. Our issued patents and those that may issue in the
future may be challenged, invalidated, rendered unenforceable or
circumvented, which could limit our ability to stop competitors
from marketing related products or the length of term of patent
protection that we may have for our products and technologies.
In addition, the rights granted under any issued patents may not
provide us with competitive advantages against competitors with
similar products or technologies. Furthermore, our competitors
may independently develop similar technologies or duplicate
technology developed by us in a manner that does not infringe
our patents or other intellectual property. Because of the
extensive time required for development and commercialization of
products based on our technologies, it is possible that, before
these products can be commercialized, any related patents may
expire or remain in force for only a short period following
commercialization, thereby reducing any advantages of these
patents and making it unlikely that we will be able to recover
investments we have made to develop our technologies and
products based on our technologies.
In addition to patent protection, we also rely on protection of
trade secrets, know-how and confidential and proprietary
information. To maintain the confidentiality of trade secrets
and proprietary information, we have entered into
confidentiality agreements with our employees, agents and
consultants upon the commencement of their relationships with
us. These agreements require that all confidential information
developed by the individual or made known to the individual by
us during the course of the individuals relationship with
us be kept confidential and not disclosed to third parties. Our
agreements with employees also provide that inventions conceived
by the individual in the course of rendering services to us will
be our exclusive property. Individuals with whom we have these
agreements may not comply with their terms. In the event of the
unauthorized use or disclosure of our trade secrets or
proprietary information, these agreements, even if obtained, may
not provide meaningful protection for our trade secrets or other
confidential information. To the extent that our employees or
consultants use technology or know-how owned by others in their
work for us, disputes may arise as to the rights in related
inventions. Adequate remedies may not exist in the event of
unauthorized use or disclosure of our confidential information.
The disclosure of our trade secrets would impair our competitive
position and could have a material adverse effect on our
operating results, financial condition and future growth
prospects.
We may
be involved in lawsuits to protect or enforce our patents, which
could be expensive and time consuming.
Competitors may infringe our patents. To counter infringement or
unauthorized use, we may be required to file patent infringement
claims, which can be expensive and time-consuming. In addition,
in an infringement proceeding, a court may decide that a patent
of ours is not valid or is unenforceable, or may refuse to stop
the other party from using the technology at issue on the
grounds that our patents do not cover its technology. An adverse
determination of any litigation or defense proceedings could put
one or more of our patents at risk of being invalidated or
interpreted narrowly and could put our patent applications at
risk of not issuing.
Interference proceedings brought by the United States Patent and
Trademark Office may be necessary to determine the priority of
inventions with respect to our patent applications. Litigation
or interference proceedings may fail and, even if successful,
may result in substantial costs and be a distraction to our
management. We may not be able to prevent misappropriation of
our proprietary rights, particularly in countries where the laws
may not protect such rights as fully as in the United States.
Furthermore, because of the substantial amount of discovery
required in connection with intellectual property litigation,
there is a risk that some of our confidential information could
be compromised by disclosure. In addition, during the course of
this litigation, there could be public announcements of the
results of hearings, motions or other interim proceedings or
developments. If securities analysts or investors perceive these
results to be negative, it could have a substantial adverse
effect on the price of our common stock and as a result, on the
value of our notes. We may not prevail in any litigation or
interference proceeding in which we are involved. Even if we do
prevail, these proceedings can be expensive and distract our
management.
S-22
Third
parties may own or control patents or patent applications that
are infringed by our products or technologies.
Our success depends in part on avoiding the infringement of
other parties patents and proprietary rights. In the
United States and most other countries, patent applications are
published 18 months after filing. As a result, there may be
patents of which we are unaware, and avoiding patent
infringement may be difficult. We also may infringe third-party
patents or patent applications inadvertently.
If a patent infringement suit were brought against us, we and
our joint venture partners and licensees could be forced to stop
or delay research, development, manufacturing or sales of
products based on our technologies in the country or countries
covered by the patent we are alleged to infringe, unless we can
obtain a license from the patent holder or spend time and money
to design around or avoid the intellectual property. We also may
be required to pay substantial damages to the patent holder in
the event of an infringement. Under some circumstances in the
United States, these damages could be triple the actual
damages the patent holder incurs. If we have supplied infringing
products to third parties for marketing or licensed third
parties to manufacture, use or market infringing products, we
may be obligated to indemnify these third parties for any
damages they may be required to pay to the patent holder and for
any losses the third parties may sustain themselves as the
result of lost sales or damages paid to the patent holder. A
license from the alleged patent holder may not be available on
acceptable terms, or at all, particularly if the third party is
developing or marketing a product competitive with products
based on our technologies. Even if we were able to obtain a
license, the rights may be nonexclusive, which would give our
competitors access to the same intellectual property.
Any successful infringement action brought against us may also
adversely affect marketing of products based on our technologies
in other markets not covered by the infringement action.
Furthermore, we may suffer adverse consequences from a
successful infringement action against us even if the action is
subsequently reversed on appeal, nullified through another
action or resolved by settlement with the patent holder. The
damages or other remedies awarded, if any, may be significant.
As a result, any infringement action against us would likely
harm our competitive position, be costly and require significant
time and attention of our key management and technical
personnel. In addition, such an occurrence could have a
substantial adverse effect on the price of our common stock and
as a result, on the value of our notes.
The
credit facility entered into by our subsidiaries, United Solar
Ovonic Corporation and United Solar Ovonic LLC, contains
covenant restrictions that may limit our ability to operate our
business.
We conduct substantially all of our United Solar Ovonic segment
operations through our subsidiaries United Solar Ovonic
Corporation and United Solar Ovonic LLC. For example, our cash
flows from that segment are dependent on the distributions to us
by United Solar Ovonic Corporation and United Solar Ovonic LLC.
In February 2008, United Solar Ovonic Corporation and United
Solar Ovonic LLC entered into a secured credit facility with an
aggregate commitment of up to $55.0 million, of which we
are a guarantor. The credit facility contains, and any other
future debt agreements may contain, covenant restrictions that
may effectively limit our ability to operate our business, due
to restrictions on our or our subsidiaries ability to,
among other things:
|
|
|
|
|
incur additional debt or issue guarantees;
|
|
|
|
create liens;
|
|
|
|
make certain investments;
|
|
|
|
enter into transactions with our affiliates;
|
|
|
|
sell certain assets;
|
|
|
|
make certain restricted payments;
|
|
|
|
declare or pay dividends or make other distributions to
stockholders; and
|
|
|
|
merge or consolidate with any person.
|
S-23
As a result of these covenants, our ability to respond to
changes in business and economic conditions and to obtain
additional financing, if needed, may be significantly
restricted, and we may be prevented from engaging in
transactions that might otherwise be beneficial to us due to the
restrictions imposed by the credit facility. In addition, the
failure to comply with these covenants could result in a
default, which could permit the lenders and debtholders to
accelerate such debt.
As a
result of this offering, we will have a significant amount of
debt outstanding. Our indebtedness, along with our other
contractual commitments, could adversely affect our business,
financial condition and results of operations, as well as our
ability to meet any of our payment obligations under the notes
and our other debt.
Together with our subsidiaries, we currently have, and, as a
result of this offering will continue to have, a significant
amount of debt and debt service requirements. As of
March 31, 2008, after giving effect to this offering, we
would have had approximately $225.0 million of outstanding
debt for borrowed money, or approximately $258.8 million if
the underwriters option to purchase additional notes is
exercised in full.
This level of debt and related debt service could have
significant consequences on our future operations, including:
|
|
|
|
|
making it more difficult for us to meet our payment and other
obligations under the notes and our other outstanding debt;
|
|
|
|
resulting in an event of default if we and our subsidiaries fail
to comply with covenants contained in our debt agreements, which
could result in such debt becoming immediately due and payable;
|
|
|
|
reducing the availability of our cash flow to fund working
capital, capital expenditures, acquisitions and other general
corporate purposes, and limiting our ability to obtain
additional financing for these purposes;
|
|
|
|
subjecting us to the risk of increased sensitivity to interest
rate increases on our indebtedness with variable interest rates,
including borrowings under our new credit facility;
|
|
|
|
limiting our flexibility in planning for, or reacting to, and
increasing our vulnerability to, changes in our business, the
industry in which we operate and the general economy; and
|
|
|
|
placing us at a competitive disadvantage compared to our
competitors that have less debt or are less leveraged.
|
Any of the above-listed factors could have an adverse effect on
our business, financial condition and results of operations and
our ability to meet our payment obligations under the notes and
our other debt.
Our ability to meet our payment and other obligations under our
debt instruments depends on our ability to generate significant
cash flow in the future. This, to some extent, is subject to
general economic, financial, competitive, legislative and
regulatory factors as well as other factors that are beyond our
control. We cannot assure you that our business will generate
cash flow from operations, or that future borrowings will be
available to us under existing or any future credit facilities
or otherwise, in an amount sufficient to enable us to meet our
payment obligations under the notes and our other debt and to
fund other liquidity needs. If we are not able to generate
sufficient cash flow to service our debt obligations, we may
need to refinance or restructure our debt, including the notes,
sell assets, reduce or delay capital investments, or seek to
raise additional capital. If we are unable to implement one or
more of these alternatives, we may not be able to meet our
payment obligations under the notes and our other debt and other
obligations.
Risks
Relating to the Notes
The
notes will be effectively subordinated to any of our existing
and future secured indebtedness and structurally subordinated to
existing and future liabilities and other indebtedness of our
subsidiaries.
The notes will be our general, unsecured obligations and will
rank equally in right of payment with all of our existing and
future unsubordinated and unsecured indebtedness and will be
structurally subordinated to any indebtedness under the
$55.0 million senior secured credit facility entered into
by our subsidiaries, United Solar
S-24
Ovonic Corporation and United Solar Ovonic LLC, which we have
guaranteed. As a result, the notes are effectively subordinated
to any secured indebtedness we may have to the extent of the
value of the assets securing such indebtedness, and structurally
subordinated to any existing and future liabilities and other
indebtedness of our subsidiaries (including any indebtedness
that United Solar Ovonic Corporation and United Solar Ovonic
LLCs may incur under their $55.0 million senior
secured credit facility). These liabilities may include
indebtedness, trade payables, guarantees, lease obligations and
letter of credit obligations. Any right of ours to receive
assets of any of our subsidiaries upon their liquidation or
reorganization and the consequent right of the holders of the
notes to participate in those assets will generally be subject
to the claims of that subsidiarys creditors, including
trade creditors. At March 31, 2008, on an as-adjusted basis
to give effect to the use of proceeds from this offering as
described in Use of Proceeds, we would not have had
any indebtedness ranking equally in right of payment with the
notes, and our subsidiaries would not have had any outstanding
indebtedness.
The
notes will not contain restrictive covenants and as a result, we
are not restricted from taking actions that may adversely affect
you.
The indenture under which the notes will be issued will not
contain restrictive covenants that would protect you from many
kinds of transactions that may adversely affect you. In
particular, the indenture will not contain covenants that will
limit our ability (or the ability of our subsidiaries) to pay
dividends or make distributions on or redeem our capital stock
or limit our ability to incur additional indebtedness and,
therefore, may not protect you in the event of a highly
leveraged transaction or other similar transaction. Further, the
notes do not require us to achieve or maintain any minimum
financial results relating to our financial condition or results
of operations. Our ability to recapitalize, incur additional
debt and take a number of other actions not limited by the terms
of the notes could have the effect of diminishing our ability to
make payments on the notes when due.
The requirement that we offer to repurchase the notes upon a
change of control is limited to the transactions specified in
the definition of fundamental change under
Description of the Notes Fundamental Change
Permits Holders to Require Us to Purchase Notes.
Similarly, the circumstances under which we are required to
adjust the conversion rate upon the occurrence of a
fundamental change are limited to the circumstances
specified under Increase of Conversion Rate Upon
Conversion Upon Make-Whole Fundamental Change.
In the
event of a default, we may have insufficient funds to make any
payments due on the notes.
A default under the indenture and the supplemental indenture
thereto pursuant to which the notes are issued could lead to a
default under existing and future agreements governing our
indebtedness. If, due to a default, the repayment of related
indebtedness were to be accelerated after any applicable notice
or grace periods, we may not have sufficient funds to repay such
indebtedness and the notes. More generally, in the event of a
default under the indenture and the supplemental indenture we
may have insufficient funds to make any payments due on the
notes.
We may
not be able to pay interest on the notes, or convert the notes,
or repurchase the notes at the option of the holder upon a
fundamental change.
The notes bear interest at a rate of % per year. In
addition, holders of notes have the right to require us to
repurchase all or a portion of their notes for cash upon the
occurrence of a fundamental change. Also, upon conversion of the
notes, we will be required to make a cash payment of up to
$1,000 for each $1,000 in principal amount of notes converted.
We may not have sufficient funds to pay interest to the note
holders or to make the required cash repurchase of the notes, or
make the cash payment, if any, required upon conversion at the
applicable time and, in such circumstances, may not be able to
arrange the necessary financing on favorable terms, if at all.
In addition, our ability to make the required repurchase or
payment upon a fundamental change or following conversion events
may be limited by law or the terms of other debt agreements or
securities. Our failure to pay interest on the notes or to make
the required cash repurchase or cash payment, as the case may
be, would constitute an event of default under the indenture
governing the notes which, in turn, could constitute an event of
default under other debt agreements or securities, thereby
resulting in their acceleration and required prepayment and
thereby further restricting our ability to make such interest
payments and repurchases. Any inability on our part to pay for
your notes that are tendered for repurchase or conversion could
result in your receiving substantially less than the principal
amount of the notes. See Description of the
Notes Interest, Description of the
Notes Conversion
S-25
Rights Payment Upon Conversion, and
Description of the Notes Fundamental Change
Permits Holders to Require Us to Purchase Notes.
Some
significant restructuring transactions may not constitute a
fundamental change, in which case we would not be obligated to
offer to repurchase the notes.
Upon the occurrence of a fundamental change, you will have the
right to require us to repurchase the notes. However, the
fundamental change provisions will not afford protection to
holders of the notes in the event of certain transactions. For
example, transactions such as leveraged recapitalizations,
refinancings, restructurings or acquisitions initiated by us, as
well as stock acquisitions by certain companies, would not
constitute a fundamental change requiring us to repurchase the
notes. In the event of any such transaction, the holders of
notes would not have the right to require us to repurchase the
notes, even though each of these transactions could increase the
amount of our indebtedness, or otherwise adversely affect our
capital structure or any credit ratings, thereby adversely
affecting the holders of the notes or our ability to meet our
payment obligations under the notes.
Provisions
of the notes could discourage an acquisition of us by a third
party.
Certain provisions of the notes could make it more difficult or
more expensive for a third party to acquire us. Upon the
occurrence of certain transactions constituting a fundamental
change, holders of the notes will have the right, at their
option, to require us to repurchase, at a cash repurchase price
equal to 100% of the principal amount plus accrued and unpaid
interest on the notes, all of their notes or any portion of the
principal amount of such notes in integral multiples of $1,000.
We may also be required to issue additional shares of our common
stock upon conversion of such notes in the event of certain
fundamental changes. See Description of the
Notes Increase of Conversion Rate Upon Conversion
Upon Make-Whole Fundamental Change.
The
adjustment to the conversion rate for notes converted in
connection with certain corporate transactions may not
compensate you adequately for any lost value of your notes as a
result of such transaction.
If a make-whole fundamental change as described
under Description of the Notes Increase of
Conversion Rate Upon Conversion Upon Make-Whole Fundamental
Change occurs, under certain circumstances we will
increase the conversion rate for notes converted in connection
with such specified corporate transaction. The increase in the
conversion rate will be determined based on the effective date
of such corporate transaction and the price paid per share for
our common stock in, or, under certain circumstances, the
average price of our common stock over a ten
trading-day
period immediately preceding the effective date of, such
corporate transaction, as described below under
Description of the Notes Increase of
Conversion Rate Upon Conversion Upon Make-Whole Fundamental
Change. Although the adjustment to the conversion rate is
designed to compensate you for the lost value of your notes as a
result of certain types of corporate transactions, the
adjustment is only an approximation of such lost value based
upon assumptions made on the date of this prospectus supplement
and may not adequately compensate you for such loss. In
addition, if the price paid per share for our common stock in,
or the average price of our common stock over a ten
trading-day
period immediately preceding the effective date of, such
corporate transaction is greater
than per share, or less
than per share, no adjustment will
be made to the conversion rate.
In addition to the foregoing, our obligation to increase the
conversion rate in connection with any such specified corporate
transaction could be considered a penalty, in which case the
enforceability thereof would be subject to general principles of
law and equity.
There
currently is no public market for the notes, and an active
trading market may not develop for the notes. The failure of a
market to develop for the notes could adversely affect the
liquidity and value of your notes.
The notes are a new issue of securities, and there is no
existing market for the notes. We do not intend to apply for
listing of the notes on any securities exchange or for quotation
of the notes on any automated dealer quotation system. Although
we have been advised by the underwriters that the underwriters
intend to make a market in the
S-26
notes, none of the underwriters is obligated to do so and may
discontinue market making at any time without notice. No
assurance can be given as to the liquidity of the trading
market, if any, for the notes.
A market may not develop for the notes, and there can be no
assurance as to the liquidity of any market that may develop for
the notes. If an active, liquid market does not develop for the
notes, the market price and liquidity of the notes may be
adversely affected. If any of the notes are traded after their
initial issuance, they may trade at a discount from their
initial offering price. Further, we may be forced to permit the
conversion of notes surrendered for conversion prior to maturity
during the five
business-day
period following any ten consecutive
trading-day
period (after a qualifying request for determination) in which
the trading price per $1,000 principal amount of notes, as
determined by the trustee, was less than 97% of the product of
the last reported sale price of our common stock for such
trading day and the conversion rate.
The liquidity of the trading market, if any, and future trading
prices of the notes will depend on many factors, including,
among other things, the market price of our common stock,
prevailing interest rates, our operating results, financial
performance and prospects, the market for similar securities and
the overall securities market, and may be adversely affected by
unfavorable changes in these factors or by unforeseeable changes
in the solar industry more generally. Historically, the market
for convertible debt has been subject to disruptions that have
caused volatility in prices. It is possible that the market for
the notes will be subject to disruptions which may have a
negative effect on the holders of the notes, regardless of our
operating results, financial performance or prospects.
Our
holding company structure creates a dependence on the earnings
of our subsidiaries and may impair our ability to repay the
notes.
The notes are our exclusive obligation and are not guaranteed by
any of our subsidiaries. We are a holding company whose assets
consist of direct and indirect ownership interests in, and whose
business is conducted substantially through, its subsidiaries.
Consequently, our ability to repay our debt, including the
notes, depends on the earnings of our subsidiaries, as well as
our ability to receive funds from such subsidiaries through
dividends, repayment of intercompany notes or other payments.
The ability of our subsidiaries to pay dividends, repay
intercompany notes or make other advances to us is subject to
restrictions imposed by applicable laws, tax considerations and
the terms of agreements governing our subsidiaries (including
the $55.0 million senior secured credit facility entered
into by United Solar Ovonic Corporation and United Solar Ovonic
LLC).
Your
right to convert the notes is conditional, which could impair
the value of the notes.
At certain times, the notes are convertible into cash and, if
applicable, shares of our common stock only if specified
conditions are met. If these conditions are not met, you will
not be able to convert your notes at that time, and, upon a
later conversion, you may not be able to receive the value of
the common stock into which the notes would otherwise have been
convertible had such conditions been met.
Settlement
of all conversions may be delayed and, as a result, you may
receive less consideration than expected for your
notes.
Upon conversion of the notes, settlement may be delayed until
after the 24th trading day following the relevant
conversion date. See Description of the Notes
Conversion Rights General. As a result, upon
conversion of the notes, the value of the consideration you
receive may be less than expected because the value of our
common stock may decline (or not appreciate as much as you may
expect) between the day that you exercise your conversion right
and the day our conversion obligation in respect of your notes
is finally determined. In addition, upon conversion, you may
receive shares of our common stock with a value less than the
principal amount of notes being converted because the value of
our common stock may decline (or not appreciate as much as you
expect) between the day that you exercise your conversion right
and the day our conversion obligation in respect of your notes
is finally determined.
S-27
The
conversion rate of the notes may not be adjusted for all
dilutive events that may adversely affect the trading price of
the notes or the common stock issuable upon conversion of the
notes.
The conversion rate of the notes is subject to adjustment upon
certain events, including the issuance of stock dividends on our
common stock, the issuance of rights or warrants, subdivisions,
combinations, distributions of capital stock, indebtedness or
assets, cash dividends and issuer tender or exchange offers as
described under Description of the Notes
Conversion Rate Adjustments. The conversion rate of the
notes will not be adjusted for certain other events, including,
for example, upon the issuance of additional shares of stock for
cash, any of which may adversely affect the trading price of the
notes or the common stock issuable upon conversion of the notes.
Even if the conversion price is adjusted for a dilutive event,
such as a leveraged recapitalization, it may not fully
compensate you for your economic loss.
Future
sales of our common stock in the public market or the issuance
of other equity may adversely affect the market price of the
notes, our common stock, or both, and our ability to raise funds
in new equity or equity-related offerings.
Except as described under Underwriting, we are not
restricted from issuing additional shares of our common stock,
or securities convertible into or exchangeable for our common
stock, during the life of the notes and have no obligation to
consider your interests for any reason. Sales of a substantial
number of shares of our common stock or other equity-related
securities in the public market could depress the market price
of the notes, our common stock, or both, and impair our ability
to raise capital through the sale of additional equity
securities. We cannot predict the effect that future sales of
our common stock or other equity-related securities could have
on the market price of our common stock or the value of the
notes. The price of our common stock could be affected by
possible sales of our common stock by investors who view the
notes as a more attractive means of equity participation in our
company and by hedging or arbitrage trading activity that we
expect to develop involving our common stock. The hedging or
arbitrage could, in turn, affect the market price of the notes.
Conversion
of the notes or future sales or issuances of common stock may
dilute the ownership interest of existing stockholders,
including holders who have previously converted their notes.
Such dilution may adversely affect the trading price of our
common stock and the notes.
We may issue equity securities in the future for a number of
reasons, including to finance our operations and business
strategy, to acquire assets or companies, to adjust our ratio of
debt to equity, or for other reasons. Any issuance of equity
securities after this offering, including the issuance of
shares, if any, upon conversion of the notes, could dilute the
interests of our existing stockholders, including holders who
have previously received shares upon conversion of their notes,
and could substantially affect the trading price of our common
stock and the notes. In addition, the anticipated conversion of
the notes into shares of our common stock could depress the
price of our common stock.
The
notes may not be rated or may receive a lower rating than
anticipated.
We do not intend to seek a rating on the notes. However, if one
or more rating agencies rates the notes (or any future debt of
ours) and assigns the notes (or future debt) a rating lower than
the rating expected by investors, or reduces its rating in the
future, the market price of the notes and our common stock could
be reduced.
Our
management has broad discretion over the use of proceeds from
this offering.
Our management has significant flexibility in applying the
proceeds that we receive from this offering. Although we have
indicated our intent to use the proceeds from this offering to
expand our manufacturing capacity and for other general
corporate purposes, our board retains significant discretion
with respect to the use of proceeds. In addition, the proceeds
of this offering may be used in a manner which does not generate
a favorable return for us.
You
may have to pay taxes with respect to distributions on our
common stock that you do not receive.
The conversion rate of the notes will be adjusted in certain
circumstances. Adjustments (or failures to make adjustments)
that have the effect of increasing your proportionate interest
in our assets or earnings may in some
S-28
circumstances result in a deemed distribution to you,
notwithstanding the fact that you do not receive such
distribution. In addition,
Non-U.S. Holders
(as defined in Material U.S. Federal Income Tax
Considerations) of the notes may, in these circumstances,
be deemed to have received a distribution subject to United
States federal withholding tax requirements, which we may
satisfy by withholding from cash payments of interest or from
cash or shares of our common stock deliverable to a holder upon
a conversion or repurchase of a note. The adjustment to the
conversion rate of notes converted in connection with certain
changes of control, as described under Description of the
Notes Increase of Conversion Rate Upon Conversion
Upon Make-Whole Fundamental Change, also may be treated as
a taxable distribution.
Risks
Relating to the Common Stock
The
price of our common stock, and therefore of the notes, may
fluctuate significantly, and a liquid trading market for our
common stock may not be sustained. Such volatility may prompt
costly securities class action litigation.
The trading price of our common stock could be subject to wide
fluctuations due to the factors discussed in this risk factors
section and in the risk factors incorporated by reference. In
addition, the stock market in general, and the Nasdaq Global
Select Market and the securities of technology companies in
particular, have experienced extreme price and volume
fluctuations. These trading prices and valuations, including our
own market valuation and those of companies in our industry
generally, may not be sustainable. These broad market and
industry factors may decrease the market price of our common
stock, regardless of our actual operating performance. Moreover,
because the notes are convertible into our common stock,
volatility or depressed prices of our common stock could have a
similar effect on the trading price of the notes. In addition,
in the past, following periods of volatility in the overall
market and the market price of a companys securities,
securities class action litigation has often been instituted
against such company. This litigation, if instituted against us,
could result in substantial costs and a diversion of our
managements attention and resources.
If you
hold notes, you will not be entitled to any rights with respect
to our common stock, but the common stock underlying the notes
you own will be subject to all changes made with respect to our
common stock.
If you hold notes, you will not be entitled to any rights with
respect to our common stock (including, without limitation,
voting rights and rights to receive any dividends or other
distributions on our common stock), but the stock underlying the
notes will be subject to all changes affecting our common stock.
You will have rights with respect to our common stock only if
you convert your notes, which you are permitted to do only in
limited circumstances described herein. For example, in the
event that an amendment is proposed to our amended and restated
certificate of incorporation or bylaws requiring stockholder
approval and the record date for determining the stockholders of
record entitled to vote on the amendment occurs prior to
delivery of our common stock to you, you will not be entitled to
vote on the amendment, although the stock underlying the notes
will nevertheless be subject to any changes in the powers,
preferences or rights of our common stock.
The
effect of the concurrent issuance of our shares of common stock,
which issuance is being made to facilitate sales of our common
stock in short sale transactions by purchasers of certain of our
securities, may be to lower the market price of our common
stock.
Concurrently with this offering of notes, we are offering
4,708,500 shares of our common stock in a separate
registered offering, 3,438,500 of which are being borrowed by an
affiliate of Credit Suisse Securities (USA) LLC, a managing
underwriter in this offering, under a share lending agreement we
have entered into with such affiliate and Credit Suisse
Securities (USA) LLC, and 1,270,000 of which are being
underwritten by the underwriters of this offering, and all of
which are being offered to the public at a price of
$
per share.
The increase in the number of outstanding shares of our common
stock could have a negative effect on the market price of our
common stock. In addition, because the borrower has agreed to
use such sales to facilitate the establishment by the note
investors and, with our consent, other securities that we may
issue in the future, of hedged
S-29
positions through short sales or privately negotiated
derivatives transactions, the market price of our common stock
could be further negatively affected by these or other short
sales of our common stock.
In addition to the foregoing, the borrowed shares may not be
available to facilitate hedging transactions in some
circumstances, including if the borrower returns our shares to
us before the expiration of our share lending agreement or if a
registration statement is unavailable prior to such time as the
borrower has completed the initial sale of such shares. Any
unavailability of borrowed shares to facilitate hedging
transactions may make it more difficult for buyers of the notes
to hedge their investment and consequently could adversely
impact the price of the notes.
If
securities or industry analysts do not publish research or
reports about us, our business or our market, or if they change
their recommendations regarding our stock, our business or our
market adversely, our stock price and trading volume could
decline.
The trading market for our common stock is influenced by the
research and reports that industry or securities analysts
publish about us, our business and our market. If one or more of
the analysts who cover us change their recommendation regarding
our stock adversely, our stock price would likely decline. If
one or more of these analysts ceases coverage of our company or
fails to regularly publish reports on us, we could lose
visibility in the financial markets, which in turn could cause
our stock price or trading volume to decline.
Changes
in the accounting treatment of certain of our existing
securities and/or the securities we are offering by this
prospectus supplement and the accompanying prospectus could
decrease our earnings per share and potentially our stock
price.
There may be, in the future, potentially new or different
accounting pronouncements or regulatory rulings, which could
impact the way we are required to account for certain of our
existing securities
and/or
the
securities we are offering by this prospectus supplement and the
accompanying prospectus, and which may have an adverse impact on
our future financial condition and results of operations. With
respect to the notes we are offering, we are required under
U.S. GAAP as presently in effect to include in outstanding
shares for purposes of computing earnings per share only a
number of shares underlying the notes that, at the end of a
given quarter, have a value in excess of the outstanding
principal amount of the notes. This is because of the net
share settlement feature of the notes, under which we are
required to pay the principal amount of the notes in cash. The
accounting method for net share settled convertible securities
has recently been revised by the Financial Accounting Standards
Board (FASB). On May 9, 2008, FASB approved a staff
position statement APB
14-1,
Accounting for Convertible Debt Instruments That May Be Settled
in Cash Upon Conversion (Including Partial Cash
Settlement) providing a new method of accounting for
net share settled convertible securities under which the debt
and equity components of the security would be bifurcated and
accounted for separately. The change will take effect for fiscal
periods beginning after December 15, 2008 and will increase
the interest expense reported on our statement of operations
and, consequently, reduce our operating results.
In addition, because the borrowed shares we are offering
concurrently must be returned to us prior to June 15, 2013,
we believe that under U.S. GAAP as presently in effect, the
borrowed shares will not be considered outstanding for the
purpose of computing and reporting our earnings per share. This
accounting method is also subject to change. If we become
required to treat the borrowed shares as outstanding for
purposes of computing earnings per share, our earnings per share
would be reduced. Any reduction in our earnings per share could
cause our stock price to decrease, possibly significantly and,
consequently, adversely impact the price of our notes.
Delaware
law and our amended and restated certificate of incorporation
and bylaws contain anti-takeover provisions that could delay or
discourage takeover attempts that stockholders may consider
favorable.
Provisions in our amended and restated certificate of
incorporation and bylaws may have the effect of delaying or
preventing a change of control or changes in our management.
These provisions include the following:
|
|
|
|
|
the right of the board of directors to elect a director to fill
a vacancy created by the expansion of the board of directors;
|
S-30
|
|
|
|
|
the prohibition of cumulative voting in the election of
directors, which would otherwise allow less than a majority of
stockholders to elect director candidates;
|
|
|
|
the requirement for advance notice for nominations for election
to the board of directors or for proposing matters that can be
acted upon at a stockholders meeting; and
|
|
|
|
no action can be taken by stockholders except at an annual or
special meeting of the stockholders called in accordance with
our bylaws, and stockholders may not act by written
consent; and
|
|
|
|
our board of directors will be able to alter our bylaws without
obtaining stockholder approval.
|
These provisions could discourage proxy contests and make it
more difficult for you and other stockholders to elect directors
and take other corporate actions. In addition, we are governed
by the provisions of Section 203 of the Delaware General
Corporation Law, or the DGCL. These provisions may prohibit
large stockholders, particularly those owning 15% or more of our
outstanding voting stock, from merging or combining with us. As
a result, these provisions could limit the price that investors
are willing to pay in the future for shares of our common stock.
In addition, our board of directors has the authority to adopt a
stockholder rights plan without stockholder approval, which may
cause substantial dilution to a person or group that attempts to
acquire us on terms that are not approved by our board of
directors. Any such rights plan, together with the provisions
described above, may have the effect of delaying, deferring or
discouraging a transaction that may otherwise be in your best
interests.
We may
issue preferred stock, which could have rights that are senior
to the rights of our common stock and that may, if convertible
into common stock, dilute the value of our common
stock.
In 2007, we sought stockholder approval to amend our certificate
of incorporation to authorize the issuance of up to
20,000,000 shares of preferred stock. We withdrew that
proposal prior to a vote at our stockholders meeting, but in the
future we may again seek stockholder approval for the same or a
similar amendment, which if adopted by favorable vote of a
majority of our outstanding voting shares, would thereafter
permit us to issue preferred shares without further stockholder
approval. Although our notes are convertible under some
circumstances into shares of common stock, the notes themselves
do not have stockholder voting rights. Thus, noteholders would
not have voting rights with respect to a proposal to authorize
preferred stock. The preferred shares may have dividend, voting,
liquidation and other rights and preferences that are senior to
the rights of our common stock. In addition, such shares of
preferred stock may be convertible into shares of our common
stock. Conversion of shares of our preferred stock into shares
of our common stock may dilute the value of our common stock,
which may adversely affect the value of your notes. The rights
and preferences of any class or series of preferred stock issued
by us would be established by our board of directors in its sole
discretion.
S-31
Ratio of
Earnings to Fixed Charges
Our ratio of earnings to fixed charges for our five fiscal years
ended June 30, 2007 is set forth below.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fiscal Year Ended June 30,
|
|
|
2003
|
|
2004
|
|
2005
|
|
2006
|
|
2007
|
|
Ratio of Earnings to Fixed
Charges
(1)
|
|
|
|
(2)
|
|
|
|
(2)
|
|
|
64.9
|
|
|
|
|
(2)
|
|
|
|
(2)
|
|
|
|
(1)
|
|
For purposes of computing the ratio of earnings to fixed
charges, earnings consist of (a) income (loss) from
continuing operations before income taxes, extraordinary items
and cumulative effect of change in accounting principle and
before adjustment for minority interests in consolidated
subsidiaries or income or loss from equity investees,
(b) distributed income of equity investees and
(c) fixed charges. Fixed charges include (a) interest
expensed and capitalized and (b) an estimate of the
interest within rental expense.
|
|
(2)
|
|
The income (loss) from continuing operations before income
taxes, extraordinary items and cumulative effect of change in
accounting principle and before adjustment for minority
interests in consolidated subsidiaries or income or loss from
equity investees for the years ended June 30, 2003 and 2004
are not sufficient to cover fixed charges by a total of
approximately $26.1 million in 2003, $48.5 million in
2004, $18.9 million in 2006, and $25.2 million in
2007. As a result, the ratio of earnings to fixed charges has
not been computed for these periods.
|
S-32
Capitalization
The following table sets forth our capitalization as of
March 31, 2008:
|
|
|
|
|
on an actual basis; and
|
|
|
|
on an as adjusted basis to reflect (i) the completion of
our sale of the convertible notes in this offering and the
receipt of the proceeds therefrom (assuming the
underwriters option to purchase additional convertible
notes is not exercised) and (ii) the completion of our
concurrent offering of 4,708,500 shares of our common stock
including (a) our receipt of the proceeds from the sale of
the 1,270,000 underwritten shares at an offering price of
$ per share (assuming the
underwriters option to purchase additional shares of
common stock is not exercised) and (b) our receipt of the
nominal lending fees from the borrowed shares also being offered
in that offering.
|
You should read this table in conjunction with the following,
which are incorporated by reference into this prospectus
supplement:
|
|
|
|
|
the historical financial statements of ECD as of and for the
nine months ended March 31, 2008, included in ECDs
quarterly report on
Form 10-Q
for the quarter ended March 31, 2008; and
|
|
|
|
the historical financial statements of ECD as of and for the
years ended June 30, 2007, June 30, 2006 and
June 30, 2005, included in ECDs annual report on
Form 10-K
for the fiscal year ended June 30, 2007.
|
|
|
|
|
|
|
|
|
|
|
|
March 31, 2008
|
|
|
|
Actual
|
|
|
As Adjusted
|
|
|
|
(Dollars in thousands)
|
|
|
Debt:
|
|
|
|
|
|
|
|
|
Obligations under capital leases
|
|
$
|
23,717
|
|
|
$
|
|
|
% convertible notes due 2013
offered hereby
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total debt
|
|
|
23,717
|
|
|
|
|
|
Common Stock, par value $0.01 per share
|
|
|
|
|
|
|
|
|
Authorized 100,000,000 shares actual and as
adjusted at March 31, 2008
|
|
|
|
|
|
|
|
|
Issued and outstanding 40,333,907 shares at
March 31, 2008, shares as adjusted
|
|
|
403
|
|
|
|
|
|
Additional paid-in capital
|
|
|
862,828
|
|
|
|
|
|
Accumulated other comprehensive loss
|
|
|
(335,037
|
)
|
|
|
|
|
Accumulated deficit
|
|
|
(1,715
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total stockholders equity
|
|
|
526,479
|
|
|
|
|
|
Total capitalization
|
|
$
|
550,196
|
|
|
|
|
|
The number of shares of common stock on an as adjusted basis
shown as issued and outstanding in the table above is based on
the number of shares of our common stock outstanding as of
March 31, 2008, giving effect to the adjustments described
above, but excluding:
|
|
|
|
|
957,913 shares of common stock issuable upon the exercise
of options outstanding as of March 31, 2008, at a weighted
average exercise price of $20.99 per share; and
|
|
|
|
2,434,350 shares of common stock reserved for future
issuance as of March 31, 2008, under our various equity
incentive plans and other arrangements.
|
S-33
Use of
Proceeds
The net proceeds from the sale of the notes will be
approximately $218.0 million, after deducting the
underwriters discount and estimated offering expenses. If
the underwriters exercise their option to purchase additional
notes in full, the net proceeds will be approximately
$251.0 million. The net proceeds from the sale of the
underwritten shares will be approximately
$ million, after deducting
the underwriters discount and estimated offering expenses.
We intend to use the net proceeds from the offering of
convertible notes and the underwritten equity offering for the
expansion of our production capacity in connection with the 1 GW
plan and for general corporate purposes.
S-34
Price
Range of Our Common Stock and Dividend Policy
Our common stock trades on the Nasdaq Global Select Market under
the symbol ENER. Set forth below, for the periods
indicated, are the
intra-day
high and low sale prices per share of common stock as reported
by the Nasdaq Global Select Market.
|
|
|
|
|
|
|
|
|
|
|
High
|
|
|
Low
|
|
|
Fiscal Year Ended June 30, 2005
|
|
|
|
|
|
|
|
|
First Quarter
|
|
$
|
14.89
|
|
|
$
|
9.62
|
|
Second Quarter
|
|
|
23.45
|
|
|
|
12.50
|
|
Third Quarter
|
|
|
23.42
|
|
|
|
15.64
|
|
Fourth Quarter
|
|
|
26.20
|
|
|
|
16.27
|
|
Fiscal Year Ended June 30, 2006
|
|
|
|
|
|
|
|
|
First Quarter
|
|
$
|
46.44
|
|
|
$
|
22.31
|
|
Second Quarter
|
|
|
46.88
|
|
|
|
28.76
|
|
Third Quarter
|
|
|
57.84
|
|
|
|
39.81
|
|
Fourth Quarter
|
|
|
56.00
|
|
|
|
31.31
|
|
Fiscal Year Ended June 30, 2007
|
|
|
|
|
|
|
|
|
First Quarter
|
|
$
|
38.98
|
|
|
$
|
29.03
|
|
Second Quarter
|
|
|
41.07
|
|
|
|
33.80
|
|
Third Quarter
|
|
|
37.24
|
|
|
|
27.21
|
|
Fourth Quarter
|
|
|
40.10
|
|
|
|
29.26
|
|
Fiscal Year Ended June 30, 2008
|
|
|
|
|
|
|
|
|
First Quarter
|
|
$
|
36.00
|
|
|
$
|
22.26
|
|
Second Quarter
|
|
|
36.45
|
|
|
|
22.90
|
|
Third Quarter
|
|
|
34.28
|
|
|
|
20.47
|
|
On June 11, 2008, the last reported sale price of our
common stock on the Nasdaq Global Select Market was $64.24 per
share.
We have never declared or paid any cash dividends on our common
stock, and we do not currently intend to pay any cash dividends
on our common stock in the foreseeable future. We intend to
retain future earnings, if any, to finance the operation and
expansion of our business.
S-35
Management
Executive
Officers, Directors and Other Senior Management
The following table sets forth information regarding the
executive officers, directors and other significant members of
our senior management team at June 10, 2008.
|
|
|
|
|
|
|
|
|
|
|
Name
|
|
Age
|
|
Office
|
|
Office Held Since
|
|
Mark D.
Morelli
(1)
|
|
|
44
|
|
|
President, Chief Executive Officer and Director
|
|
|
2007
|
|
Joseph Conroy
|
|
|
44
|
|
|
Vice President, Operations
|
|
|
2008
|
|
Mike A. Fetcenko
|
|
|
50
|
|
|
Vice President Ovonic Materials
|
|
|
2008
|
|
Subhendu
Guha
(1)
|
|
|
65
|
|
|
Senior Vice President, Photovoltaic Technology
|
|
|
2007
|
|
Jay B.
Knoll
(1)
|
|
|
45
|
|
|
Senior Vice President, General Counsel and Chief Administrative
Officer
|
|
|
2006
|
|
Sanjeev
Kumar
(1)
|
|
|
44
|
|
|
Vice President and Chief Financial Officer
|
|
|
2006
|
|
Arthur A. Rogers
|
|
|
57
|
|
|
Vice President of HR and Administration
|
|
|
2007
|
|
Marcelino Susas
|
|
|
41
|
|
|
Vice President of Strategic Marketing
|
|
|
2008
|
|
Tom Toner
|
|
|
49
|
|
|
Vice President System Engineering
|
|
|
2008
|
|
Corby C. Whitaker
|
|
|
38
|
|
|
Vice President of Global Sales
|
|
|
2008
|
|
Joseph A. Avila
|
|
|
57
|
|
|
Director
|
|
|
2007
|
|
Christopher P. Belden
|
|
|
47
|
|
|
Director
|
|
|
2008
|
|
Robert I. Frey
|
|
|
64
|
|
|
Director
|
|
|
2004
|
|
William J. Ketelhut
|
|
|
55
|
|
|
Director
|
|
|
2004
|
|
Florence I. Metz
|
|
|
78
|
|
|
Director
|
|
|
1995
|
|
Stephen Rabinowitz
|
|
|
65
|
|
|
Director and Chairman of the Board
|
|
|
2004
|
|
George A. Schreiber, Jr.
|
|
|
60
|
|
|
Director
|
|
|
2006
|
|
|
|
|
(1)
|
|
This individual is an executive officer of the Company (within
the meaning of
Rules 3b-7
and 16a-1 under the Securities Exchange Act of 1934).
|
Executive
Officers and Other Senior Management Officers of the
Company
Mark D. Morelli
is President, Chief Executive
Officer and a Director of ECD. He served as President of Carrier
Commercial Refrigeration, a division of Carrier Corporation,
from April 2006 until he joined ECD in 2007. From June 2004 to
April 2006, Mr. Morelli was Vice President and General
Manager of the Marine Container Business with Carrier
Transicold, and from September 2002 to June 2004 he was the
Managing Director of Transport Air Conditioning with Carrier
Transicold. Prior to 2002, he also served as Vice President
Marketing & Strategy for United Technologies
Corporation and in various positions for Carrier. His customer
and strategic business experience includes developing and
marketing building-integrated products.
Joseph Conroy
has served as Vice President,
Operations of ECD since January 2008. Before coming to ECD,
Mr. Conroy had been at American Axle &
Manufacturing, Inc. since March 1994. While with American
Axle & Manufacturing, Inc., Mr. Conroy served as
general manager of the Driveline Americas Division, the
companys largest division, from July 2006 until he joined
ECD, general manager of the Metal Formed Products Division from
July 2004 to July 2006, and plant manager for the Three Rivers
Driveline facility from January 2003 to July 2004.
S-36
He holds a B.S.M.E. from General Motors Institute (GMI), now
known as Kettering University, and an MBA from Wayne State
University.
Mike A. Fetcenko
became Vice President Ovonic
Materials at ECD in April 2008. He joined ECD in 1980 and was
one of the founding members of Ovonic Battery Company (OBC)
where he served as Senior Vice President and Director of
Technology from 1992 until the time when OBC was integrated into
the Ovonic Materials segment of ECD in 2008 as part of
ECDs restructuring. Mr. Fetcenko has also played a
pivotal role in the enforcement and licensing of the
companys intellectual property and was responsible for
technical and business-related interactions with OBCs
licensees. As the head of the Ovonic Materials Division,
Mr. Fetcenko leads the operations and strategic planning
and drives commercialization of our diverse ECD technologies
including biofuel reformation, fuel cell, hydrogen storage and
information technology while continuing to grow our Ovonic NiMH
battery business.
Subhendu Guha
is Senior Vice President,
Photovoltaic Technology of ECD and Chairman of its wholly owned
subsidiary, United Solar Ovonic. Dr. Guha joined ECD in
1982. He was named United Solar Ovonics President in 2000
and its President and Chief Operating Officer in May 2003, a
position he held from 2003 until 2007, when he became Senior
Vice President, Photovoltaic Technology of ECD. Dr. Guha is
a world-renowned authority in PV technology, with many years of
experience in the development and manufacture of solar panels.
He serves on many national and international PV committees,
including the Advisory Board of National Center for
Photovoltaics, the body responsible for directing and
implementing the U.S. Department of Energys strategy
in PV. He has a PhD in Electronics.
Jay B. Knoll
is Senior Vice President, General
Counsel, and Chief Administrative Officer of ECD. Prior to
joining the Company in 2006, Mr. Knoll was Vice President,
General Counsel and Corporate Secretary of Collins &
Aikman Corporation from November 2002 to September 2005.
Collins & Aikman filed for bankruptcy in May 2005. On
November 8, 2007, Mr. Knoll was advised by the staff
of the SEC that it is considering recommending that the SEC
bring a civil injunctive action against Mr. Knoll, alleging
violation of federal securities laws, including the anti-fraud
provisions, based on his actions regarding two March 2005 press
releases by Collins & Aikman. The press releases
related to an internal investigation and financial restatement
by Collins & Aikman. None of the allegations involve
ECD. ECD believes that Mr. Knoll had no prior knowledge of
the underlying accounting that was the subject of
Collins & Aikmans financial restatement, and ECD
continues to have confidence in Mr. Knolls integrity
and professional competence. The staff of the SEC, in accordance
with its customary practices, offered Mr. Knoll the
opportunity to make a submission setting forth why he believes
that such action should not be brought. Mr. Knoll made such
submission in December 2007. Mr. Knoll has held positions
at Lear Corporation, Covisint LLC, Visteon Corporation, and
Detroit Diesel Corporation. Mr. Knoll holds a B.A. degree
from the University of Michigan and has a J.D. degree from the
Wayne State University School of Law.
Sanjeev Kumar
is Vice President and Chief
Financial Officer of ECD. Mr. Kumar served as Chief
Financial Officer of Rutheford Chemicals LLC, a New Jersey-based
company owned by a private equity firm, from 2004 until June
2006 when he joined ECD. From 2002 to 2004, Mr. Kumar
co-founded Clean Fuel Generation, LLC, a California-based
company that performed research and development in emerging fuel
cell technology. Mr. Kumar also brings with him experience
from Rhodia, Inc., where he served as Vice President of Finance
and Chief Financial Officer, and from Occidental Petroleum
Corporation, where he served in a variety of positions from 1991
to 2000. Mr. Kumar holds a B.A. in Business Administration
and has an MBA from the University of Southern California.
Arthur A. Rogers
is Vice President of HR and
Administration of ECD. Mr. Rogers has more than thirty
years of experience in Human Resources and developing and
executing organizational strategy. He served as Vice President
of HR and Administration of United Solar Ovonic from December
2005 until May 2007, when he joined ECD. From 1998 until joining
ECD in 2005, Mr. Rogers served as Senior Vice President of
Human Resources for GKN Sinter Metals. Prior to that, he served
in various positions including as International Human Resources
Director for Hills Pet Nutrition in 1997 and Vice
President of Management Resourcing for Lucasvarity Corporation
from 1995 to 1997. Mr. Rogers holds a B.S. in
Labor & Industrial Relations with a concentration in
Management, Economics and Psychology from Michigan State
University.
Marcelino Susas
is Vice President of Strategic
Marketing of ECD. Prior to joining ECD in January 2008,
Mr. Susas served as Business Director of Lumber/Retail at
CertainTeed Corporation, a subsidiary of Saint-Gobain,
S-37
from June 2007 to January 2008 and Director of Business
Development Insulation Group at CertainTeed Corporation from
August 2005 to May 2007. Before joining CertainTeed,
Mr. Susas was a manager at Carrier from July 2003 to August
2005. From March 2002 to June 2003, he was Manager of Business
Development and Strategic Planning at United Technologies Fuel
Cells. Mr. Susas also did consulting at
McKinsey & Company from January 1999 to March 2002,
primarily working in their energy practice. He also brings with
him experience from Public Service Electric & Gas
where he served in various positions from 1989 to 1999.
Mr. Susas holds a B.S. in Electrical Engineering from the
New Jersey Institute of Technology and has an MBA from New York
Universitys Stern Graduate School of Business.
Tom Toner
is Vice President Systems Engineering at
ECD. He most recently served as Senior Director of Operations
for Varian Semiconductor Equipment Assoc. from 2006 to 2007.
From 2001 to 2006, Mr. Toner worked at Applied Materials,
Inc., serving as Senior Director of System Engineering of the
Front End Products Group from 2001 to 2004, Managing Director of
Global Operations for the Front End Products Group from 2004 to
2006, and Managing Director of Global Operations, New Business
and New Products in 2006. From 1980 to 2001, he held various
leadership roles in both engineering and operations at United
Technologies Corporation. He has extensive experience in complex
product development and global operations. Mr. Toner holds
his M.S. in Engineering and Management from MIT and his B.S. in
Mechanical Engineering from the University of Virginia.
Corby C. Whitaker
has served as Vice President,
Global Sales of ECD since January 2008. From 2004 until 2008,
Mr. Whitaker served as Director of Sales with Johns
Manville Corporation. Before joining Johns Manville Corporation,
Mr. Whitaker served as Regional Vice President of Sales for
Tractebel Energy Services, Inc. (formerly AES NewEnergy, Inc.)
from 2002 to 2004. Mr. Whitaker holds a B.S.M.E. from Texas
A&M University.
Directors
of the Company
Joseph A. Avila
has served as an officer and
Executive Vice President of Strategic Operations and Process of
Quanta Services, Inc. since October 1, 2006. From 1978
until May 2006, he held various positions with
McKinsey & Company, a global management consulting
firm, most recently as a Director providing leadership to the
Energy and Technology Management Practices. In addition,
Mr. Avila serves on the Advisory Board of the Houston
Technology Center.
Christopher P. Belden
is, since March 2008, the
Senior Vice President - Global Manufacturing, at NXP
Semiconductors. From February 2005 to February 2007, he was
Group Vice President of Global Operations for Applied Materials,
Inc., a global leader in nanomanufacturing technology solutions
for the electronics industry, where he was responsible for
volume manufacturing, supply chain management, reliability,
quality and worldwide facilities. Prior to joining Applied
Materials, Mr. Belden had a 23 year career at Motorola
where his last role was Senior Vice President of Global
Manufacturing and Operations.
Robert I. Frey
is an Assistant Professor of Global
Management and Business Ethics and serves as the Director of the
Business Ethics Center at Seidman School of Business, Grand
Valley State University, in Grand Rapids, Michigan. He joined
Herman Miller, Inc. in 1996, where he was an Executive Vice
President and member of the Executive Committee and President of
Herman Miller International, accountable for international
strategic planning, manufacturing, sales and marketing until his
retirement in 2002. He also serves as Director and Treasurer for
Holland Chorale, a charitable organization.
William J. Ketelhut
was, from 2001 to 2002,
President of Control Products at Honeywell International, a
global company with fifteen major lines of businesses including
semiconductors, consumer products and sensors products. From
1994 to 2001, he served as president of several business units
of Invensys plc, a global automation, controls and process
solutions group. He was president and chief executive officer at
GE/Micro Switch Control Inc. (a joint venture between GE and
Honeywell Microswitch Division) from 1992 to 1994.
Mr. Ketelhut has also been involved in consulting and
private company board work. He received an MBA from the
University of Chicago with an emphasis on Finance and Marketing.
Florence I. Metz
held, until her retirement in
1996, various executive positions with Inland Steel, including
General Manager, New Ventures, Inland Steel Company
(1989-1991);
General Manager, New Ventures, Inland Steel
S-38
Industries
(1991-1992)
and Advanced Graphite Technologies
(1992-1993);
and Program Manager for Business and Strategic Planning at
Inland Steel
(1993-1996).
Stephen Rabinowitz
currently serves as Chairman of
the Board. He was Chairman and Chief Executive Officer of
General Cable, Inc., a leader in the development, design,
manufacture, marketing and distribution of copper, aluminum and
fiber optic wire and cable products for the communications,
energy and specialty markets, until he retired in 2001. Prior to
joining General Cable as President and CEO in 1994, he served as
President and CEO of Allied Signal Braking Systems, and before
that as President and CEO of General Electrics Electrical
Distribution and Control business. He has also held management
positions in manufacturing operations and technology at the
General Electric Company and the Ford Motor Company.
Mr. Rabinowitz was appointed as a member of the Board of
Directors of Columbus McKinnon Corp. in October 2004 and serves
on its Audit and Compensation Committees, as well as chairing
its Compensation and Succession Committee. He is also a Director
of MicroHeat, Inc. and Chairman of its Audit Committee.
George A. Schreiber, Jr.
is President, CEO
and Director of SEMCO Energy, a natural gas distribution company
serving markets in Michigan and Alaska. From September 1999 to
March 2004, he was the Chairman, Global Energy Group, at Credit
Suisse First Boston, New York.
S-39
Description
of the Notes
The terms of the notes we are offering are described below. The
notes are a series of debt securities that are described in the
prospectus that follows this prospectus supplement. The
provisions described below supplement, and to the extent they
conflict with, they supersede, the information in the prospectus
with respect to the notes.
In this description, the words we, us,
our or ECD refer only to Energy
Conversion Devices, Inc. and not to any of its subsidiaries.
We will issue the notes as a series of debt securities under our
indenture and a supplemental indenture (which we frequently
refer to together in this prospectus supplement as the
indenture), each to be dated as of the closing of
this offering between us and The Bank of New York
Trust Company, N.A. The indenture and the supplemental
indenture with respect to the notes are governed by the
Trust Indenture Act of 1939, or the
Trust Indenture Act. The terms of the notes
include those stated in the indenture and the supplemental
indenture and those made part of the indenture by reference to
the Trust Indenture Act. We urge you to read the indenture
and the supplemental indenture because they, and not this
description, define your rights as a holder of the notes.
You may request a copy of the indenture from us. See Where
You Can Find More Information.
References to days in this Description of the Notes
refer to calendar days.
General
We are offering $225,000,000 aggregate principal amount of
our % Convertible Senior Notes
due 2013 (or $258,750,000 if the underwriters exercise their
over-allotment option in full), which we refer to as the
notes. We use the term note in this
prospectus supplement to refer to each $1,000 principal amount
of notes. The notes will mature on June 15, 2013, subject to
earlier conversion or repurchase.
The notes:
|
|
|
|
|
will be general unsecured senior obligations;
|
|
|
|
will be issued in denominations of $1,000 and integral multiples
of $1,000;
|
|
|
|
will be represented by one or more registered notes in global
form, but in certain limited circumstances may be represented by
notes in certificated form as described below under
Book-Entry, Settlement and Clearance;
|
|
|
|
will not be subject to defeasance or any sinking fund provision;
|
|
|
|
will rank equally in right of payment to any of our existing or
future unsecured senior debt; and
|
|
|
|
will effectively rank junior to any of our secured debt to the
extent of the value of the assets securing such indebtedness,
and will be structurally subordinated to all liabilities of our
subsidiaries.
|
On or prior to the business day immediately preceding the
maturity date, subject to certain conditions described herein,
the notes may be converted based on the conversion rate
described below under Conversion
Rights General. As described below under
Conversion Rights Payment Upon
Conversion, we will settle conversions of notes by
delivering cash and, if applicable, shares of our common stock
subject to the fulfillment of certain conditions applicable to
the conversion rate. Holders will not receive any separate cash
payment for interest, if any, accrued and unpaid to the
conversion date except under the circumstances described below
under Conversion Rights Conversion
Procedures.
The notes will be subject to repurchase by us at each
holders option upon the occurrence of a fundamental change
and on the terms and at the purchase prices set forth below
under Fundamental Change Permits Holders to
Require Us to Purchase Notes.
If any interest payment date, maturity date, or fundamental
change repurchase date falls on a day that is not a business
day, then the required payment or delivery will be made on the
next succeeding business day with the same force and effect as
if made on the date that the payment or delivery was due, and no
additional interest will accrue on
S-40
that payment for the period from and after the interest payment
date, maturity date, or fundamental change repurchase date, as
the case may be, to that next succeeding business day.
We may, without the consent of the holders, reopen the indenture
for the notes and issue additional notes under the indenture
with the same terms and with the same CUSIP numbers as the notes
offered hereby in an unlimited aggregate principal amount;
provided
that no such additional notes will be treated as
part of the same series as the notes unless they will be
fungible with the notes offered hereby for U.S. federal
income tax purposes. We may also, from time to time, repurchase
the notes in open market purchases or negotiated transactions
without prior notice to holders.
The registered holder of a note will be treated as the owner of
it for all purposes.
The indenture does not limit the amount of debt that may be
issued by us or our subsidiaries under the indenture or
otherwise.
Other than restrictions described under
Fundamental Change Permits Holders to Require
Us to Purchase Notes and Consolidation,
Merger and Sale of Assets below, and except for the
provisions set forth under Increase of
Conversion Rate Upon Conversion Upon Make-Whole Fundamental
Change, the indenture does not contain any covenants or
other provisions designed to afford holders of the notes
protection in the event of a highly leveraged transaction
involving us or in the event of a decline in our credit rating,
including as a result of a takeover, recapitalization, highly
leveraged transaction or similar restructuring involving us that
could adversely affect the holders of the notes.
Payments
on the Notes; Paying Agent and Registrar
We will pay principal of certificated notes at the office or
agency designated by us in the United States. We have initially
designated a corporate trust office of The Bank of New York
Trust Company, N.A. as the paying agent and registrar of
the notes and its agency in The Bank of New York
Trust Company, N.A., as a place where notes may be
presented for payment or for registration of transfer. We may,
however, change the paying agent or registrar without prior
notice to the holders of the notes, and we may act as paying
agent or registrar. Interest on certificated notes will be
payable (1) to holders holding certificated notes having an
aggregate principal amount of $1,000,000 or less of notes by
check mailed to the holders of such notes and (2) to
holders holding certificated notes having an aggregate principal
amount of more than $1,000,000 of notes either by check mailed
to each holder or, upon application by a holder to the registrar
not later than the relevant record date, by wire transfer in
immediately available funds to that holders account within
the United States, which application shall remain in effect
until the holder notifies, in writing, the registrar to the
contrary.
We will pay principal of and interest on notes in global form
registered in the name of or held by The Depository
Trust Company or its nominee in immediately available funds
to The Depository Trust Company or its nominee, as the case
may be, as the registered holder of such global note.
Interest
The notes will bear interest at a rate
of % per year. Interest will accrue
from June , 2008, and will be
payable semi-annually in arrears on June 15 and December 15 of
each year, beginning December 15, 2008.
Interest will be paid to the person in whose name a note is
registered at the close of business (i.e.,
5:00 p.m. New York City time) on June 1 or
December 1 (each a record date), as the case may be
(whether or not a business day), immediately preceding the
relevant interest payment date;
provided
,
however
,
if notes are surrendered for conversion after 5:00 p.m.,
New York City time, on a regular record date but prior to
9:00 a.m., New York City time, on the immediately
following interest payment date, holders of such notes at
5:00 p.m., New York City time, on the record date will
receive the interest, if any, payable on such notes on the
corresponding interest payment date notwithstanding the
conversion. Notes, upon surrender for conversion during the
period after 5:00 p.m., New York City time, on any regular
record date but prior to 9:00 a.m., New York City time, on
the
S-41
immediately following interest payment date, must be accompanied
by funds equal to the amount of interest, if any, payable on the
notes so converted;
provided
that no such payment need be
made:
|
|
|
|
|
to the extent of any overdue interest, if any overdue interest
exists at the time of conversion with respect to such
note; or
|
|
|
|
if the notes are surrendered for conversion after
5:00 p.m., New York City time, on the regular record date
immediately preceding the maturity date and before
5:00 p.m., New York City time, on the business day
immediately preceding the maturity date for the notes.
|
Interest on the notes will be computed on the basis of a
360-day
year
composed of twelve
30-day
months.
Unless the context requires otherwise, all references to the
term interest in this prospectus supplement are
deemed to include additional interest, if any, that accrues and
is payable in connection with our failure to comply with our
reporting obligations under the indenture as set forth below
under Events of Default.
Ranking
The notes will be:
|
|
|
|
|
general unsecured senior obligations;
|
|
|
|
equal
(pari passu)
in ranking with all of our
existing and future unsecured senior indebtedness; and
|
|
|
|
senior in right of payment to all of our existing and future
indebtedness if any, that is subordinated to the notes.
|
At March 31, 2008, we did not have any indebtedness for
borrowed money ranking
pari passu
in right of payment
with the notes. The notes will be effectively subordinated in
right of payment to all of our existing and future secured
indebtedness to the extent of the value of the assets securing
such indebtedness. In addition, we are a holding company and
conduct substantially all of our operations through
subsidiaries, and the notes will be structurally subordinated to
all obligations of our subsidiaries. At March 31, 2008, our
subsidiaries did not have any balance sheet liabilities to which
the notes would have been structurally subordinate, including
the $55.0 million senior secured credit facility of our
United Solar Ovonic subsidiaries, under which there were not any
outstanding borrowings as of March 31, 2008. At
June 11, 2008, there were borrowings of approximately
$1.9 million outstanding under the senior secured credit
facility.
Substantially all of our operating income and cash flow is
generated by our subsidiaries. As a result, funds necessary to
meet our debt service obligations are provided, in part, by
distributions or advances from our subsidiaries. Under certain
circumstances, contractual and legal restrictions, as well as
the financial condition and operating requirements of our
subsidiaries, could limit our ability to obtain cash from our
subsidiaries for the purpose of meeting our debt service
obligations, including the payment of principal and interest on
the notes and payment of our obligations upon conversion or
repurchase of the notes.
Conversion
Rights
General
Our ability to convert the notes may be limited by restrictions
on our ability to obtain funds for such conversion through
dividends from our subsidiaries and the terms of our then
existing borrowing agreements. See Risk
Factors We may not be able to pay interest on the
notes, or convert the notes or repurchase the notes at the
option of the holder upon a fundamental change. If we fail
to convert the notes when required, we will be in default under
the indenture. In addition, we have, and may in the future
incur, other indebtedness with provisions permitting our holders
to require us to repurchase our indebtedness on some specific
dates.
Subject to the restrictions described in this Description of the
Notes section, a holder may convert any outstanding notes into
cash and, if applicable, shares of our common stock based on the
conversion rate and in accordance with the procedures described
below.
S-42
Prior to March 15, 2013, the notes will be convertible as
provided herein only in the circumstances described below under
Conversion Upon Satisfaction of Common Stock
Price Condition, Conversion Upon
Satisfaction of Trading Price Condition, or
Conversion Upon Specified Corporate
Transactions. On or after March 15, 2013, a holder
may surrender notes for conversion at any time prior to
5:00 p.m., New York City time, on the business day
immediately preceding the maturity date without regard to the
foregoing conditions. In addition, if a holder has exercised its
right to require us to repurchase its notes, subject to all
other restrictions on conversion, such holder may convert its
notes only if it withdraws its repurchase notice and converts
its notes prior to 5:00 p.m., New York City time, on the
business day immediately preceding such repurchase date.
Our delivery to the holder of the settlement amount (as defined
below under Payment Upon Conversion)
together with any cash payment for such holders fractional
shares, will be deemed to satisfy our obligation to pay the
principal amount of the notes and to satisfy our obligation to
pay accrued and unpaid interest through the conversion date,
except as provided above under Interest.
As a result, accrued interest is deemed paid in full rather than
cancelled, extinguished or forfeited.
The
conversion rate
is
initially shares of our common
stock, subject to adjustment as described under
Conversion Rate Adjustments. The
conversion rate may also be adjusted in certain corporate
transactions. See Increase of Conversion Rate
Upon Conversion Upon Make-Whole Fundamental Change.
The
conversion price
is a dollar amount
(initially, approximately )
determined by dividing $1,000 by the conversion rate.
The
applicable stock price
per share of our
common stock on any trading day means the per share
volume-weighted average price as displayed under the heading
Bloomberg VWAP on Bloomberg (or any successor
service) page ENER <Equity> AQR (or any
equivalent successor page) in respect of the period from the
scheduled open of trading on the principal securities U.S.
national exchange or quotation system on which the common stock
is traded on such trading day, or, if such volume-weighted
average price is not available, the applicable stock price means
the volume-weighted average price per share of our common stock
on such day as determined by a nationally recognized investment
banking firm retained for this purpose by us. The applicable
stock price of other securities that constitute reference
property and that are traded on a national securities exchange
shall be determined in a manner substantially equivalent to the
foregoing as determined in good faith by us.
Scheduled trading day
means any day that is
scheduled to be a trading day.
Trading day
means a day during which trading
in our common stock generally occurs on the principal
U.S. national or regional securities exchange or quotation
system on which our common stock is listed for trading and
during which there is no market disruption event;
provided
that if our common stock is not listed for trading on a
U.S. national or regional securities exchange or quotation
system, trading day will mean a business day.
Market disruption event
means (1) a
failure by the primary exchange or quotation system on which our
common stock trades or is quoted to open for trading during its
regular trading session or (2) the occurrence or existence
on any trading day for our common stock of any suspension or
limitation imposed on trading (by reason of movements in price
exceeding limits permitted by the stock exchange or otherwise)
in our common stock or in any options contracts or future
contracts relating to our common stock for an aggregate period
in excess of one half hour.
Conversion
Upon Satisfaction of Common Stock Price Condition
With respect to any calendar quarter commencing after
June 30, 2008, a holder may surrender any of its notes for
conversion during such calendar quarter (and only during such
quarter) if the last reported sale price of our common stock for
at least 20 trading days during the period of 30 consecutive
trading days ending on the last trading day of the immediately
preceding calendar quarter (appropriately adjusted to take into
account the occurrence, during such 30 consecutive trading days,
of any event requiring adjustment of the conversion price under
the indenture) is greater than 130% of the conversion price on
such last trading day.
S-43
Conversion
Upon Satisfaction of Trading Price Condition
A holder may surrender notes for conversion prior to maturity
during the five
business-day
period following any ten consecutive
trading-day
period in which the trading price per $1,000 principal amount of
notes using the procedures set forth below following a request
by a holder of notes in accordance with the procedures described
below, for each trading day of such ten
trading-day
period was less than 97% of the product of the last reported
sale price of our common stock for such trading day and the
conversion rate.
The bid solicitation agent shall have no obligation to determine
the trading price of the notes for this purpose unless we have
requested such determination in writing, and we shall have no
obligation to make such request unless the holder properly makes
such a request in writing and provides us with reasonable
evidence that the trading price of the notes on the date of such
request would be less than 97% of the product of the last
reported sale price and the conversion rate on such date. At
such time, we shall instruct the bid solicitation agent to
determine the trading price of the notes beginning on the next
trading day and on each successive trading day until the trading
price of the notes is greater than or equal to 97% of the
product of the last reported sale price and the conversion rate
on such date.
For purposes of the foregoing, if the bid solicitation agent
cannot reasonably obtain at least one bid for $5,000,000
aggregate principal amount of the notes from an independent
nationally recognized securities dealer, then the trading price
of the notes will be deemed to be less than 97% of the product
of the last reported sale price of our common stock for such
trading day and the conversion rate.
Trading price
of the notes on any
determination date means the average of the secondary market bid
quotations per note obtained by the bid solicitation agent for
$5,000,000 aggregate principal amount of the notes at
approximately 3:30 p.m., New York City time, on the
determination date from three independent nationally recognized
securities dealers we select;
provided
that if:
|
|
|
|
|
three such bids cannot reasonably be obtained by the bid
solicitation agent, but two such bids are obtained, then the
average of the two bids shall be used, and
|
|
|
|
only one such bid can reasonably be obtained by the bid
solicitation agent, that one bid shall be used.
|
The
last reported sale price
of our common
stock on any date means the closing sale price per share (or if
no closing sale price is reported, the average of the last bid
and ask prices or, if more than one in either case, the average
of the average last bid and the average last ask prices) on that
date as reported in composite transactions for the principal
U.S. national or regional securities exchange on which our
common stock is listed for trading. If our common stock is not
listed for trading on a U.S. national or regional
securities exchange on the relevant date, the last
reported sale price will be the last quoted bid price for
our common stock in the over-the-counter market on the relevant
date as reported by the National Quotation Bureau or similar
organization. If our common stock is not so quoted, the
last reported sale price will be the average of the
mid-point of the last bid and ask prices for our common stock on
the relevant date from each of at least three nationally
recognized independent investment banking firms selected by us
for this purpose.
The bid solicitation agent shall be any reputable financial
services provider that customarily provides administrative
agency or trustee services as the Company may designate from
time to time.
Conversion
Prior to Maturity
A holder may surrender notes for conversion at any time during
the period beginning March 15, 2013, and ending at the
close of business on the business day immediately preceding the
maturity date.
Conversion
Upon Specified Corporate Transactions
If we elect to:
|
|
|
|
|
distribute, to all or substantially all holders of our common
stock, rights, warrants or options entitling them to subscribe
for or purchase, for a period commencing no earlier than the
date of distribution and expiring not more than 45 days
from the record date of the distribution, shares of our common
stock at a price per share
|
S-44
|
|
|
|
|
less than the average of the last reported sale price of our
common stock for each of the ten trading days immediately
preceding the date that such distribution was first publicly
announced; or
|
|
|
|
|
|
distribute, to all or substantially all holders of our common
stock, cash or other assets, debt securities or rights or
warrants to purchase our securities (other than those referred
to in the preceding bullet), which distribution has a per share
fair market value (as determined by our board of directors)
exceeding 10% of the last reported sale price of our common
stock on the trading day immediately preceding the date that
such distribution was first publicly announced,
|
we must notify the holders of notes at least 20 trading days
prior to the ex-dividend date for such distribution. Once we
have given such notice, holders may surrender their notes for
conversion until the earlier of the close of business on the
business day prior to the ex-dividend date or our announcement
that such distribution will not take place. If the distribution
does not occur as anticipated, we will issue a press release and
notify holders who have elected to convert their notes promptly
after we determine that the distribution will not occur and each
such holder may elect to withdraw any then pending election to
convert by a written notice of withdrawal delivered to the
conversion agent within ten business days after we make such
announcement. In such event, holders who do not make such a
withdrawal election will receive the applicable settlement
amount with respect to notes surrendered for conversion three
trading days following the later of (i) the end of the
applicable cash settlement averaging period or (ii) the
expiration of the ten business day withdrawal period referred to
above.
In addition, if we are a party to a consolidation, merger, share
exchange, sale of all or substantially all of our assets or
other similar transaction (in each case other than with one of
our wholly-owned subsidiaries), in each case pursuant to which
the shares of our common stock would be converted into (or
holders of such shares would be entitled to receive) cash,
securities or other property, a holder may surrender its notes
for conversion at any time from and including the effective date
of such transaction until and including the date that is
30 days after the effective date of such transaction.
In the event of a make-whole fundamental change (as defined
below under Increase of Conversion Rate Upon
Conversion Upon Make-Whole Fundamental Change), a holder
may surrender its notes for conversion at any time from and
including the effective date of the make-whole fundamental
change (or 15 trading days prior to the date we have announced
as the anticipated effective date of such make-whole fundamental
change if such event constitutes a fundamental change as
described under clause (4) of the definition of fundamental
change as described below under Fundamental
Change Permits Holders to Require Us to Purchase Notes)
until and including the date that is 30 days after the
effective date of such fundamental change;
provided
,
however
, we will have no obligation to deliver any
settlement amount in respect of any such conversion prior to the
effective date of such make-whole fundamental change. However,
in the case of a transaction described in clause (4) of the
definition of fundamental change as described below under
Fundamental Change Permits Holders to Require
Us to Purchase Notes, if we determine that such
transaction will not occur on substantially the terms
anticipated, we will not be obligated to increase the conversion
rate, regardless of the fact that holders may have elected to
convert notes in anticipation of the effective date of such
event and we will issue a press release and notify holders who
have so elected to convert their notes promptly after we
determine that the transaction in question will not occur and
each such holder may elect to withdraw any then pending election
to convert by a written notice of withdrawal delivered to the
conversion agent within ten business days (or longer period if
required by law) after we make such announcement. In such event,
holders who do not make such a withdrawal election will receive
the applicable settlement amount with respect to notes
surrendered for conversion three trading days following the
later of (i) the end of the applicable cash settlement
averaging period or (ii) the expiration of the ten business
day (or longer period if required by law) withdrawal period
referred to above.
If a transaction also constitutes a fundamental change (as
described below), such holder can instead require us to
repurchase all or a portion of its notes as described under
Fundamental Change Permits Holders to Require
Us to Purchase Notes.
Payment
Upon Conversion
Subject to certain exceptions described below under
Increase of Conversion Rate Upon Conversion
Upon Make-Whole Fundamental Change, we will deliver to
holders in respect of each $1,000 principal amount of notes
S-45
surrendered for conversion a settlement amount equal
to the sum of the daily settlement amounts for each of the 20
consecutive trading days during the applicable cash settlement
averaging period.
The
daily settlement amount,
for each of the
20 consecutive trading days during the cash settlement averaging
period, shall consist of:
|
|
|
|
|
cash equal to $50 or, if less, the daily conversion
value; and
|
|
|
|
to the extent the daily conversion value exceeds $50, a number
of shares equal to (A) the difference between the daily
conversion value and $50, divided by (B) the applicable
stock price of our common stock for such day.
|
The
daily conversion value
means, for each of
the 20 consecutive trading days during the cash settlement
averaging period, one-twentieth (1/20) of the product of
(1) the conversion rate (as determined under
General above) and (2) the applicable stock
price of our common stock on such day. In addition, for purposes
of the foregoing, the daily conversion values of reference
property (as defined below under Conversion
Rate Adjustments Treatment of Reference
Property) will be determined by reference to (i) in
the case of reference property or part of reference property
that is traded on a U.S. national securities exchange the
applicable stock price of such security or common stock,
(ii) in the case of any other property other than cash, the
value thereof as determined by two independent nationally
recognized investment banks as of the effective date of the
applicable reference property transaction (as defined below
under Conversion Rate Adjustments
Treatment of Reference Property), and (iii) in the
case of cash, at 100% of the amount thereof.
The
cash settlement averaging period
with
respect to any note being converted means the 20 consecutive
trading-day
period beginning on and including the second trading day after
the conversion date (as defined below), except that with respect
to any conversion date that is on or after the
24th scheduled trading day immediately preceding the
maturity date, the cash settlement averaging period means the 20
consecutive trading days beginning on and including the
22nd scheduled trading day prior to the maturity date.
Except as otherwise provided in the indenture, we will deliver
the settlement amount to holders who have surrendered notes for
conversion on the third business day immediately following the
last day of the cash settlement averaging period in respect of
such notes;
provided
that, in the event of reference
property which consists entirely of assets under
clauses (ii) and (iii) of the second preceding
paragraph, we will pay the holders as promptly as practicable,
but in no event later than the third business day after the date
of determination of the value of such consideration;
provided
that no payment will be made prior to the occurrence of the
applicable reference property transaction.
No fractional shares of common stock or securities representing
fractional shares of common stock will be issued upon
conversion. Any fractional interest in a share of common stock
resulting from conversion will be paid in cash based on the
average of the applicable stock prices on each trading day
during the relevant cash settlement averaging period. For
purposes of the foregoing, fractional shares arising from the
calculation of the daily settlement amount for any day in the
cash settlement averaging period shall be aggregated with
fractional shares for all other days in such period in
determining the settlement amount, and any whole shares
resulting therefrom shall be issued and any remaining fractional
shares shall be paid in cash.
Conversion
Procedures
If you hold a beneficial interest in a global note, to convert
you must comply with DTCs procedures for converting a
beneficial interest in a global note and, if required, pay funds
equal to interest payable on the next interest payment date and
all transfer or similar taxes, if any.
If you hold a certificated note, to convert you must:
|
|
|
|
|
complete and manually sign the conversion notice on the back of
the note, or a facsimile of the conversion notice;
|
|
|
|
deliver the conversion notice, which is irrevocable, and the
note to the conversion agent;
|
|
|
|
if required, furnish appropriate endorsements and transfer
documents;
|
S-46
|
|
|
|
|
if required, pay all transfer or similar taxes; and
|
|
|
|
if required, pay funds equal to interest payable on the next
interest payment date.
|
The date you comply with these requirements is the
conversion date under the indenture.
If a holder converts notes, we will pay any documentary, stamp
or similar issue or transfer tax due on the issue of any shares
of our common stock upon the conversion, unless the tax is due
because the holder requests any shares to be issued in a name
other than the holders name, in which case the holder will
pay that tax.
Exchange
in Lieu of Conversion
When a holder surrenders notes for conversion, we may direct in
writing the conversion agent to surrender such notes to a
financial institution designated by us for exchange in lieu of
conversion. In order to accept any notes surrendered for
conversion, the designated financial institution must agree to
deliver, in exchange for such notes, the cash and number of
shares of our common stock, if any, due upon conversion as
determined above under Payment Upon Conversion. By
the close of business on the scheduled trading day immediately
preceding the start of the cash settlement averaging period (or,
if provision of notice on such date is impracticable, promptly
following conversion), we will provide written notification to
the holder surrendering notes for conversion that we have
directed the designated financial institution to make an
exchange in lieu of conversion. If the designated financial
institution accepts any such notes, it will deliver the cash,
and the number of shares of our common stock, if any, due upon
conversion to the conversion agent and the conversion agent will
deliver such cash and shares of our common stock to the
converting holder. Any notes exchanged by the designated
financial institution will remain outstanding. If such
designated financial institution does not accept the notes for
exchange, or if the designated financial institution agrees to
accept any notes for exchange but does not timely deliver the
related cash and shares of our common stock, we will, as
promptly as practical thereafter (but no later than the third
trading day immediately following the last trading day of the
relevant cash settlement averaging period) convert the notes
into cash and, if applicable, shares of our common stock based
on the conversion rate as set forth above under
Conversion Rights Payment Upon
Conversion. Our designation of a financial institution to
which the notes may be submitted for exchange does not require
the institution to accept any notes. We will not pay any
consideration to, or otherwise enter into any agreement with,
the designated financial institution for or with respect to such
designation.
Conversion
Rate Adjustments
Adjustment
Events
The conversion rate will be subject to adjustment as described
below.
(1) If we issue shares of our common stock as a dividend or
distribution on all of the outstanding shares of our common
stock, or if we effect a share split or share combination, the
conversion rate will be adjusted based on the following formula:
where,
CR
0
= the conversion rate in effect immediately prior to the open of
business on the ex-dividend date for such dividend or
distribution, or the open of business on the effective date of
such share split or share combination, as the case may be;
CR
¢
=
the new conversion rate in effect immediately after the open of
business on the ex-dividend date for such dividend or
distribution, or the open of business on the effective date of
such share split or share combination, as the case may be;
OS
0
= the number of shares of our common stock outstanding
immediately prior to the open of business on the ex-dividend
date for such dividend or distribution, or the open of business
on the effective date of such share split or share combination,
as the case may be; and
S-47
OS
¢
= the number of shares of our common stock outstanding
immediately after such dividend or distribution, or the open of
business on the effective date of such share split or share
combination, as the case may be.
If any dividend or distribution described in this
clause (1) is declared but not so paid or made, or any
split or combination described in this clause (1) is
announced but the outstanding shares of our common stock are not
split or combined, the new conversion rate shall be readjusted
to the conversion rate that would then be in effect if such
dividend or distribution had not been declared.
(2) If we distribute to all or substantially all holders of
our common stock any rights or warrants entitling them for a
period of not more than 45 days from the record date of
such distribution to subscribe for or purchase shares of our
common stock, at a price per share less than the average of the
last reported sale prices of our common stock on the ten trading
days immediately preceding the date that such distribution was
first publicly announced, the conversion rate will be adjusted
based on the following formula:
|
|
|
|
|
CR
¢
= CR
0
×
|
|
OS
0
+
X
|
|
|
|
OS
0
+
Y
|
|
|
where,
CR
0
= the conversion rate in effect immediately prior to the open of
business on the ex-dividend date for such distribution;
CR
¢
= the new conversion rate in effect immediately after the open
of business on the ex-dividend date for such distribution;
OS
0
= the number of shares of our common stock outstanding
immediately prior to the open of business on the ex-dividend
date for such distribution;
X = the total number of shares of our common stock issuable
pursuant to such rights or warrants; and
Y = the number of shares of our common stock equal to the
aggregate price payable to exercise such rights or warrants
divided by the average of the last reported sale prices of our
common stock over the ten consecutive
trading-day
period ending on the trading day immediately preceding the
ex-dividend date for such distribution.
For purposes of this clause (2), in determining whether any
rights or warrants entitle the holders to subscribe for or
purchase common stock at less than the applicable last reported
sale prices of our common stock, and in determining the
aggregate exercise or conversion price payable for such common
stock, there shall be taken into account any consideration
received by us for such rights or warrants and any amount
payable upon exercise or conversion thereof, with the value of
such consideration, if other than cash, to be determined by our
board of directors. If any right or warrant described in this
clause (2) is not exercised or converted prior to the
expiration of the exercisability or convertability thereof, the
new conversion rate shall be readjusted to the conversion rate
that would then be in effect if such right or warrant had not
been so issued.
(3) If we distribute shares of our capital stock, evidences
of our indebtedness or other assets or property of ours to all
or substantially all holders of our common stock, excluding:
|
|
|
|
|
dividends or distributions referred to in clause (1) or
(2) above;
|
|
|
|
dividends or distributions paid exclusively in cash; and
|
|
|
|
spin-offs to which the provisions set forth below in this
paragraph (3) shall apply,
|
then the conversion rate will be adjusted based on the following
formula:
|
|
|
|
|
CR
¢
= CR
0
×
|
|
SP
0
|
|
|
|
SP
0
−
FMV
|
|
|
where,
CR
0
= the conversion rate in effect immediately prior to the open of
business on the ex-dividend date for such distribution;
S-48
CR
¢
= the new conversion rate in effect immediately after the open
of business on the ex-dividend date for such distribution;
SP
0
= the average of the last reported sale prices of our common
stock over the ten consecutive
trading-day
period ending on the trading day immediately preceding the
ex-dividend date for such distribution; and
FMV = the fair market value (as determined by our board of
directors or a committee thereof) of the shares of capital
stock, evidences of indebtedness, assets or property distributed
with respect to each outstanding share of our common stock on
the ex-dividend date for such distribution.
Such adjustment shall become effective immediately prior to the
open of business on the ex-dividend date for such distribution;
provided
that if FMV as set forth above is
equal to or greater than
SP
0
as set forth above, in lieu of the foregoing adjustment,
adequate provision shall be made so that each noteholder shall
receive on the date on which the distributed property is
distributed to holders of our common stock, for each $1,000
principle amount of notes upon conversion, the amount of
distributed property such holder would have received had such
holder owned a number of shares of common stock equal to the
conversion rate on the record date for such distribution.
With respect to an adjustment pursuant to this clause (3)
where there has been a payment of a dividend or other
distribution on our common stock of shares of capital stock of
any class or series, or similar equity interest, of or relating
to a subsidiary or other business unit, which we refer to as a
spin-off, the conversion rate in effect immediately
before 5:00 p.m., New York City time, on the tenth trading
day immediately following, and including, the effective date of
the spin-off will be increased based on the following formula:
|
|
|
|
|
CR
¢
= CR
0
×
|
|
FMV +
MP
0
|
|
|
|
MP
0
|
|
|
where,
CR
0
= the conversion rate in effect immediately prior to the close
of business on the tenth trading day immediately following, and
including, the effective date of the spin-off;
CR
¢
=
the new conversion rate in effect immediately after the close of
business on the tenth trading day immediately following, and
including, the effective date of the spin-off;
FMV = the average of the last reported sale prices of the
capital stock or similar equity interest distributed to holders
of our common stock applicable to one share of our common stock
over the first ten consecutive
trading-day
period immediately following, and including, the effective date
of the spin-off; and
MP
0
= the average of the last reported sale prices of our common
stock over the first ten consecutive
trading-day
period immediately following, and including, the effective date
of the spin-off.
The adjustment to the conversion rate under the preceding
paragraph will occur immediately prior to the open of business
on the day immediately following the tenth trading day
immediately following, and including, the effective date of the
spin-off;
provided
that, for purposes of determining the
conversion rate, in respect of any conversion during the ten
trading days following the effective date of any spin-off,
references within the portion of this paragraph (3) related
to spin-offs to ten trading days shall be deemed
replaced with such lesser number of trading days as have elapsed
between the effective date of such spin-off and the relevant
conversion date (but in no event less than five trading days).
If any such dividend or distribution described in this
clause (3) is declared but not paid or made, the new
conversion rate shall be readjusted to be the conversion rate
that would then be in effect if such dividend or distribution
had not been declared.
(4) If we pay any cash dividend or distribution to all or
substantially all holders of our common stock, the conversion
rate will be adjusted based on the following formula:
|
|
|
|
|
CR
¢
= CR
0
×
|
|
SP
0
|
|
|
|
SP
0
−
C
|
|
|
where,
S-49
CR
0
= the conversion rate in effect immediately prior to the open of
business on the ex-dividend date for such distribution;
CR
¢
= the new conversion rate in effect immediately after the open
of business on the ex-dividend date for such distribution;
SP
0
= the average of the last reported sale prices of our common
stock on the ten trading days immediately preceding the
ex-dividend date for such distribution; and
C = the amount in cash per share we distribute to holders of our
common stock.
Such adjustment shall become effective immediately after the
open of business on the ex-dividend date for such dividend or
distribution;
provided
that if the portion of the cash so
distributed applicable to one share or our common stock is equal
to or greater than
SP
0
as set forth above, in lieu of the foregoing adjustment,
adequate provision shall be made so that each noteholder shall
have the right to receive on the date on which relevant cash
dividend or distribution is distributed to holders of common
stock for each $1,000 principle amount of notes upon conversion,
the amount of cash such holder would have received had such
holder owned a number of shares equal to the conversion rate on
the record date for such distribution.
If any dividend or distribution described in this
clause (4) is declared but not so paid or made, the new
conversion rate shall be readjusted to the conversion rate that
would then be in effect if such dividend or distribution had not
been declared.
(5) If we or any of our subsidiaries makes a payment in
respect of a tender offer or exchange offer for our common stock
and if the cash and value of any other consideration included in
the payment per share of common stock exceeds the average of the
last reported sale prices of our common stock over the ten
consecutive
trading-day
period commencing on, and including, the trading day next
succeeding the last date on which tenders or exchanges may be
made pursuant to such tender or exchange offer, the conversion
rate will be increased based on the following formula:
|
|
|
|
|
CR
¢
= CR
0
×
|
|
AC +
(
SP×OS
¢
)
|
|
|
|
OS
0
×
SP
¢
|
|
|
where,
CR
0
= the conversion rate in effect immediately prior to the close
of business on the day immediately following the last trading
day of the ten consecutive
trading-day
period commencing on, and including, the trading day next
succeeding the date such tender or exchange offer expires;
CR
¢
= the new conversion rate in effect immediately after the close
of business on the last trading day of the ten consecutive
trading-day
period commencing on, and including, the trading day next
succeeding the date such tender or exchange offer expires;
AC = the aggregate value of all cash and any other consideration
(as determined by our board of directors or a committee thereof)
paid or payable for shares purchased in such tender or exchange
offer;
OS
0
= the number of shares of our common stock outstanding
immediately prior to the date such tender or exchange offer
expires;
OS
¢
= the number of shares of our common stock outstanding
immediately after the date such tender or exchange offer expires
(after giving effect to the purchase of all shares accepted for
purchase or exchange pursuant to such tender offer or exchange
offer); and
SP
¢
= the average of the last reported sale prices of our common
stock over the ten consecutive
trading-day
period commencing on, and including, the trading day next
succeeding the date such tender or exchange offer expires.
The adjustment to the conversion rate under the preceding
paragraph will occur on the day immediately following the tenth
trading day immediately following, but excluding, the date such
tender or exchange offer expires;
provided
that, for
purposes of determining the conversion rate, in respect of any
conversion during the ten trading days immediately following,
and including, the date that any tender or exchange offer
expires, references
S-50
within this paragraph (5) to ten trading days shall be
deemed replaced with such lesser number of trading days as have
elapsed between the date such tender or exchange offer expires
and the relevant conversion date (but in no event less then five
trading days). If we or one of our subsidiaries is obligated to
purchase our common stock pursuant to any such tender or
exchange offer but is permanently prevented by applicable law
from effecting any such purchase or all or any portion of such
purchases are rescinded, the new conversion rate shall be
readjusted to the conversion rate that would be in effect if
such tender or exchange offer (or such portion) had not been
made.
Except as stated herein, we will not adjust the conversion rate
for the issuance of shares of our common stock or any securities
convertible into or exchangeable for shares of our common stock
or the right to purchase shares of our common stock or such
convertible or exchangeable securities.
Treatment
of Reference Property
In the event of:
|
|
|
|
|
any reclassification of our common stock (other than a change
only in par value, or from par value to no par value or from no
par value to par value or a change as a result of a subdivision
or combination of our stock);
|
|
|
|
a consolidation, merger or combination involving us; or
|
|
|
|
a sale or conveyance to another person of the property and
assets of us as an entirety or substantially as an entirety,
|
in each case as a result of which our common stock is converted
into, or exchanged for, stock, other securities, other property
or assets (including cash) or any combination thereof, then, at
the effective time of the transaction (each, a reference
property transaction), the right to receive shares of our
common stock upon conversion of a note, if any, will be changed
into the right to receive the kind and amount of shares of
stock, other securities or other property or assets (including
cash) or any combination thereof that a holder would have been
entitled to receive (the
reference property
)
upon such transaction in respect of such common stock.
From and after the effective time of such transaction:
|
|
|
|
|
the conversion rate will relate to units of such reference
property (a unit of reference property being the
kind and amount of reference property that a holder of one share
of our common stock would receive in such transaction); and
|
|
|
|
the daily conversion values will be determined based on the
value of one unit of reference property determined as provided
under Conversion Rights Payment
Upon Conversion.
|
If the transaction causes our common stock to be converted into
the right to receive more than a single type of consideration
(determined based in part upon any form of stockholder
election), the reference property into which the notes will be
convertible will be deemed to be the weighted average of the
types and amounts of such consideration received by the holders
of our common stock that affirmatively make such an election.
Voluntary
Increases in Conversion Rate
We are permitted to increase the conversion rate of the notes by
any amount for a period of at least 20 business days if our
board of directors determines that such increase would be in our
best interest. We may also (but are not required to) increase
the conversion rate to avoid or diminish income tax to holders
of our common stock or rights to purchase shares of our common
stock in connection with a dividend or distribution of shares
(or rights to acquire shares) or similar event.
A holder may, in some circumstances, including the distribution
of cash dividends to holders of our shares of common stock, be
deemed to have received a distribution or dividend subject to
U.S. federal income tax as a result of an adjustment or the
nonoccurrence of an adjustment to the conversion rate. For a
discussion of the U.S. federal income tax treatment of an
adjustment to the conversion rate, see Material
U.S. Federal Income Tax Considerations.
S-51
Events
That Will Not Result in Adjustment
The conversion rate will not be adjusted:
|
|
|
|
|
upon the issuance of any shares of our common stock pursuant to
any present or future plan providing for the reinvestment of
dividends or interest payable on our securities and the
investment of additional optional amounts in shares of our
common stock under any plan;
|
|
|
|
upon the issuance of any shares of our common stock or
restricted stock units or options or rights (including
stockholder appreciation rights) to purchase those shares
pursuant to any present or future employee, director or
consultant benefit plan or program of or assumed by us or any of
our subsidiaries;
|
|
|
|
upon the issuance of any shares of our common stock pursuant to
any option, warrant, right or exercisable, exchangeable or
convertible security not described in the preceding bullet and
either outstanding as of the date the notes were first issued or
issued after such date and not expressly covered by a
transaction described in Adjustment Events above;
|
|
|
|
upon the issuance of any shares of our common stock not
described in the preceding bullets that is not expressly covered
by a transaction described in Adjustment Events
above regardless of the price at which such shares are issued;
|
|
|
|
upon the repurchase of any of our shares pursuant to an
open-market share repurchase program or other buy-back
transaction that is not a tender offer or exchange offer of the
nature described in Conversion
Rights Conversion Rate Adjustments
Adjustment Events;
|
|
|
|
for a change in the par value of the common stock; or
|
|
|
|
for accrued and unpaid interest, if any.
|
Adjustments to the conversion rate will be calculated to the
nearest 1/10,000th.
Notwithstanding anything to the contrary in the sections
Conversion Rights; Conversion Rate
Adjustments, we will not be required to adjust the
conversion rate unless the adjustment would result in a change
of at least 1% of the conversion rate. However, we will carry
forward any adjustments that are less than 1% of the conversion
rate and take them into account when determining subsequent
adjustments. In addition, we will make any carry forward
adjustments not otherwise effected (1) upon conversion of
the notes, (2) upon required purchases of the notes in
connection with a fundamental change, and (3) 25 scheduled
trading days prior to the maturity date of the notes. No
adjustment to the conversion rate will be made if it results in
a conversion price that is less than the par value (if any) of
our common stock.
Increase
of Conversion Rate Upon Conversion Upon Make-Whole Fundamental
Change
If you elect to convert your notes in connection with a
make-whole fundamental change (as defined below), we
will increase the conversion rate (for such conversion only) by
a number of shares (the
additional shares
) as
described below. Any conversion of the notes by a holder will be
deemed for these purposes to be in connection with
such make-whole fundamental change if it occurs during the
period that begins on the date on which such make-whole
fundamental change becomes effective (or 15 trading days prior
to the date we announce as the anticipated effective date of
such make-whole fundamental change if such event constitutes a
fundamental change as described under clause (4) of the
definition of fundamental change as described below under
Fundamental Change Permits Holders to Require
Us to Purchase Notes) and ends on (and includes) the
business day prior to the repurchase date relating to such
make-whole fundamental change as described below under
Fundamental Change Permits Holders to Require
Us to Purchase Notes. A
make-whole fundamental
change
means any transaction or event that constitutes
a fundamental change pursuant to clause (1) or
clause (4) under the definition of fundamental change as
described below under Fundamental Change
Permits Holders to Require Us to Purchase Notes. However,
in the case of a transaction described in clause (4) of the
definition of fundamental change as described below under
Fundamental Change Permits Holders to Require
Us to Purchase Notes, if we determine that such
transaction will not occur on substantially the terms
anticipated, we will not be obligated to increase the conversion
rate, regardless of the fact that holders may have elected to
convert notes in anticipation
S-52
of the effective date of such event, and we will issue a press
release and notify holders who have so elected to convert their
notes promptly after we determine that the transaction in
question will not occur. Each such holder may elect to withdraw
any election to convert by a written notice of withdrawal
delivered to the conversion agent within ten business days after
we announce that the transaction will not occur as anticipated.
We will give notice of an anticipated make-whole fundamental
change to all record holders of the notes no later than the
15th scheduled trading day prior to the date on which such
make-whole fundamental change is anticipated to become
effective, to the extent practicable.
The number of additional shares by which the conversion rate for
the notes will be increased for conversions in connection with a
make-whole fundamental change will be determined by reference to
the table below, based on the date on which the fundamental
change occurs or becomes effective (the
effective
date
), and the price, referred to as the stock
price, paid or deemed to be paid per share of our common
stock in the transaction constituting the make-whole fundamental
change, subject to adjustment as described under the next
paragraph. If holders of our common stock receive only cash in
such transaction, the stock price shall be the cash amount paid
per share. In all other cases, the stock price will be the
average of the last reported sale prices of our common stock
over the ten consecutive trading days prior to but not including
the date of effectiveness of the make-whole fundamental change.
Our board of directors may make appropriate adjustments, in its
good faith determination, to account for any adjustments in the
conversion rate that becomes effective, or any event requiring
adjustment to the conversion rate where the ex-dividend date
occurs, during such ten consecutive trading days.
The stock prices set forth in the first row of the table below
(i.e., column headers) will be adjusted as of any date on which
the conversion rate of the notes is otherwise adjusted. The
adjusted stock prices will equal the stock prices applicable
immediately prior to such adjustment, multiplied by a fraction,
the numerator of which is the conversion rate in effect
immediately prior to the adjustment giving rise to the stock
price adjustment and the denominator of which is the conversion
rate as so adjusted. The number of additional shares will be
adjusted in the same manner as the conversion rate as set forth
above under Conversion Rights
Conversion Rate Adjustments.
The following table sets forth the stock price, effective date
and number of additional shares by which the conversion rate
will be increased upon a conversion in connection with a
make-whole fundamental change that occurs in the corresponding
period to be determined by reference to the stock price and
effective date of the make-whole fundamental change:
Number of
Additional Shares
(per $1,000 principal amount of the notes)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock Price
|
|
Effective Date
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
June , 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
June 15, 2009
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
June 15, 2010
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
June 15, 2011
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
June 15, 2012
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
June 15, 2013
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The exact stock prices and effective dates may not be set forth
in the table above, in which case:
|
|
|
|
|
if the stock price is between two stock prices in the table or
the effective date is between two effective dates in the table,
the number of additional shares will be determined by us by a
straight-line interpolation between the number of additional
shares set forth for the higher and lower stock prices and the
earlier and later effective dates, based on a
365-day
year, as applicable;
|
|
|
|
if the stock price is greater than
$ per share (subject to adjustment
in the same manner as the stock prices set forth in the first
row of the table above), no additional shares will be issued
upon conversion; and
|
|
|
|
if the stock price is less than $
per share (subject to adjustment in the same manner as the stock
prices set forth in the first row of the table above), no
additional shares will be issued upon conversion.
|
S-53
Our obligation to increase the conversion rate as described
above could be considered a penalty, in which case the
enforceability thereof would be subject to general principles of
law and equity. In addition, in no event will the conversion
rate after adjustment exceed per
$1,000 principal amount of notes, subject to adjustments in the
same manner as the conversion rate as set forth under
Conversion Rights Conversion Rate
Adjustments.
Fundamental
Change Permits Holders to Require Us to Purchase Notes
If a fundamental change (as defined below in this section)
occurs at any time, you will have the right, at your option, to
require us to purchase any or all of your notes, or any portion
of the principal amount thereof that is equal to $1,000 or an
integral multiple of $1,000, on a date (the date being referred
to as the fundamental change repurchase date) of our
choosing that is not less than 20 or more than 35 days (or
any longer period required by law) after the effective date for
such fundamental change. The price we are required to pay is
equal to 100% of the principal amount of the notes to be
purchased plus accrued and unpaid interest, to, but excluding,
the fundamental change repurchase date (unless the fundamental
change repurchase date is after a regular record date and on or
prior to the interest payment date to which it relates, in which
case interest accrued to the interest payment date will be paid
to holders of the notes as of the preceding record date and the
price we are required to pay will be equal to the principal
amount of notes subject to repurchase). Any notes purchased by
us will be paid for in cash.
A
fundamental change
will be deemed to have
occurred at the time after the notes are originally issued that
any of the following occurs:
(1) a
person
or
group
within the meaning of Section 13(d)(3) of the Exchange Act
becomes the direct or indirect beneficial owner, as
defined in
Rule 13d-3
under the Exchange Act, of shares of our common stock
representing more than 50% of the voting power of our common
stock entitled to vote generally in the election of directors
and (i) files a Schedule 13D or Schedule TO or
any other schedule, form or report under the Exchange Act
disclosing such beneficial ownership or (ii) we otherwise
become aware of any such person or group;
provided
that
this clause (1) shall not apply to a transaction covered in
clause (4) below, including any exception thereto; or
(2) the common stock into which the notes are then
convertible ceases to be listed for trading on the New York
Stock Exchange, the Nasdaq Global Select Market, the Nasdaq
Global Market or another U.S. national securities
exchange; or
(3) the first day on which a majority of the members of our
board of directors does not consist of continuing
directors; or
(4) we are a party to a consolidation, merger or binding
share exchange, or any conveyance, transfer, sale, lease or
other disposition in a single transaction or a series of
transactions of all or substantially all of our properties and
assets other than any transaction:
(i) that does not result in any reclassification,
conversion, exchange or cancellation of outstanding shares of
our capital stock or pursuant to which holders of our capital
stock immediately prior to the transaction have the entitlement
to exercise, directly or indirectly, 50% or more of the total
voting power of all shares of capital stock entitled to vote
generally in elections of directors of the continuing or
surviving or successor person (or any parent thereof)
immediately after giving effect to such transaction; or
(ii) that is effected solely for the purpose of changing
our jurisdiction of incorporation and resulting in a
reclassification, conversion or exchange of outstanding shares
of common stock, if at all, solely into shares of common stock
of the surviving entity or a direct or indirect parent of the
surviving corporation; or
(iii) with any of our wholly-owned subsidiaries, so long as
such transaction is not part of a plan or a series of
transactions designed to or having the effect of merging or
consolidating with, or conveying, transferring, selling, leasing
or disposing of all or substantially all our properties and
assets to any other person or persons; or
(5) our stockholders approve any plan or proposal for our
liquidation or dissolution.
S-54
For purposes of this fundamental change definition:
|
|
|
|
|
board of directors
means the board of
directors or other governing body charged with the ultimate
management of any person;
|
|
|
|
continuing director
means a director who
either was a member of our board of directors on the date of the
supplemental indenture or who becomes a member of our board of
directors subsequent to that date and whose initial election,
appointment or nomination for election by our stockholders is
duly approved by a majority of the continuing directors on our
board of directors at the time of such approval, either by a
specific vote or by approval of the proxy statement issued by us
on behalf of our entire board of directors in which such
individual is named as a nominee for director; and
|
|
|
|
the term
person
includes any syndicate or
group that would be deemed to be a person under
Section 13(d)(3) of the Exchange Act.
|
However, a fundamental change will be deemed not to have
occurred if more than 90% of the consideration in the
transaction or transactions (other than cash payments for
fractional shares and cash payments made in respect of
dissenters appraisal rights) which otherwise would
constitute a fundamental change under clause (4) above
consists of shares of common stock, depositary receipts or other
certificates representing common equity interests traded or to
be traded immediately following such transaction on the New York
Stock Exchange, the Nasdaq Global Select Market, the Nasdaq
Global Market or another U.S. national securities exchange and,
as a result of the transaction or transactions, the notes become
convertible into such common stock, depositary receipts or other
certificates representing common equity interests (and any
rights attached thereto) and other applicable consideration.
This fundamental change repurchase feature may make more
difficult or discourage a takeover of us and the removal of
incumbent management. We are not, however, aware of any specific
effort to accumulate shares of our common stock or to obtain
control of us by means of a merger, tender offer, solicitation
or otherwise. In addition, the fundamental change repurchase
feature is not part of a plan by management to adopt a series of
anti-takeover provisions.
The term fundamental change is limited to specified transactions
and may not include other events that might adversely affect our
financial condition. In addition, the requirement that we
provide holders of notes with notice of the occurrence of a
fundamental change and their resulting purchase right upon a
fundamental change may not protect holders in the event of a
highly leveraged transaction, reorganization, merger or similar
transaction involving us.
We could, in the future, enter into certain transactions,
including mergers or recapitalizations, that would not
constitute a fundamental change but would increase the amount of
debt, including other senior indebtedness, outstanding or
otherwise adversely affect a holder. Neither we nor our
subsidiaries are prohibited from incurring debt, including other
senior indebtedness, under the indenture. The incurrence of
significant amounts of additional debt could adversely affect
our ability to service our debt, including the notes.
Our ability to repurchase notes may be limited by restrictions
on our ability to obtain funds for such repurchase through
dividends from our subsidiaries and the terms of our then
existing borrowing agreements. See Risk
Factors We may not be able to pay interest on the
notes, or convert the notes or repurchase the notes at the
option of the holder upon a fundamental change. If we fail
to repurchase the notes when required, we will be in default
under the indenture. In addition, we have, and may in the future
incur, other indebtedness with provisions permitting our holders
to require us to repurchase our indebtedness on some specific
dates.
Within 15 days after a fundamental change, we will provide
to all holders of the notes and the trustee, paying agent and
conversion agent a written notice of the occurrence of the
fundamental change and of the resulting purchase right. Such
notice shall state, among other things:
|
|
|
|
|
the events causing a fundamental change;
|
|
|
|
the effective date of the fundamental change;
|
|
|
|
the last date on which a holder may exercise the purchase right;
|
|
|
|
the fundamental change purchase price;
|
S-55
|
|
|
|
|
the fundamental change repurchase date;
|
|
|
|
the name and address of the paying agent and the conversion
agent;
|
|
|
|
the conversion rate and, if applicable, any adjustments to the
conversion rate;
|
|
|
|
if applicable, that the notes with respect to which a
fundamental change purchase notice has been delivered by a
holder may be converted only if the holder withdraws the
fundamental change purchase notice in accordance with the terms
of the indenture; and
|
|
|
|
the procedures that holders must follow to require us to
purchase their notes.
|
Simultaneously with providing such notice, we will publish a
notice containing this information in a newspaper of general
circulation in The City of New York or publish the information
on our website or through such other public medium as we may use
at that time.
To exercise the purchase right, you must deliver, on or before
the close of business (i.e., 5:00 p.m., New York City time)
on the business day immediately preceding the fundamental change
repurchase date, a written purchase notice and the form entitled
Form of Fundamental Change Purchase Notice on the
reverse side of the notes duly completed, to the paying agent
and at any time after delivery of such notice, you must deliver
the notes to be purchased, duly endorsed for transfer. Your
purchase notice must state:
|
|
|
|
|
if certificated notes have been issued, the certificate numbers
of your notes to be delivered for purchase, or if not
certificated, your notice must comply with appropriate DTC
procedures;
|
|
|
|
the portion of the principal amount of notes to be purchased,
which must be $1,000 or an integral multiple thereof; and
|
|
|
|
that the notes are to be purchased by us pursuant to the
applicable provisions of the notes and the indenture.
|
You may withdraw any purchase notice (in whole or in part) by a
written notice of withdrawal delivered to the paying agent prior
to 5:00 p.m., New York City time, on the business day
immediately preceding the fundamental change repurchase date.
The notice of withdrawal must state:
|
|
|
|
|
the principal amount of the withdrawn notes;
|
|
|
|
if certificated notes have been issued, the certificate numbers
of the withdrawn notes, or if not certificated, your notice must
comply with appropriate DTC procedures; and
|
|
|
|
the principal amount, if any, which remains subject to the
purchase notice.
|
We will be required to purchase the notes for which a repurchase
notice has been delivered and not validly withdrawn on the
fundamental change repurchase date. You will receive payment of
the fundamental change purchase price promptly following the
later of the business day following the fundamental change
repurchase date or the time of book-entry transfer or the
delivery of the notes. If on the business day following the
fundamental change repurchase date, the paying agent holds money
sufficient to pay the fundamental change purchase price of the
notes for which a repurchase notice has been delivered and not
validly withdrawn then:
|
|
|
|
|
the notes will cease to be outstanding and interest, if any,
will cease to accrue (whether or not book-entry transfer of the
notes is made or whether or not the note is delivered to the
paying agent); and
|
|
|
|
all other rights of the holder will terminate (other than the
right to receive the fundamental change purchase price upon
delivery or transfer of the notes).
|
No notes may be repurchased by us at the option of the holders
upon a fundamental change if the principal amount of the notes
has been accelerated, and such acceleration has not been
rescinded, on or prior to such date (except in the case of an
acceleration resulting from a default by us in the payment of
the fundamental change purchase price with respect to such
notes).
The definition of fundamental change includes a phrase relating
to the conveyance, transfer, sale, lease or disposition of
all or substantially all of our assets. There is no
precise, established definition of the phrase
substantially all under applicable law. Accordingly,
the ability of a holder of the notes to require us to purchase
its
S-56
notes as a result of the conveyance, transfer, sale, lease or
other disposition of less than all of our assets may be
uncertain.
In connection with any repurchase of notes, we will, to the
extent applicable:
|
|
|
|
|
comply with the provisions of
Rule 13e-4,
Rule 14e-1
and any other applicable tender offer rules under the Exchange
Act;
|
|
|
|
file a Schedule TO or any successor or similar schedule, if
required, under the Exchange Act; and
|
|
|
|
otherwise comply with all applicable federal and state
securities laws in connection with any offer by us to purchase
the notes.
|
Consolidation,
Merger and Sale of Assets
We may not consolidate with or merge into any other person or
convey, transfer or lease all or substantially all of our assets
to any successor person in a single transaction or series of
transactions, unless:
|
|
|
|
|
we are the continuing person or the resulting, surviving or
transferee person, if other than us, is organized and validly
existing under the laws of the United States of America, any
state thereof, or the District of Columbia and assumes our
obligations on the notes and under the indenture;
|
|
|
|
immediately after giving effect to the transaction, no default
or event of default shall have occurred and be
continuing; and
|
|
|
|
any other applicable conditions described in the indenture are
met.
|
When such a person assumes our obligations in such
circumstances, subject to certain exceptions, we shall be
discharged from all obligations under the notes and the
indenture. Although the indenture permits these transactions,
some of the transactions could constitute a fundamental change
of us and as a result could permit each holder to require us to
repurchase the notes of such holder as described under
Fundamental Change Permits Holders to Require
Us to Purchase Notes. Some of the transactions may also
allow you to exercise conversion rights as described under
Conversion Rights Conversion Upon
Specified Corporate Transactions or increase the
conversion rate as described in Increase of
Conversion Rate Upon Conversion Upon Make-Whole Fundamental
Change. An assumption of our obligations under the notes
and the indenture by such person might be deemed for
U.S. federal income tax purposes to be an exchange of the
notes for new notes by the beneficial owners thereof, possibly
resulting in recognition of gains or losses for such purposes
and other adverse tax consequences to the beneficial owner. You
should consult your own tax advisors regarding the tax
consequences of such an assumption.
This covenant includes a phrase relating to the conveyance,
transfer, sale, lease or other disposition of all or
substantially all of our assets. There is no precise,
established definition of the phrase substantially
all under applicable law. Accordingly, the effect of this
covenant may be uncertain in connection with a conveyance,
transfer, sale, lease or other disposition of less than all of
our assets. This covenant and the other provisions in this
prospectus supplement relating to our ability to consummate a
consolidation, merger or asset sale supersede and replace the
applicable provisions of the prospectus.
Events
of Default
The following events constitute events of default under the
indenture and the supplemental indenture (and supersede and
replace the events of default described in the prospectus):
(1) our failure to pay the principal of any note when due;
(2) our failure to pay the cash and shares of common stock
(if any) owing upon conversion of any note (including any
additional shares) within the time period required by the
indenture;
(3) our failure to pay any interest amounts on any note
when due if such failure continues for 30 days;
(4) our failure to comply with our obligations under
Consolidation, Merger and Sale of Assets;
S-57
(5) our failure to issue a fundamental change notice when
such notice becomes due in accordance with the terms of the
indenture;
(6) our failure to comply with our obligation to repurchase
the notes at the option of a holder upon a fundamental change as
required by the indenture;
(7) failure to perform any covenant or agreement in the
indenture applicable to the notes (other than those covenants
and agreements specifically dealt with by other events of
default), but other than a covenant included in the indenture
solely for the benefit of a different series of our debt
securities, which failure to comply continues for 90 days
after written notice stating that it is a notice of
default from the trustee or holders of 25% of the
outstanding principal amount of the notes as provided in the
indenture;
(8) any indebtedness for money borrowed by us or one of our
significant subsidiaries in an outstanding principal amount in
excess of $20.0 million is not paid at final maturity or is
accelerated and such indebtedness is not discharged, or such
default in payment or acceleration is not cured or rescinded,
within 60 days after written notice stating that it is a
notice of default from the trustee or holders of 25%
of the outstanding principal amount of the notes as provided in
the indenture;
(9) we fail or any of our significant subsidiaries fails to
pay one or more final and non-appealable judgments entered by a
court or courts of competent jurisdiction, the aggregate
uninsured or unbonded portion of which is in excess of
$50.0 million, if the judgments are not paid, discharged or
stayed within 60 days after written notice stating that it
is a notice of default from the trustee or holders
of 25% of the outstanding principal amount of the notes as
provided in the indenture; or
(10) certain events of bankruptcy, insolvency, or
reorganization relating to any of our subsidiaries that is a
significant subsidiary (as defined in
Regulation S-X
under the Exchange Act) or any group of our subsidiaries that in
the aggregate would constitute a significant
subsidiary.
Notwithstanding anything in the prospectus, if we so elect, the
sole remedy of holders for an event of default relating to the
failure to comply with the reporting obligations in the
indenture, which are described below under
Reports, will, for the period beginning
on the 91st day and ending on the 180th day after the
written notice of the occurrence of such failure to report from
the trustee or holders of 25% of the outstanding principal
amount of the notes, consist exclusively of the right to receive
additional interest on the notes at an annual rate equal to
0.25% of the principal amount of the notes and for the period
beginning on the 181st day and ending on the 360th day
after such written notice consist exclusively of the right to
receive additional interest on the notes at an annual rate of
0.50% of the principal amount of the notes. This additional
interest will be payable in the same manner and on the same
dates as the stated interest payable on the notes. If we so
elect, this additional interest will accrue on all outstanding
notes from and including the 91st day following the date of
such written notice of the failure to comply with the reporting
obligations in the indenture to but not including the date on
which the event of default relating to the reporting obligations
shall have been cured or waived. On the 270th day after the
commencement of such additional interest (if such violation is
not cured or waived prior to such 270th day), the notes will be
subject to acceleration upon written notice from the trustee or
holders of 25% of the outstanding principal amount of the notes.
In order to exercise the extension right and elect to pay the
additional interest as the sole remedy following the occurrence
of any event of default relating to the failure to comply with
the reporting obligations in accordance with the preceding
paragraph, we must notify all holders of notes and the trustee
and paying agent of our election prior to the close of business
on the 91st day after the written notice to us of such
failure to report (or, if such date is not a business day, on
the first business day thereafter). Upon our failure to timely
give such notice, the notes will be subject to acceleration as
provided in the indenture.
The provisions of the indenture described in the preceding two
paragraphs will not affect the rights of holders of notes in the
event of an occurrence of any other event of default. See
Description of Debt Securities Events of
Default; Notice and Waiver in the attached prospectus.
The trustee shall be under no obligation to exercise any of the
rights or powers vested in it by the indenture at the request or
direction of any of the holders pursuant to the indenture unless
such holders shall have offered to the
S-58
trustee security or indemnity satisfactory to the trustee
against the costs, expenses and liabilities which might be
incurred by it in compliance with such request.
Modification
and Amendment
Subject to certain exceptions, the indenture or the notes may be
amended with the consent of the holders of at least a majority
in principal amount of the notes then outstanding (including,
without limitation, consents obtained in connection with a
purchase of, or tender offer or exchange offer for, notes) and,
subject to certain exceptions, any past default or compliance
with any provisions may be waived with the consent of the
holders of a majority in principal amount of the notes then
outstanding (including, without limitation, consents obtained in
connection with a purchase of, or tender offer or exchange offer
for, notes). However, without the consent of each holder of an
outstanding note affected, no amendment may, among other things:
(1) reduce the percentage in aggregate principal amount of
notes whose holders must consent to an amendment of the
indenture or to waive any past default;
(2) reduce the rate of or extend the stated time for
payment of interest, including any additional interest, on any
note;
(3) reduce the principal of or extend the stated maturity
of any note;
(4) make any change that impairs or adversely affects the
conversion rights of any notes;
(5) reduce any amount payable upon repurchase of any note
(including upon the occurrence of a fundamental change) or
change the time at which or circumstances under which the notes
may or shall be repurchased; or reduce the fundamental change
purchase price of any note or amend or modify in any manner
adverse to the holders of notes our obligation to make such
payments, whether through an amendment or waiver of provisions
in the covenants, definitions or otherwise.;
(6) make any note payable in a currency other than that
stated in the note;
(7) change the ranking of the notes;
(8) impair the right of any holder to receive payment of
principal of and interest, including any additional interest, on
such holders notes on or after the due dates therefor or
to institute suit for the enforcement of any payment on or with
respect to such holders notes; or
(9) make any change in the amendment provisions which
require each holders consent or in the waiver provisions
of the indenture.
Without the consent of any holder, we and the trustee may amend
the indenture to:
(1) cure any ambiguity, omission, defect or inconsistency
in the indenture or conform the terms of the indenture or the
notes to the Description of the Notes section of
this prospectus supplement;
(2) provide for the assumption by a successor corporation,
partnership, trust or limited liability company of our
obligations under the indenture as described above under the
heading Consolidation, Merger and Sale of
Assets;
(3) add guarantees with respect to the notes;
(4) secure the notes;
(5) add to our covenants for the benefit of the holders or
surrender any right or power conferred upon us;
(6) make any change that does not adversely affect the
rights of any holder; or
(7) comply with any requirement of the SEC in connection
with the qualification of the indenture under the
Trust Indenture Act.
The consent of the holders is not necessary under the indenture
to approve the particular form of any proposed amendment. It is
sufficient if such consent approves the substance of the
proposed amendment. After an amendment
S-59
under the indenture becomes effective, we are required to mail
to the holders a notice briefly describing such amendment.
However, the failure to give such notice to all the holders, or
any defect in the notice, will not impair or affect the validity
of the amendment.
Calculations
in Respect of Notes
Except as otherwise provided above, we will be responsible for
making all calculations called for under the notes. These
calculations include, but are not limited to, determinations of
the last reported sale prices and the applicable stock prices of
our common stock, accrued interest payable on the notes and the
conversion rate. We will make all these calculations in good
faith and, absent manifest error, our calculations will be final
and binding on holders of notes. We will provide a schedule of
our calculations to each of the trustee and the conversion
agent, and each of the trustee and conversion agent is entitled
to rely conclusively upon the accuracy of our calculations
without independent verification. The trustee will forward our
calculations to any holder of notes upon the request of that
holder.
Trustee
The Bank of New York Trust Company, N.A. is the trustee and
has been appointed by us as registrar and paying agent with
regard to the notes. From time to time, we may have banking
relationships in the ordinary course of business with The Bank
of New York Trust Company, N.A. or its affiliates.
Reports
We must provide the trustee with a copy of the reports we must
file with the SEC pursuant to Section 13 or 15(d) of the
Exchange Act no later than 15 calendar days after those reports
are filed with the SEC. We also will comply with the provisions
of Section 314(a) of the Trust Indenture Act.
Governing
Law
The indenture provides that it and the notes will be governed
by, and construed in accordance with, the laws of the State of
New York.
Book-Entry,
Settlement and Clearance
The
Global Notes
The notes will be initially issued in the form of one or more
registered notes in global form, without interest coupons, which
we refer to as the global notes. Upon issuance, each
of the global notes will be deposited with the trustee as
custodian for DTC and registered in the name of Cede &
Co., as nominee of DTC.
Ownership of beneficial interests in a global note will be
limited to persons who have accounts with DTC, which we refer to
as DTC participants, or persons who hold interests
through DTC participants. We expect that under procedures
established by DTC:
|
|
|
|
|
upon deposit of a global note with DTCs custodian, DTC
will credit portions of the principal amount of the global note
to the accounts of the DTC participants designated by the
underwriter; and
|
|
|
|
ownership of beneficial interests in a global note will be shown
on, and transfer of ownership of those interests will be
effected only through, records maintained by DTC (with respect
to interests of DTC participants) and the records of DTC
participants (with respect to other owners of beneficial
interests in the global note).
|
Beneficial interests in global notes may not be exchanged for
notes in physical, certificated form except in the limited
circumstances described below.
S-60
Book-Entry
Procedures for the Global Notes
All interests in the global notes will be subject to the
operations and procedures of DTC. We provide the following
summary of those operations and procedures solely for the
convenience of investors. The operations and procedures of DTC
are controlled by that settlement system and may be changed at
any time. Neither we nor the underwriter are responsible for
those operations or procedures.
DTC has advised us that it is:
|
|
|
|
|
a limited purpose trust company organized under the laws of the
State of New York;
|
|
|
|
a
banking organization
within the meaning of
the New York State Banking Law;
|
|
|
|
a member of the Federal Reserve System;
|
|
|
|
a
clearing corporation
within the meaning of
the Uniform Commercial Code; and
|
|
|
|
a
clearing agency
registered under
Section 17A of the Exchange Act.
|
DTC was created to hold securities for its participants and to
facilitate the clearance and settlement of securities
transactions between its participants through electronic
book-entry changes to the accounts of its participants.
DTCs participants include securities brokers and dealers,
including the underwriters; banks and trust companies; clearing
corporations and other organizations. Indirect access to
DTCs system is also available to others such as banks,
brokers, dealers and trust companies; these indirect
participants clear through or maintain a custodial relationship
with a DTC participant, either directly or indirectly. Investors
who are not DTC participants may beneficially own securities
held by or on behalf of DTC only through DTC participants or
indirect participants in DTC.
So long as DTCs nominee is the registered owner of a
global note, that nominee will be considered the sole owner or
holder of the notes represented by that global note for all
purposes under the indenture. Except as provided below, owners
of beneficial interests in a global note:
|
|
|
|
|
will not be entitled to have notes represented by the global
note registered in their names;
|
|
|
|
will not receive or be entitled to receive physical,
certificated notes; and
|
|
|
|
will not be considered the owners or holders of the notes under
the indenture for any purpose, including with respect to the
giving of any direction, instruction or approval to the trustee
under the indenture.
|
As a result, each investor who owns a beneficial interest in a
global note must rely on the procedures of DTC to exercise any
rights of a holder of notes under the indenture (and, if the
investor is not a participant or an indirect participant in DTC,
on the procedures of the DTC participant through which the
investor owns its interest).
Payments of principal, and interest with respect to the notes
represented by a global note will be made by the trustee to
DTCs nominee as the registered holder of the global note.
Neither we nor the trustee will have any responsibility or
liability for the payment of amounts to owners of beneficial
interests in a global note, for any aspect of the records
relating to or payments made on account of those interests by
DTC, or for maintaining, supervising or reviewing any records of
DTC relating to those interests.
Payments by participants and indirect participants in DTC to the
owners of beneficial interests in a global note will be governed
by standing instructions and customary industry practice and
will be the responsibility of those participants or indirect
participants and DTC.
Transfers between participants in DTC will be effected under
DTCs procedures and will be settled in
same-day
funds.
S-61
Certificated
Notes
Notes in physical, certificated form will be issued and
delivered to each person that DTC identifies as a beneficial
owner of the related notes only if:
|
|
|
|
|
DTC notifies us at any time that it is unwilling or unable to
continue as depositary for the global notes and a successor
depositary is not appointed within 90 days;
|
|
|
|
DTC ceases to be registered as a clearing agency under the
Exchange Act and a successor depositary is not appointed within
90 days; or
|
|
|
|
an event of default in respect of the notes has occurred and is
continuing and any holder of notes requests that the notes be
issued in physical, certificated form.
|
In addition, beneficial interests in a global note may be
exchanged for certificated notes upon request of a DTC
participant by written notice given to the trustee by or on
behalf of DTC in accordance with customary procedures of DTC.
S-62
Description
of Common Stock
This section describes the general terms and provisions of our
common stock. The summary set forth below does not purport to be
complete and is subject to and qualified in its entirety by
reference to our amended and restated certificate of
incorporation and amended and restated bylaws, each of which is
incorporated by reference. We encourage you to read our amended
and restated certificate of incorporation and amended and
restated bylaws for additional information before you decide
whether to invest in this offering.
General
Our amended and restated certificate of incorporation authorizes
the issuance of up to 100,000,000 shares of common stock,
par value $0.01 per share.
Voting
Rights
Shares of common stock are entitled to one vote per share on all
matters to be voted on by our stockholders. Holders of shares of
our capital stock are not entitled to cumulate their votes in
the election of directors to our board of directors. Generally,
all matters to be voted on by stockholders must be approved by a
majority of the votes entitled to be cast at a meeting by all
shares of common stock present in person or represented by
proxy, voting together as a single class. Except as otherwise
provided by law, and subject to any voting rights granted to any
outstanding preferred stock, amendments to our amended and
restated certificate of incorporation generally must be approved
by at least a majority of the combined voting power of all our
common stock, voting together as a single class.
Dividend
Rights
The holders of outstanding shares of common stock are entitled
to receive dividends out of assets legally available at the
times and in the amounts that our board of directors may
determine from time to time.
No
Preemptive or Redemption Rights
Shares of our common stock are not entitled to preemptive rights
and are not subject to redemption or sinking fund provisions.
Right to
Receive Liquidation Distributions
Upon our liquidation, dissolution or
winding-up,
the holders of common stock are entitled to share equally in all
of our assets remaining after payment of all liabilities and the
liquidation preferences of any outstanding preferred stock.
Anti-Takeover
Effects of Certain Provisions of Delaware Law
We are subject to the provisions of Section 203 of the
DGCL, regulating corporate takeovers. In general, those
provisions prohibit a Delaware corporation from engaging in any
business combination with any interested stockholder for a
period of three years following the date that the stockholder
became an interested stockholder, unless:
|
|
|
|
|
the transaction is approved by the board before the date the
interested stockholder attained that status;
|
|
|
|
upon consummation of the transaction that resulted in the
stockholder becoming an interested stockholder, the interested
stockholder owned at least 85% of the voting stock of the
corporation outstanding at the time the transaction
commenced; or
|
|
|
|
on or after the date the business combination is approved by the
board and authorized at a meeting of stockholders, by at least
two-thirds of the outstanding voting stock that is not owned by
the interested stockholder.
|
S-63
Section 203 defines business combination to
include the following:
|
|
|
|
|
any merger or consolidation involving the corporation and the
interested stockholder;
|
|
|
|
any sale, transfer, pledge or other disposition of 10% or more
of the assets of the corporation involving the interested
stockholder;
|
|
|
|
subject to certain exceptions, any transaction that results in
the issuance or transfer by the corporation of any stock of the
corporation to the interested stockholder;
|
|
|
|
any transaction involving the corporation that has the effect of
increasing the proportionate share of the stock of any class or
series of the corporation beneficially owned by the interested
stockholder; or
|
|
|
|
the receipt by the interested stockholder of the benefit of any
loans, advances, guarantees, pledges or other financial benefits
provided by or through the corporation.
|
In general, Section 203 defines an interested stockholder
as any entity or person beneficially owning 15% or more of the
outstanding voting stock of a corporation and any entity or
person affiliated with or controlling or controlled by any of
these entities or persons.
A Delaware corporation may opt out of this provision either with
an express provision in its original certificate of
incorporation or in an amendment to its certificate of
incorporation or bylaws approved by its stockholders.
However, we have not opted out, and do not currently intend to
opt out, of this provision. The statute could prohibit or delay
mergers or other takeover or change in control attempts and,
accordingly, may discourage attempts to acquire us.
Anti-Takeover
Effects of Our Amended and Restated Certificate of Incorporation
and Bylaws
Certain provisions of our amended and restated certificate of
incorporation and bylaws, which are summarized in the following
paragraphs, may have an anti-takeover effect and may delay,
defer or prevent a tender offer or takeover attempt that a
stockholder might consider in its best interest, including those
attempts that might result in a premium over the market price
for the shares held by stockholders.:
|
|
|
|
|
No Stockholder Action by Written Consent; Calling of Special
Meetings of Stockholders.
Our bylaws do not
permit stockholder action by written consent. Our bylaws also
provide that special meetings of our stockholders may be called
only by the board of directors.
|
|
|
|
Advance Notice Requirements for Stockholder Proposals and
Director Nominations.
Our bylaws provide that
stockholders seeking to nominate candidates for election as
directors or to bring business before an annual meeting of
stockholders must provide timely notice of their proposal in
writing to the corporate secretary. Generally, to be timely, a
stockholders notice must be received at our principal
executive offices not less than 90 days nor more than
120 days prior to the first anniversary date of the
previous years annual meeting. Our bylaws also specify
requirements as to the form and content of a stockholders
notice. These provisions may impede stockholders ability
to bring matters before an annual meeting of stockholders or
make nominations for directors at an annual meeting of
stockholders.
|
|
|
|
Vacancies.
Our amended and restated
certificate of incorporation and bylaws provide that any
vacancies on our board of directors will be filled only by the
affirmative vote of a majority of the remaining directors,
although less than a quorum.
|
Limitation
of Liability and Indemnification Matters
We have adopted provisions in our amended and restated
certificate of incorporation that limit the liability of our
directors for monetary damages for breach of their fiduciary
duty as directors, except for liability that cannot be
eliminated under the DGCL. Delaware law provides that directors
of a company will not be personally liable for monetary damages
for breach of their fiduciary duty as directors, except for
liabilities:
|
|
|
|
|
for any breach of their duty of loyalty to us or our
stockholders;
|
S-64
|
|
|
|
|
for acts or omissions not in good faith or which involve
intentional misconduct or a knowing violation of law;
|
|
|
|
for unlawful payment of dividend or unlawful stock repurchase or
redemption, as provided under Section 174 of the
DGCL; or
|
|
|
|
for any transaction from which the director derived an improper
personal benefit.
|
Our amended and restated certificate of incorporation and
amended and restated bylaws also provide that we will indemnify
our directors and officers to the fullest extent permitted by
Delaware law. Our amended and restated bylaws also permit us to
purchase insurance on behalf of any officer, director, employee
or other agent for any liability arising out of his actions as
our officer, director, employee or agent, regardless of whether
the amended and restated bylaws would permit indemnification. We
have entered into separate indemnification agreements with our
directors and executive officers that could require us, among
other things, to indemnify them against certain liabilities that
may arise by reason of their status or service as directors and
to advance their expenses incurred as a result of any proceeding
against them as to which they could be indemnified.
Nasdaq
Global Select Market Listing Symbol
Our common stock trades on the Nasdaq Global Select Market under
the symbol ENER.
S-65
Description
of the Share Lending Agreement
Concurrently with this offering of notes, we are offering, by
means of a separate prospectus supplement and accompanying
prospectus, 3,438,500 shares of common stock, which we will
loan to an affiliate of Credit Suisse Securities (USA) LLC, a
managing underwriter in this offering, pursuant to the terms of
a share lending agreement described below. These shares are
often referred to as the borrowed shares.
To make the purchase of the notes offered pursuant to this
prospectus supplement and the accompanying prospectus more
attractive to prospective investors, we have entered into a
share lending agreement, dated June , 2008,
with Credit Suisse Securities (USA) LLC, as agent for its
affiliate, Credit Suisse International, which we refer to as
CSI, as principal, under which we have agreed to loan to CSI
3,438,500 shares of our common stock for a period beginning
on the date we entered into the share lending agreement and
ending on June 15, 2013, or, if earlier, the date as of
which we have notified CSI in writing of our intention to
terminate the agreement at any time after the entire principal
amount of the notes ceases to be outstanding as a result of
conversion or repurchase, or earlier in certain circumstances,
which period we refer to as the loan availability
period.
CSI will receive all of the proceeds from the sale of the
borrowed shares pursuant to the share lending agreement, and we
will receive only a nominal lending fee of $0.01 per share for
each share of common stock that we loan pursuant to the share
lending agreement.
Share loans under the share lending agreement will terminate and
the borrowed shares must be returned to us if this offering of
notes is not consummated or upon the termination of the loan
availability period, as well as under the following
circumstances:
|
|
|
|
|
CSI may terminate all or any portion of a loan at any time;
|
|
|
|
we may terminate any or all of the outstanding loans upon a
default by CSI under the share lending agreement, including a
breach by CSI of any of its representations and warranties,
covenants or agreements under the share lending agreement, or
the bankruptcy of CSI; or if we enter into a merger or similar
business combination transaction with an unaffiliated third
party (as defined in the agreement) pursuant to which the shares
are converted into or exchanged for cash, securities or other
property, all outstanding loans will terminate on the effective
date of such event.
|
Any shares that we loan to CSI will be issued and outstanding
for corporate law purposes and, accordingly, the holders of the
borrowed shares will have all of the rights of a holder of our
outstanding shares, including the right to vote the shares on
all matters submitted to a vote of our stockholders and the
right to receive any dividends or other distributions that we
may pay or make on our outstanding shares of common stock.
However, under the share lending agreement, CSI has agreed:
|
|
|
|
|
to pay to us an amount equal to any cash dividends that we pay
on the borrowed shares, and
|
|
|
|
to pay or deliver to us any other distribution, in liquidation
or otherwise, that we make on the borrowed shares.
|
CSI also has agreed that it will not vote any borrowed shares of
which it is the record owner, and it will not transfer or
dispose of any borrowed shares except pursuant to a registration
statement that is effective under the Securities Act. However,
investors that purchase the shares from CSI (and any subsequent
transferees of such purchasers) will be entitled to the same
voting
,
dividend or other rights with respect to those
shares as any other holder of our common stock.
Under the share lending agreement, if CSI receives a rating
downgrade of its long term, unsecured and subordinated
indebtedness below a specified level by Standard &
Poors Ratings Group or Moodys Investor Services,
Inc., CSI has agreed to post and maintain with Credit Suisse
Securities (USA) LLC, acting as collateral agent on our behalf,
collateral in the form of cash, government securities,
certificates of deposit, high-grade commercial paper of
U.S. issuers or money market shares with a market value at
least equal to 100% of the market value of the borrowed shares
as security for the obligation of CSI to return the borrowed
shares of common stock to us when required under the terms of
the share lending agreement. In certain limited circumstances,
primarily if CSI
S-66
is prohibited by law or court order from returning the borrowed
shares, we may elect to receive a distribution of the posted
collateral in lieu of the delivery of the shares.
Our issuance of borrowed shares of our common stock offered
pursuant to the share lending agreement will be essentially
analogous to a sale of shares coupled with a prepaid forward
purchase contract for the reacquisition of the shares at a
future date. An instrument that requires physical settlement by
repurchase of a fixed number of shares in exchange for cash is
considered a forward purchase instrument. While the share
lending agreement does not require a cash payment upon return of
the shares, physical settlement is required (i.e., the borrowed
shares must be returned at the end of the arrangement). In view
of this and the contractual undertakings of CSI in the share
lending agreement, which have the effect of substantially
eliminating the economic dilution that otherwise would result
from the issuance of the borrowed shares, we believe that under
U.S. GAAP, the borrowed shares will not be considered
outstanding for the purpose of computing and reporting our
earnings per share. Notwithstanding the foregoing, the shares
will nonetheless be issued and outstanding and will be eligible
for trading on the Nasdaq Global Select Market.
CSI has agreed that it, or its affiliates, will use the borrowed
shares initially to facilitate privately negotiated transactions
or short sales by which investors hedge their investment in the
notes being offered hereby, and, with our consent, other
securities that we may issue in the future. In addition, CSI, or
its affiliates, may engage in such transactions with respect to
any such securities at any time and from time to time during the
term of the share lending agreement in share amounts to be
determined by CSI and such affiliates. Up to of the
borrowed shares may be offered on a delayed basis for this
purpose. We refer to these shares as the supplemental
hedge shares. In connection with the sale of these
supplemental hedge shares, CSI, or an affiliate, may effect such
transactions by selling the supplemental hedge shares to or
through dealers, and these dealers may receive compensation in
the form of discounts, concessions or commissions from
purchasers of shares for whom the dealers may act as agents or
to whom they may sell as principals. Over the same period that
CSI, or its affiliates, sells these supplemental hedge shares,
it may, in its discretion, purchase a number of shares of our
common stock at least equal to the number of the supplemental
hedge shares it is selling on the open market to facilitate
hedging transactions by investors in the notes and
counterparties to the capped call transactions.
The existence of the share lending agreements and the short
positions established in connection with the sale of the notes
and potentially certain of our other securities could have the
effect of causing the market price of our common stock to be
lower over the term of the share lending agreement than it would
have been had we not entered into the agreement. See Risk
Factors Risks Relating to the Common
Stock The effect of the concurrent issuance of our
shares of common stock, which issuance is being made to
facilitate sales of our common stock in short sale transactions
by purchasers of certain of our securities, may be to lower the
market price of our common stock. However, we have
determined that the entry into the share lending agreements is
in our best interests as they are a means to facilitate the
offer and sale of the notes pursuant to this prospectus
supplement and accompanying prospectus on terms more favorable
to us than we could have otherwise obtained.
S-67
Description
of Underwritten Equity Offering
Concurrently with this offering of notes, we are offering, by
means of a separate prospectus supplement and accompanying
prospectus, 4,708,500 shares of our common stock.
1,270,000 shares of the common stock offered by that
prospectus supplement and accompanying prospectus are being
underwritten by the underwriters of this offering of convertible
senior notes and are being offered to the public at a price of
$ per share.
S-68
Material
United States Federal Income Tax Considerations
The following is a summary of the material U.S. federal
income tax consequences of the purchase, ownership and
disposition of the notes and our common stock into which the
notes may be converted. This summary deals only with a note or
common stock held as a capital asset by a holder who purchases
the note on original issuance at its initial offering price. It
does not describe all of the tax consequences that may be
relevant to a holder in light of its particular circumstances or
to a holder subject to special rules, such as:
|
|
|
|
|
a dealer in securities or currencies;
|
|
|
|
a financial institution;
|
|
|
|
a regulated investment company;
|
|
|
|
a real estate investment trust;
|
|
|
|
a tax-exempt organization;
|
|
|
|
an insurance company;
|
|
|
|
a cooperative;
|
|
|
|
a person holding the notes as part of a hedging, integrated,
conversion or constructive sale transaction or straddle;
|
|
|
|
a trader in securities that has elected the mark-to-market
method of accounting;
|
|
|
|
a person liable for alternative minimum tax;
|
|
|
|
a person who is an investor in a pass-through entity such as a
partnership;
|
|
|
|
a United States person whose functional currency is
not the U.S. dollar; or
|
|
|
|
a United States expatriate.
|
This summary is based on the provisions of the Internal Revenue
Code of 1986, as amended (the Code), final,
temporary, and proposed Treasury Regulations, administrative
pronouncements of the Internal Revenue Service (IRS)
and judicial decisions, all as of the date hereof. Those
authorities may be changed, possibly retroactively, so as to
result in U.S. federal income tax consequences different
from those summarized herein. Persons considering the purchase
of notes should consult their tax advisors with respect to the
application of the United States federal income tax laws to
their particular situations as well as any tax consequences
arising under the laws of any state, local or foreign taxing
jurisdiction.
Tax
Consequences to United States Holders
As used here, the term United States Holder means a
beneficial owner of a note or our common stock that is, for
United States federal income tax purposes:
|
|
|
|
|
an individual citizen or resident of the United States;
|
|
|
|
a corporation or other entity taxable as a corporation for
United States federal income tax purposes that is created or
organized in or under the laws of the United States, any state
thereof or the District of Columbia;
|
|
|
|
an estate the income of which is subject to United States
federal income taxation regardless of its source; or
|
|
|
|
a trust if it (1) is subject to the primary supervision of
a court within the United States and one or more
U.S. persons have the authority to control all substantial
decisions of the trust or (2) has a valid election in
effect under applicable U.S. Treasury regulations to be
treated as a U.S. person.
|
If a partnership, including an entity treated as a partnership
for United States federal income tax purposes, is a holder of a
note or our common stock, the United States federal income tax
treatment of a partner in the partnership will generally depend
on the status of the partner and the activities of the
partnership. Partners in such a partnership
S-69
are urged to consult their tax advisors as to the particular
United States federal income tax consequences applicable to them
of purchasing, holding or disposing of the notes or our common
stock.
Payments
of Interest
It is anticipated that the notes will not be issued with greater
than de minimis original issue discount for federal income tax
purposes. Accordingly, interest paid on a note will be taxable
to a United States Holder as ordinary interest income at the
time it accrues or is received in accordance with the
holders method of accounting for federal income tax
purposes.
Sale,
Exchange or Retirement of the Notes
Upon the sale, exchange or retirement of a note (other than a
conversion into common stock and cash), a United States
Holder will recognize taxable gain or loss equal to the
difference between the amount realized on the sale, exchange or
retirement and the holders adjusted tax basis in the note.
For these purposes, the amount realized does not include any
amount attributable to accrued interest. Amounts attributable to
accrued interest are treated as interest as described under
Payments of Interest above. Gain or loss
realized on the sale, exchange or retirement of a note will
generally be capital gain or loss and will generally be
long-term capital gain or loss if at the time of sale, exchange
or retirement the note has been held by the United States Holder
for more than one year. If you are a non-corporate United States
Holder, long-term capital gains currently are subject to reduced
rates of taxation. Your ability to deduct capital losses may be
limited.
Conversion
of the Notes Into Cash
If a United States Holder converts a note and we deliver solely
cash, the United States Holder will recognize gain or loss in
the same amount as if such holder had disposed of the note in a
taxable disposition as described under Sale,
Exchange or Retirement of the Notes above.
Conversion
of the Notes Into Common Stock and Cash
If a United States Holder converts a note and we deliver a
combination of our common stock and cash, we intend to take the
position (and the following discussion assumes) that the
conversion will be treated as a recapitalization for United
States federal income tax purposes, although this tax treatment
is not free from doubt.
Assuming such treatment is respected, a United States Holder
will recognize gain, but not loss, equal to the excess of the
sum of the fair market value of our common stock and cash
received (other than amounts attributable to accrued interest,
which will be treated as described under
Payments of Interest above) over such
holders adjusted tax basis in the note, but in no event
will the gain recognized exceed the amount of cash received
(excluding cash attributable to accrued interest or received in
lieu of a fractional share).
In such circumstances, a United States Holders tax basis
in our common stock received upon conversion of a note (other
than common stock received with respect to accrued interest, but
including any basis allocable to a fractional share) will equal
the tax basis of the note that was converted, reduced by the
amount of cash received (excluding cash received in respect of
accrued interest and cash received in lieu of a fractional
share) and increased by any gain recognized upon conversion
(other than gain recognized upon receipt of cash in lieu of a
fractional share). The receipt of cash in lieu of a fractional
share generally will result in capital gain or loss (measured by
the difference between the cash received in lieu of the
fractional share and the United States Holders tax basis
in the fractional share). A holders tax basis in the
fractional share will be determined by allocating the
holders tax basis in the common stock between the common
stock received upon conversion and the fractional share, in
accordance with their respective fair market values.
A United States Holders holding period for our common
stock received upon conversion will include the period during
which the holder held the notes, except that the holding period
of any common stock received in respect of accrued interest will
commence on the day after conversion.
If the conversion is not treated as a recapitalization, an
alternative characterization would treat the cash payment
received on conversion as proceeds from a sale of a portion of
the note, and would require a holder to
S-70
recognize gain or loss in the manner described under
Sale, Exchange or Retirement of the
Notes above with respect to the portion of the note
treated as sold for cash. Under this alternative
characterization, the United States Holder would not recognize
gain or loss with respect to our common stock received (other
than stock attributable to accrued interest), and the
holders holding period for such stock would include the
period during which such holder held the notes. In such case,
the holders basis in the note would be allocated pro rata
between the common stock and cash received, in accordance with
their fair market values. United States Holders should consult
their tax advisors regarding the tax treatment of the receipt of
cash and our common stock for notes upon conversion.
Constructive
Dividends
If at any time we were to make a distribution of cash or
property to our stockholders that would be taxable to the
stockholders as a dividend for United States federal income tax
purposes and, in accordance with the anti-dilution provisions of
the notes, the conversion rate of the notes were increased, such
increase would be a deemed distribution, taxable as a dividend
to holders of the notes to the extent of our current and
accumulated earnings and profits (and otherwise as discussed
below), notwithstanding the fact that the holders do not receive
a cash payment.
If the conversion rate is increased at our discretion or in
certain other circumstances (including adjustment to the
conversion rate in connection with a fundamental change), such
increase also may be a deemed distribution, taxable as a
dividend to holders of the notes to the extent of our current
and accumulated earnings and profits (and otherwise as discussed
below), notwithstanding the fact that the holders do not receive
a cash payment. In certain circumstances the failure to make an
adjustment of the conversion rate under the indenture may result
in a deemed taxable distribution to holders of our common stock.
If there is a deemed distribution, such distribution will be
taxable as a dividend to the extent of our current and
accumulated earnings and profits, and thereafter as a return of
capital or capital gain in accordance with the tax rules
applicable to corporate distributions, but may not be eligible
for the reduced rates of tax applicable to certain dividends
paid to individual holders or the dividends-received deduction
applicable to certain dividends paid to corporate holders.
Generally, an increase in the conversion rate under the
indenture made pursuant to a bona fide reasonable adjustment
formula in the event of stock dividends or distributions of
rights to subscribe for our common stock will not be a taxable
constructive dividend.
Distributions
on Common Stock
Distributions paid on our common stock received upon a
conversion of a note, other than certain pro rata distributions
of common shares, will be treated as a dividend to the extent
paid out of our current or accumulated earnings and profits (as
determined under United States federal income tax principles)
and will be includible in income by the United States Holder and
taxable as ordinary income when received. If a distribution
exceeds our current and accumulated earnings and profits, the
excess will be treated as a tax-free return of the United States
Holders investment, up to the United States Holders
basis in the common stock. Any remaining excess generally will
be treated as a capital gain. Dividends received by
non-corporate United States Holders in taxable years beginning
prior to January 1, 2011 will be eligible to be taxed at
reduced rates if the holder meets certain holding period and
other applicable requirements. Dividends received by a corporate
United States Holder will be eligible for the dividends-received
deduction if the holder meets certain holding period and other
applicable requirements.
Sale or
Other Disposition of Common Stock
Gain or loss realized by a United States Holder on the sale or
other disposition of our common stock received upon conversion
of a note will be capital gain or loss for United States federal
income tax purposes, and will be long-term capital gain or loss
if the United States Holders holding period for the common
stock is more than one year. The amount of the United States
Holders gain or loss will be equal to the difference
between the United States Holders tax basis in the common
stock disposed of and the amount realized on the disposition. If
you are a non-corporate United States Holder, long-term capital
gains currently are subject to reduced rates of taxation. Your
ability to deduct capital losses may be limited.
S-71
Possible
Effect of the Change In Conversion Consideration After a
Consolidation, Merger or Sale of Assets
In certain situations, including a consolidation, merger or
combination involving us or a transfer of all or substantially
all of our property and assets, the notes may become convertible
into property other than our common stock. See Description
of the Notes Conversion Rate Adjustments.
Depending on the circumstances, the conversion of the notes into
such property other than our common stock may be a fully taxable
event.
Backup
Withholding and Information Reporting
Information returns will be filed with the IRS in connection
with payments on the notes, dividends on the common stock and
proceeds from a sale or other disposition of the notes or the
common stock. A United States Holder will be subject to United
States backup withholding tax on these payments if the United
States Holder fails to provide its taxpayer identification
number to the paying agent and comply with certain certification
procedures or otherwise establish an exemption from backup
withholding. The amount of any backup withholding from a payment
to a United States Holder will be allowed as a credit against
the United States Holders United States federal income tax
liability and may entitle the United States Holder to a refund,
provided that the required information is furnished to the IRS.
Tax
Consequences to
Non-U.S.
Holders
As used herein, the term
Non-U.S. Holder
means a beneficial owner of a note that is, for United States
federal income tax purposes:
|
|
|
|
|
an individual who is classified as a nonresident alien for
United States federal income tax purposes;
|
|
|
|
a foreign corporation; or
|
|
|
|
a foreign estate or trust.
|
Non-U.S. Holder
does not include a holder who is an individual present in the
United States for 183 days or more in the taxable year of
the disposition of the notes or common stock and who is not
otherwise a resident of the United States for United States
federal income tax purposes. Such a holder should consult his or
her own tax advisor regarding the United States federal income
tax consequences of the sale, exchange or other disposition of
the notes or common stock.
Payments
on the Notes
Subject to the discussion below concerning backup withholding,
payments of principal and interest (including interest deemed to
be received upon conversion) on the notes to a
Non-U.S. Holder
will not be subject to United States federal withholding
tax, provided that, in the case of interest:
|
|
|
|
|
the holder does not own, actually or constructively,
10 percent or more of the total combined voting power of
all classes of our stock entitled to vote, is not a bank
described in section 881(c)(3)(A) of the Code, and is not a
controlled foreign corporation related, directly or indirectly,
to us through stock ownership; and
|
|
|
|
the certification requirement described below has been fulfilled
with respect to the beneficial owner.
|
Certification
Requirement
Interest on a note will generally not be exempt from withholding
tax unless the beneficial owner of the note certifies on IRS
Form W-8BEN,
under penalties of perjury, that it is not a United States
person.
If a
Non-U.S. Holder
of a note is engaged in a trade or business in the United
States, and if interest on the note is effectively connected
with the conduct of this trade or business, the
Non-U.S. Holder,
although exempt from the withholding tax discussed above, will
generally be taxed in the same manner as a United States Holder
(see Tax Consequences to United States Holders
above), except that the holder will be required to provide a
properly executed IRS
Form W-8ECI
in order to claim an exemption from withholding tax. These
holders should consult
S-72
their own tax advisors with respect to other United States tax
consequences of the ownership and disposition of notes,
including the possible imposition of a branch profits tax at a
rate of 30% (or a lower treaty rate).
Sale,
Exchange or Other Disposition of Notes or Common Stock
Subject to the discussion below concerning backup withholding, a
Non-U.S. Holder
generally will not be subject to United States federal income
tax on gain realized on a sale, exchange or other taxable
disposition (including upon conversion) of notes or common stock
unless:
|
|
|
|
|
the gain is effectively connected with a trade or business of
the
Non-U.S. Holder
in the United States; or
|
|
|
|
we are or have been within the shorter of the five-year period
preceding such sale, exchange, or other disposition and the
period during which the
Non-U.S. Holder
held the notes or common stock, a United States real
property holding corporation, as defined in the Code.
|
We believe that we are not, and do not anticipate becoming, a
United States real property holding corporation.
Taxation
of Dividends on Common Stock and Constructive Dividends on the
Notes
Dividends on our common stock paid (including constructive
dividends deemed paid to the holders of the notes, see
Tax Consequences to United States
Holders Constructive Dividends above), to a
Non-U.S. Holder
generally will be subject to United States withholding tax at a
30% rate, subject to reduction under an applicable treaty. In
the case of any constructive dividend, it is possible that the
United States federal income tax on this constructive dividend
would be withheld from interest payments on the notes, shares of
your common stock or sales proceeds subsequently paid or
credited to the
Non-U.S. Holder.
In order to obtain a reduced rate of withholding, a
Non-U.S. Holder
will be required to provide a properly executed IRS
Form W-8BEN
certifying its entitlement to benefits under an applicable
treaty. A
Non-U.S. Holder
who is subject to withholding tax under such circumstances
should consult its tax advisor as to whether it can obtain a
refund for all or a portion of the withholding tax.
If a
Non-U.S. Holder
of common stock is engaged in a trade or business in the United
States, and if the dividends (or constructive dividends) are
effectively connected with the conduct of this trade or
business, the
Non-U.S. Holder
although exempt from United States withholding tax, will
generally be taxed in the same manner as a United States Holder
(see Tax Consequences to United States
Holders above), except that the
Non-U.S. Holder
will be required to provide a properly executed IRS
Form W-8ECI
in order to claim an exemption from withholding tax. Such
Non-U.S. Holders
should consult their own tax advisors with respect to other tax
consequences of the ownership of our common stock, including the
possible imposition of a branch profits tax at 30% (or at a
reduced rate under an applicable tax treaty) for corporate
Non-U.S. Holders.
Backup
Withholding and Information Reporting
Information returns will be filed with the IRS in connection
with payments on the notes and on the common stock. Unless the
Non-U.S. Holder
complies with certification procedures to establish that it is
not a United States person, information returns may be filed
with the IRS in connection with the proceeds from a sale or
other disposition of the notes or common stock and the
Non-U.S. Holder
may be subject to United States backup withholding on payments
on the notes and on the common stock or on the proceeds from a
sale or other disposition of the notes or common stock. The
certification procedures required to claim the exemption from
withholding tax on interest described above will satisfy the
certification requirements necessary to avoid the backup
withholding as well. The amount of any backup withholding from a
payment to a
Non-U.S. Holder
will be allowed as a credit against the
Non-U.S. Holders
United States federal income tax liability and may entitle the
Non-U.S. Holder
to a refund, provided that the required information is furnished
to the IRS.
S-73
Underwriting
Credit Suisse Securities (USA) LLC and UBS Securities LLC are
acting as the representatives of the underwriters and the
book-running managers of this offering. Under the terms and
subject to the conditions contained in an underwriting agreement
to be filed as an exhibit relating to this prospectus
supplement, we have agreed to sell to the underwriters named
below, and the underwriters have severally agreed to purchase
from us, the following respective principal amount of the notes:
|
|
|
|
|
|
|
Principal
|
|
|
|
Amount of
|
|
Underwriter
|
|
Notes
|
|
|
Credit Suisse Securities (USA) LLC
|
|
|
|
|
UBS Securities LLC
|
|
|
|
|
J.P. Morgan Securities Inc.
|
|
|
|
|
Deutsche Bank Securities Inc.
|
|
|
|
|
Lazard Capital Markets LLC
|
|
|
|
|
Total
|
|
$
|
225,000,000
|
|
|
|
|
|
|
The underwriting agreement provides that the obligation of the
underwriters to purchase the notes depends on the satisfaction
of conditions contained in the underwriting agreement, including:
|
|
|
|
|
the obligation to purchase all of the notes offered hereby
(other than those notes covered by their option to purchase
additional notes as described below), if any of the notes are
purchased;
|
|
|
|
the representations and warranties made by us to the
underwriters are true;
|
|
|
|
there is no material change in the financial markets; and
|
|
|
|
we deliver customary closing documents to the underwriters.
|
Commissions
and Expenses
The following table summarizes the underwriting discounts and
commission we will pay to the underwriters. These amounts are
shown assuming both no exercise and full exercise of the
underwriters option to purchase additional notes. The
underwriting discounts and commissions are equal
to % of the public offering price
without the exercise of the underwriters option
and % if the underwriters exercise
of the underwriters option:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
No Exercise
|
|
Full Exercise
|
|
|
|
Per note
|
|
$
|
|
|
|
$
|
|
|
|
|
|
|
Total
|
|
$
|
|
|
|
$
|
|
|
|
|
|
|
The representatives of the underwriters have advised us that the
underwriters propose to offer the notes directly to the public
at the public offering price on the cover page of this
prospectus supplement and to selected dealers, which may include
the underwriters, at such offering price less a selling
concession not in excess of
$ per note. After the
offering, the representatives may change the offering price and
other selling terms.
The expenses of this offering and the concurrent offering of our
common stock that are payable by us are estimated to be $800,000
(excluding underwriting discounts and commissions).
Option to
Purchase Additional Notes
We have granted the underwriters an option exercisable for
30 days after the date of this prospectus supplement, to
purchase from time to time, in whole or in part, up to an
aggregate of approximately $33.8 million principal amount
of notes at the public offering price, less the underwriting
discounts and commissions. This option may be exercised if the
underwriters sell more than $225.0 million aggregate
principal amount of notes in connection with this offering. To
the extent that this option is exercised, each underwriter will
be obligated, subject to certain conditions, to purchase its pro
rata portion of these additional notes based on the
underwriters percentage underwriting commitment in the
offering as indicated in the table at the beginning of this
Underwriting section.
S-74
Lock-Up
Agreements
We have agreed that we will not offer, sell, contract to sell,
pledge or otherwise dispose of, directly or indirectly, or file
with the SEC a registration statement under the Securities Act
relating to, any shares of our common stock regardless of class
(the Securities), or securities convertible into or
exchangeable or exercisable for any shares of our Securities, or
publicly disclose the intention to make any offer, sale, pledge,
disposition or filing, without the prior written consent of
Credit Suisse Securities (USA) LLC and UBS Securities LLC for a
period of 90 days after the date of this prospectus
supplement, subject to certain exceptions, including grants of
equity awards pursuant to terms of an equity award plan in
effect on the date hereof, issuances pursuant to the exercise of
employee stock options outstanding on the date hereof and the
issuance of the notes and shares of our common stock pursuant to
our concurrent offering of such stock.
Our officers and directors have agreed that, subject to certain
exceptions (including an exception for certain tax-driven sales
by our executive officers), they will not offer, sell, contract
to sell, pledge or otherwise dispose of, directly or indirectly,
any Securities, or securities convertible into or exchangeable
or exercisable for Securities, enter into a transaction that
would have the same effect, or enter into any swap, hedge or
other arrangement that transfers, in whole or in part, any of
the economic consequences of ownership of the common stock,
whether any of these transactions are to be settled by delivery
of the Securities or other securities, in cash or otherwise, or
publicly disclose the intention to make any offer, sale, pledge
or disposition, or to enter into any transaction, swap, hedge or
other arrangement, without, in each case, the prior written
consent of Credit Suisse Securities (USA) LLC and UBS Securities
LLC for a period of 90 days after the date of this
prospectus supplement except for issuances pursuant to the
exercise of employee stock options outstanding on the date
hereof and for securities acquired in the open market and
transfers to family members or certain other parties or as a
gift.
Notwithstanding the foregoing, if (1) during the last
17 days of the
lock-up
period, we issue an earnings release or material news of a
material event relating to us occurs or (2) prior to the
expiration of the
lock-up
period, we announce that we will release earnings results during
the
16-day
period beginning on the last day of the
lock-up
period, then the
lock-up
period shall continue until the expiration of the
18-day
period beginning on the issuance of the earnings release or the
announcement of the material news of the occurrence of the
material event, unless Credit Suisse Securities (USA) LLC and
UBS Securities LLC waive such extension in writing.
Credit Suisse Securities (USA) LLC and UBS Securities LLC have
also agreed to permit our directors and executive officers who
entered into
lock-up
agreements with the underwriters to (i) sell or trade any
such securities during the
lock-up
period in accordance with the directors and officers
existing
Rule 10b5-1
trading plans and (ii) enter into any new, or renew or
amend any existing,
Rule 10b5-1
trading plan, provided that in connection with the entry,
renewal or amendment of such plan no securities shall be
scheduled for sale thereunder during the
lock-up
period. Under these
Rule 10b5-1
trading plans, these individuals have contracted or will
contract with brokers to buy or sell our common stock on a
periodic basis. Under these plans, a broker executes trades
pursuant to the parameters established by the executive officer
or director at the time of the creation of the plan, without
further direction from them.
Indemnification
We have agreed to indemnify the underwriters against certain
liabilities, including liabilities under the Securities Act, or
to contribute to any payments that the underwriters may be
required to make for these liabilities.
Stabilization,
Short Positions and Penalty Bids
The representatives may engage in stabilizing transactions,
short sales and purchases to cover positions created by short
sales, and penalty bids or purchases, or passive market making
for the purpose of pegging, fixing or maintaining the price of
the notes and our common stock, in accordance with
Regulation M under the Exchange Act:
|
|
|
|
|
Stabilizing transactions permit bids to purchase the underlying
security so long as the stabilizing bids do not exceed a
specified maximum.
|
S-75
|
|
|
|
|
A short position involves a sale by the underwriters of notes in
excess of the principal amount of notes the underwriters are
obligated to purchase in the offering, which creates the
syndicate short position. This short position may be either a
covered short position or a naked short position. In a covered
short position, the principal amount of notes involved in the
sales made by the underwriters in excess of the principal amount
of notes they are obligated to purchase is not greater than the
principal amount of notes that they may purchase by exercising
their option to purchase additional notes. In a naked short
position, the principal amount of notes involved is greater than
the principal amount of notes in their option to purchase
additional notes. The underwriters may close out any short
position by either exercising their option to purchase
additional notes
and/or
purchasing notes in the open market. In determining the source
of notes to close out the short position, the underwriters will
consider, among other things, the price of notes available for
purchase in the open market as compared to the price at which
they may purchase notes through their option to purchase
additional notes. A naked short position is more likely to be
created if the underwriters are concerned that there could be
downward pressure on the price of the notes in the open market
after pricing that could adversely affect investors who purchase
in the offering.
|
|
|
|
Syndicate covering transactions involve purchases of the notes
in the open market after the distribution has been completed in
order to cover syndicate short positions.
|
|
|
|
Penalty bids permit the representatives to reclaim a selling
concession from a syndicate member when the notes originally
sold by the syndicate member are purchased in a stabilizing or
syndicate covering transaction to cover syndicate short
positions.
|
|
|
|
Passive market making consists of displaying bids on the Nasdaq
Global Select Market no higher than the bid prices of
independent market makers and making purchases at prices no
higher than those independent bids and effected in response to
order flow. Net purchases by a passive market maker on each day
are limited to a specified percentage of the passive market
makers average daily trading volume in our common stock
during a specified period and must be discontinued when such
limit is reached. Passive market making may cause the price of
common stock to be higher than the price that otherwise would
exist in the open market in the absence of such transactions.
|
These stabilizing transactions, syndicate covering transactions
and penalty bids may have the effect of raising or maintaining
the market price of our notes or preventing or retarding a
decline in the market price of the notes. As a result, the price
of the notes may be higher than the price that might otherwise
exist in the open market. These transactions may be effected on
the Nasdaq Global Select Market or otherwise and, if commenced,
may be discontinued at any time.
Neither we nor any of the underwriters make any representation
or prediction as to the direction or magnitude of any effect
that the transactions described above may have on the price of
the notes. In addition, neither we nor any of the underwriters
make any representation that the representatives will engage in
these stabilizing transactions or that any transaction, once
commenced, will not be discontinued without notice.
Nasdaq
Global Select Market Quotation
Our shares of common stock are listed on the Nasdaq Global
Select Market under the symbol ENER.
The notes are a new issue of securities with no established
market. We do not intend to apply for the notes to be listed on
any securities exchange or to arrange for the notes to be quoted
on any quotation system. We have been advised by the
underwriters that the underwriters intend to make a market in
the notes but none of the underwriters is obligated to do so and
may discontinue market making at any time without notice. No
assurance can be given as to the liquidity of the trading
market, if any, for the notes.
Electronic
Distribution
A prospectus in electronic format may be made available on
websites or through other online services maintained by one or
more of the underwriters
and/or
selling group members participating in this offering, or by
their affiliates. In those cases, prospective investors may view
offering terms online and, depending upon the particular
underwriter or selling group member, prospective investors may
be allowed to place orders online. The
S-76
underwriters may agree with us to allocate a specific number of
notes for sale to online brokerage account holders. Any such
allocation for online distributions will be made by the
representatives on the same basis as other allocations.
Other than this prospectus supplement and the accompanying
prospectus in electronic format, the information on any
underwriters or selling group members website and
any information contained in any other web site maintained by an
underwriter or selling group member is not part of this
prospectus supplement and the accompanying prospectus or the
registration statement of which this prospectus supplement and
the accompanying prospectus forms a part, has not been approved
and/or
endorsed by us or any underwriter or selling group member in its
capacity as underwriter or selling group member and should not
be relied upon by investors.
Stamp
Taxes
If you purchase notes offered in this prospectus supplement and
the accompanying prospectus, you may be required to pay stamp
taxes and other charges under the laws and practices of the
country of purchase, in addition to the offering price listed on
the cover page of this prospectus supplement. Accordingly, we
urge you to consult a tax advisor with respect to whether you
may be required to pay taxes or charges, as well as any other
consequences that may arise under the laws of the country of
purchase.
Relationships
Several of the underwriters have in the past performed
investment banking services for us. Concurrently with this
offering, we are offering, by means of a separate prospectus
supplement and accompanying prospectus, 3,438,500 shares of
our common stock that we have agreed to loan to CSI, an
affiliate of Credit Suisse Securities (USA) LLC, pursuant to a
share lending agreement described in Description of the
Share Lending Agreement. The borrower has agreed that it
or its affiliates will use the short sales of our common stock
pursuant to that offering to facilitate transactions by which
investors in the notes and, with our consent, other securities
we may offer in the future, will hedge their respective
investments. See Description of the Share Lending
Agreement. In connection with facilitating those
transactions, the borrower and its affiliates expect to receive
customary, negotiated fees from investors.
The underwriters may in the future perform investment banking
and advisory services for us from time to time for which they
may receive customary fees and expenses. The underwriters may,
from time to time, engage in transactions with or perform other
services for us in the ordinary course of their business.
Lazard Frères & Co. LLC referred this transaction to
Lazard Capital Markets LLC and will receive a referral fee from
Lazard Capital Markets LLC in connection therewith.
S-77
Notice to
Canadian Residents
Resale
Restrictions
The distribution of the notes in Canada is being made only on a
private placement basis exempt from the requirement that we
prepare and file a prospectus with the securities regulatory
authorities in each province where trades of the notes are made.
Any resale of the notes in Canada must be made under applicable
securities laws which will vary depending on the relevant
jurisdiction, and which may require resales to be made under
available statutory exemptions or under a discretionary
exemption granted by the applicable Canadian securities
regulatory authority. Purchasers are advised to seek legal
advice prior to any resale of the notes.
Representations
of Purchasers
By purchasing the notes in Canada and accepting a purchase
confirmation a purchaser is representing to us and the dealer
from whom the purchase confirmation is received that:
|
|
|
|
|
the purchaser is entitled under applicable provincial securities
laws to purchase the notes without the benefit of a prospectus
qualified under those securities laws;
|
|
|
|
where required by law, that the purchaser is purchasing as
principal and not as agent;
|
|
|
|
the purchaser has reviewed the text above under Resale
Restrictions; and
|
|
|
|
the purchaser acknowledges and consents to the provision of
specified information concerning its purchase of the notes to
the regulatory authority that by law is entitled to collect the
information.
|
Further details concerning the legal authority for this
information is available on request.
Rights of
Action Ontario Purchasers Only
Under Ontario securities legislation, certain purchasers who
purchase a security offered by this prospectus during the period
of distribution will have a statutory right of action for
damages, or while still the owner of the notes, for rescission
against us in the event that this prospectus contains a
misrepresentation without regard to whether the purchaser relied
on the misrepresentation. The right of action for damages is
exercisable not later than the earlier of 180 days from the
date the purchaser first had knowledge of the facts giving rise
to the cause of action and three years from the date on which
payment is made for the notes. The right of action for
rescission is exercisable not later than 180 days from the
date on which payment is made for the notes. If a purchaser
elects to exercise the right of action for rescission, the
purchaser will have no right of action for damages against us.
In no case will the amount recoverable in any action exceed the
price at which the notes were offered to the purchaser and if
the purchaser is shown to have purchased the securities with
knowledge of the misrepresentation, we will have no liability.
In the case of an action for damages, we will not be liable for
all or any portion of the damages that are proven to not
represent the depreciation in value of the notes as a result of
the misrepresentation relied upon. These rights are in addition
to, and without derogation from, any other rights or remedies
available at law to an Ontario purchaser. The foregoing is a
summary of the rights available to an Ontario purchaser. Ontario
purchasers should refer to the complete text of the relevant
statutory provisions.
Enforcement
of Legal Rights
All of our directors and officers as well as the experts named
herein may be located outside of Canada and, as a result, it may
not be possible for Canadian purchasers to effect service of
process within Canada upon us or those persons. All or a
substantial portion of our assets and the assets of those
persons may be located outside of Canada and, as a result, it
may not be possible to satisfy a judgment against us or those
persons in Canada or to enforce a judgment obtained in Canadian
courts against us or those persons outside of Canada.
Taxation
and Eligibility for Investment
Canadian purchasers of the notes should consult their own legal
and tax advisors with respect to the tax consequences of an
investment in the notes in their particular circumstances and
about the eligibility of the notes for investment by the
purchaser under relevant Canadian legislation.
S-78
Legal
Matters
The validity of the notes and the shares of common stock
underlying the notes will be passed upon for us by
Covington & Burling LLP, Washington, D.C.
Selected legal matters with respect to the notes will be passed
upon for the underwriters by Skadden, Arps, Slate,
Meagher & Flom LLP, Chicago, IL.
Experts
Our consolidated financial statements appearing in our Annual
Report on
Form 10-K
for the year ended June 30, 2007 (including the schedule
appearing therein), have been audited by Grant Thornton LLP,
independent registered public accountants, as set forth in their
reports thereon included therein, and incorporated herein by
reference. Such financial statements and schedule are
incorporated herein in reliance upon the reports of Grant
Thornton LLP pertaining to such financial statements (to the
extent covered by consents filed with the Securities and
Exchange Commission) given on the authority of such firm as
experts in accounting and auditing.
Where You
Can Find More Information
Available
Information
We file annual, quarterly and current reports, proxy statements
and other information with the SEC. You may read and copy any of
this information at the SECs public reference room at
100 F Street, N.E., Washington, D.C. 20549.
Please call the SEC at (800) SEC-0330 for further
information on the public reference room. The SEC also maintains
an Internet website that contains reports, proxy statements and
other information regarding issuers, including us, who file
electronically with the SEC. The address of that website is
www.sec.gov
. The information contained on the SECs
website is expressly not incorporated by reference into this
prospectus supplement.
Our SEC filings are also available on our website at
www.ovonic.com
, although the information on our website
is expressly not incorporated by reference into, and does not
constitute a part of, this prospectus supplement.
This prospectus supplement contains summaries of provisions
contained in some of the documents discussed in this prospectus
supplement, but reference is made to the actual documents for
complete information. All of the summaries are qualified in
their entirety by the actual documents. Copies of some of the
documents referred to in this prospectus supplement have been
filed or will be filed or incorporated by reference as exhibits
to the registration statement of which this prospectus
supplement is a part. If any contract, agreement or other
document is filed or incorporated by reference as an exhibit to
the registration statement, you should read the exhibit for a
more complete understanding of the document or matter involved.
Incorporation
of Documents by Reference
The SEC allows us to incorporate by reference information into
this prospectus supplement. This means we can disclose
information to you by referring you to another document we filed
with the SEC. We will make those documents available to you
without charge upon your oral or written request. Requests for
those documents should be directed to Energy Conversion Devices,
Inc., 2956 Waterview Drive, Rochester Hills, Michigan 48309,
Attention: Corporate Secretary. In addition, you may obtain
copies of this information by calling us
(248) 293-0440
or sending us an
e-mail
at
investor.relations@ovonic.com. This prospectus supplement
incorporates by reference the following documents:
|
|
|
|
|
our annual report on
Form 10-K
for the fiscal year ended June 30, 2007;
|
|
|
|
our quarterly reports on
Form 10-Q
for the quarters ended September 30, 2007,
December 31, 2007 and March 31, 2008;
|
|
|
|
our current reports on
Form 8-K
filed on August 31, 2007, October 17, 2007,
January 10, 2008, February 11, 2008 (with the
exception of the information furnished in response to Items 2.02
and 9.01 of that
Form 8-K),
February 19, 2008 and April 11, 2008; and
|
|
|
|
the description of the common stock included in the
Form 8-A
filed on November 27, 1968, and any amendment or report we
may file with the SEC for the purpose of updating such
description.
|
S-79
We are also incorporating by reference additional documents we
may file pursuant to Sections 13(a), 13(c), 14 or 15(d) of
the Exchange Act after the date of this prospectus supplement
until the offering of the particular securities covered by this
prospectus supplement has been completed, other than any portion
of the respective filings furnished, rather than filed, under
the applicable SEC rules. This additional information is a part
of this prospectus supplement from the date of filing of those
documents.
Any statements made in this prospectus supplement or in a
document incorporated or deemed to be incorporated by reference
into this prospectus supplement will be deemed to be modified or
superseded for purposes of this prospectus supplement to the
extent that a statement contained in this prospectus supplement
or in any other subsequently filed document which is also
incorporated or deemed to be incorporated into this prospectus
supplement modifies or supersedes the statement. Any statement
so modified or superseded will not be deemed, except as so
modified or superseded, to constitute a part of this prospectus
supplement. Information that we file later with the SEC will
automatically update and supercede the information contained in
documents filed earlier with the SEC or contained in this
prospectus supplement.
The information relating to us contained in this prospectus
supplement and the accompanying prospectus should be read
together with the information in the documents incorporated by
reference.
S-80
PROSPECTUS
Energy Conversion Devices,
Inc.
Common Stock
Warrants
Subscription Rights
Debt Securities
Stock Purchase
Contracts
Stock Purchase Units
We may offer, from time to time, common stock, warrants,
subscription rights, debt securities, which may be senior debt
securities or subordinated debt securities, stock purchase
contracts or stock purchase units.
We will provide you with the specific terms of the particular
securities being offered in supplements to this prospectus. Any
prospectus supplement may also add, update or change information
contained in this prospectus. You should read this prospectus
and each accompanying prospectus supplement carefully before you
invest. This prospectus may not be used to sell securities
unless accompanied by a prospectus supplement.
The specific manner in which any particular securities may be
offered and sold will be described in the applicable prospectus
supplement.
Our common stock is quoted on the Nasdaq National Market under
the symbol ENER. The last reported sale price of our
common stock on February 14, 2006 was $42.29 per share.
Neither the Securities and Exchange Commission, any state
securities commission or any other regulatory body has approved
or disapproved of these securities or determined if this
prospectus or the accompanying prospectus supplement is truthful
or complete. Any representation to the contrary is a criminal
offense.
The date of this prospectus is February 15, 2006.
You should rely only on the information contained in or
incorporated by reference in this prospectus or any prospectus
supplement. We have not authorized anyone to provide you with
information in addition to or different from that contained in
this prospectus or any prospectus supplement. We will be
offering to sell, and seeking offers to buy, these securities
only in jurisdictions where offers and sales are permitted. You
should not assume that the information in this prospectus or any
prospectus supplement is accurate as of any date other than the
date on the front of those documents.
TABLE OF
CONTENTS
|
|
|
|
|
|
|
|
1
|
|
|
|
|
1
|
|
|
|
|
2
|
|
|
|
|
2
|
|
|
|
|
12
|
|
|
|
|
12
|
|
|
|
|
12
|
|
|
|
|
12
|
|
|
|
|
13
|
|
|
|
|
13
|
|
|
|
|
13
|
|
Unless the context otherwise requires, throughout this
prospectus and any prospectus supplement the words
ECD, we, us and
our refer to Energy Conversion Devices, Inc. and its
consolidated subsidiaries.
Ovonic
®
and
Ovonic
tm
are trademarks and service marks of Energy Conversion Devices,
Inc. and its affiliated companies. Each of the other trademarks,
trade names or service marks appearing in this prospectus or any
prospectus supplement belongs to its respective holder.
i
ABOUT
THIS PROSPECTUS
This prospectus is part of a registration statement that we
filed with the Securities and Exchange Commission, or SEC, using
a shelf registration process. Using this process, we
may, from time to time, sell any combination of common stock,
warrants, subscription rights, debt securities, stock purchase
contracts and stock purchase units described in this prospectus
in one or more offerings. This prospectus provides you with a
general description of the securities we may offer. Each time
securities are sold, we will provide you with a prospectus
supplement that will contain information about the specific
terms of that particular offering. The prospectus supplement may
also add, update or change information contained in this
prospectus. To obtain additional information that may be
important to you, you should read the exhibits filed by us with
the registration statement of which this prospectus is a part or
our other filings with the SEC. You also should read this
prospectus and any prospectus supplement together with the
additional information described below under Where You Can
Find More Information.
ENERGY
CONVERSION DEVICES, INC.
Energy Conversion Devices, Inc. is a technology, product
development and manufacturing company engaged in the invention,
engineering, development and commercialization of new materials,
products and production technology in the fields of alternative
energy technology and information technology. Based upon the
fundamental and pioneering inventions of Stanford R. Ovshinsky,
principal inventor, we have established a leadership role in the
development of proprietary materials, products and production
technology based on our atomically engineered amorphous and
disordered materials using chemical and structural disorder to
provide multiple degrees of freedom that result in our ability
to make many new materials.
We have developed materials that permit us to design and
commercialize products such as thin-film solar cell
(photovoltaic) products, nickel metal hydride (NiMH) batteries,
and phase-change memory devices. These products have unique
chemical, electrical, mechanical and optical properties and
superior performance characteristics. Our proprietary materials,
products and technologies are referred to as Ovonic.
We have established a multi-disciplinary business, scientific,
technical and manufacturing organization to commercialize
products based on our technologies, and have enabling
proprietary technologies in the important fields of energy
generation and storage and information technology.
We manufacture and sell our proprietary products through our
subsidiaries and joint venture companies and through licensing
arrangements with major companies throughout the world. In
addition, in support of these activities, we are engaged in
research and development, production of our proprietary
materials and products, as well as in designing and building
production machinery. Our extensive patent portfolio includes
numerous basic and fundamental patents applicable to each of our
business segments. We invent not only materials, but also
develop low-cost production technologies and high-performance
products. Our patents, therefore, cover not only materials, but
also the production technology and products we develop.
Our principal executive offices are located at 2956 Waterview
Drive, Rochester Hills, Michigan 48309. Our telephone number is
(248) 293-0440.
We maintain an Internet website at www.ovonic.com. The
information contained on our website, or on other websites
linked to our website, is not part of this prospectus.
1
CAUTIONARY
NOTE REGARDING FORWARD-LOOKING STATEMENTS
This prospectus and the documents we incorporate by reference
contain forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995, including in
particular statements about our financial condition, results of
operations, plans, objectives, expectations, future performance
and business prospects. You can identify these statements by
forward-looking words such as may, will,
anticipate, believe,
estimate, expect, intend,
plan, seek and similar expressions. We
have based these forward-looking statements on our current
expectations with respect to future events and occurrences.
Investors are cautioned that our actual results in the future
may differ materially from the expected results reflected in our
forward-looking statements. Important factors that could cause
our actual results to differ materially from the results
anticipated by the forward-looking statements include the risks
and uncertainties described from time to time in our filings
with the SEC incorporated in this prospectus by reference, and
the risk factors included in the accompanying prospectus
supplement. Any or all of these factors could cause our actual
results and financial or legal status for future periods to
differ materially from those expressed or referred to in any
forward-looking statement. All written or oral forward-looking
statements attributable to us are expressly qualified in their
entirety by these cautionary statements. Forward-looking
statements speak only as of the date on which they are made.
Except as required by law, we undertake no obligation to update,
amend or clarify forward-looking statements, whether as a result
of new information, future events or otherwise.
DESCRIPTION
OF THE SECURITIES
This prospectus contains summary descriptions of the common
stock, warrants, subscription rights, debt securities, stock
purchase contracts and stock purchase units that we may sell
from time to time. These summary descriptions are not meant to
be complete descriptions of each security. However, this
prospectus and the accompanying prospectus supplement contain
the material terms of the securities being offered.
Description
of Common Stock
We may issue shares of our common stock either alone or
underlying other securities convertible into or exercisable or
exchangeable for shares of our common stock.
Holders of our common stock are entitled to receive dividends
declared by our Board of Directors out of funds legally
available for the payment of dividends, subject to rights, if
any, of preferred stock holders. Currently, we do not pay a
dividend. The holders of our common stock are entitled to one
vote per share and are not entitled to cumulative voting rights
for the election of our directors. The holders of our common
stock have no preemptive rights.
Our certificate of incorporation and bylaws contain provisions
that could make it difficult for a third party to acquire us
without the consent of our Board of Directors. For example, if a
potential acquiror were to make a hostile bid for us, the
acquiror would not be able to call a special meeting of
stockholders to remove our Board of Directors or act by written
consent without a meeting. The acquiror would also be required
to provide advance notice of its proposal to replace directors
at any annual meeting, and would not be able to cumulate votes
at a meeting, which would require the acquiror to hold more
shares to gain representation on the Board of Directors than if
cumulative voting were permitted.
Our Board of Directors also has the ability to issue additional
shares of common stock that could significantly dilute the
ownership of a hostile acquiror. In addition, Section 203
of the Delaware General Corporation Law limits mergers and other
business combination transactions involving 15% or greater
stockholders of Delaware corporations unless certain board or
stockholder approval requirements are satisfied. These
provisions and other similar provisions make it difficult for a
third party to acquire us without negotiation. These provisions
may apply even if the offer may be considered beneficial by some
stockholders.
Description
of Warrants
We may issue warrants to purchase common stock or debt
securities (collectively, the underlying warrant
securities). Warrants may be issued independently or
together with any such underlying warrant securities and may be
attached to or separate from the underlying warrant securities.
Each series of warrants will be issued under a separate warrant
agreement to be entered into between us and a warrant agent. The
warrant agent will act solely as
2
our agent in connection with the warrants of such series and
will not assume any obligation or relationship of agency for or
with holders or beneficial owners of warrants.
The applicable prospectus supplement will describe the specific
terms of any warrants offered thereby, including:
|
|
|
|
|
the title of the warrants;
|
|
|
|
the aggregate number of the warrants;
|
|
|
|
the price or prices at which the warrants will be issued;
|
|
|
|
the currency or currencies, including composite currencies, in
which the exercise price of the warrants may be payable;
|
|
|
|
the designation and terms of the underlying warrant securities
purchasable upon exercise of the warrants;
|
|
|
|
the price at which the underlying warrant securities purchasable
upon exercise of the warrants may be purchased;
|
|
|
|
the date on which the right to exercise the warrants will
commence and the date on which such right will expire;
|
|
|
|
whether the warrants will be issued in registered form or bearer
form;
|
|
|
|
if applicable, the minimum or maximum amount of the warrants
which may be exercised at any one time;
|
|
|
|
if applicable, the designation and terms of the underlying
warrant securities with which the warrants are issued and the
number of warrants issued with each such underlying warrant
security;
|
|
|
|
if applicable, the date on and after which the warrants and the
related underlying warrant securities will be separately
transferable;
|
|
|
|
information with respect to book-entry procedures, if any;
|
|
|
|
if applicable, a discussion of certain United States federal
income tax considerations; and
|
|
|
|
any other terms of the warrants, including terms, procedures and
limitations relating to the exchange and exercise of the
warrants.
|
Description
of Subscription Rights
General
We may issue subscription rights to purchase common stock or
warrants. Subscription rights may be issued independently or
together with any other offered security and may or may not be
transferable by the person purchasing or receiving the
subscription rights. In connection with any subscription rights
offering, we may enter into a standby underwriting arrangement
with one or more underwriters pursuant to which such underwriter
will purchase any offered securities remaining unsubscribed for
after such subscription rights offering. In connection with a
subscription rights offering to our stockholders, we will
distribute certificates evidencing the subscription rights and a
prospectus supplement to our stockholders on the record date
that we set for receiving the subscription rights in such
subscription rights offering.
The applicable prospectus supplements will describe the specific
terms of any subscription:
|
|
|
|
|
the title of such subscription rights;
|
|
|
|
the securities for which the subscription rights are exercisable;
|
|
|
|
the exercise price for the subscription rights;
|
|
|
|
the number of the subscription rights issued to each stockholder;
|
|
|
|
the extent to which the subscription rights are transferable;
|
|
|
|
if applicable, a discussion of certain United States federal
income tax consideration;
|
|
|
|
the date on which the right to exercise the subscription rights
will commence, and the date on which such right will expire;
|
3
|
|
|
|
|
the extent to which such subscription rights include an
over-subscription privilege with respect to unsubscribed
securities;
|
|
|
|
if applicable, certain term of any standby underwriting
agreement that we may enter into in connection with the
subscription rights offering; and
|
|
|
|
any other terms of the subscription rights, including terms,
procedures and limitations relating to the exchange and exercise
of such subscription rights.
|
Exercise
of Subscription Rights
Each subscription right will entitle the holder of subscription
rights to purchase for cash such principal amount of shares of
common stock, warrants or any combination thereof, at such
exercise price as will in each case be set forth in, or be
determinable as set forth in, the prospectus supplement relating
to the subscription rights offered thereby. Subscription rights
may be exercised at any time up to the close of business on the
expiration date for such subscription rights set forth in the
prospectus supplement. After the close of business on the
expiration date, all unexercised subscription rights will become
void. Subscription rights may be exercised as set forth in the
prospectus supplement relating to the subscription rights
offered thereby. Upon receipt of payment and the subscription
rights certificate properly completed and duly executed at the
corporate trust office of the subscription rights agent or any
other office indicated in the prospectus supplement, we will
forward, as soon as practicable, the shares of common stock or
warrants purchasable upon such exercise. In the event that not
all of the subscription rights issued in any offering are
exercised, we may determine to offer any unsubscribed offered
securities directly to persons other than stockholders, to or
through agents, underwriters or dealers or through a combination
of such methods, including pursuant to standby underwriting
arrangements, as set forth in the applicable prospectus
supplement.
Description
of Debt Securities
As used in this prospectus, debt securities means the
debentures, notes, bonds and other evidences of indebtedness
that we may issue from time to time. The debt securities will
either be senior debt securities or subordinated debt
securities. Senior debt securities will be issued under a
senior indenture and subordinated debt securities
will be issued under a subordinated indenture. This
prospectus sometimes refers to the senior indenture and the
subordinated indenture collectively as the
indentures.
The forms of indenture are filed as exhibits to the registration
statement. The statements and descriptions in this prospectus or
in any prospectus supplement regarding provisions of the
indenture and debt securities are summaries thereof, do not
purport to be complete and are subject to, and are qualified in
their entirety by reference to, all of the provisions of the
indentures and the debt securities, including the definitions
therein of certain terms.
General
The debt securities will be direct unsecured obligations of
ours. Senior debt securities of any series will be our
unsubordinated obligations and rank equally with all of our
other unsecured and unsubordinated debt, including any other
series of debt securities issued under the senior indenture.
Subordinated debt securities of any series will be junior in
right of payment to our senior indebtedness, as defined and
described more fully under Subordination.
The indentures do not limit the aggregate principal amount of
debt securities that we may issue and provide that we may issue
debt securities from time to time in one or more series, in each
case with the same or various maturities, at par or at a
discount. We may issue additional debt securities of a
particular series without the consent of the holders of the debt
securities of such series outstanding at the time of the
issuance. Any such additional debt securities, together with all
other outstanding debt securities of that series, will
constitute a single series of debt securities under the
applicable indenture. The indentures also do not limit our
ability to incur other debt.
Each prospectus supplement will describe the terms relating to
the specific series of debt securities being offered. These
terms will include some or all of the following:
|
|
|
|
|
the title of debt securities and whether they are subordinated
debt securities or senior debt securities;
|
|
|
|
any limit on the aggregate principal amount of the debt
securities;
|
|
|
|
the price or prices at which we will sell the debt securities;
|
4
|
|
|
|
|
the maturity date or dates of the debt securities;
|
|
|
|
the rate or rates of interest, if any, which may be fixed or
variable, at which the debt securities will bear interest, or
the method of determining such rate or rates, if any;
|
|
|
|
the date or dates from which any interest will accrue or the
method by which such date or dates will be determined;
|
|
|
|
the right, if any, to extend the interest payment periods and
the duration of any such deferral period, including the maximum
consecutive period during which interest payment periods may be
extended;
|
|
|
|
whether the amount of payments of principal of (and premium, if
any) or interest on the debt securities may be determined with
reference to any index, formula or other method, such as one or
more currencies, commodities, equity indices or other indices,
and the manner of determining the amount of such payments;
|
|
|
|
the dates on which we will pay interest on the debt securities
and the regular record date for determining who is entitled to
the interest payable on any interest payment date;
|
|
|
|
the place or places where the principal of (and premium, if any)
and interest on the debt securities will be payable;
|
|
|
|
if we possess the option to do so, the periods within which and
the prices at which we may redeem the debt securities, in whole
or in part, pursuant to optional redemption provisions, and the
other terms and conditions of any such provisions;
|
|
|
|
our obligation, if any, to redeem, repay or purchase debt
securities by making periodic payments to a sinking fund or
through an analogous provision or at the option of holders of
the debt securities, and the period or periods within which and
the price or prices at which we will redeem, repay or purchase
the debt securities, in whole or in part, pursuant to such
obligation, and the other terms and conditions of such
obligation;
|
|
|
|
the denominations in which the debt securities will be issued,
if other than denominations of $1,000 in the case of registered
securities and any integral multiple thereof;
|
|
|
|
the portion, or methods of determining the portion, of the
principal amount of the debt securities which we must pay upon
the acceleration of the maturity of the debt securities in
connection with an Event of Default (as described below), if
other than the full principal amount;
|
|
|
|
the currency or currencies, including composite currencies or
currency units in which that series of debt securities may be
denominated or in which we will pay the principal of (and
premium, if any) or interest, if any, on that series of debt
securities, if other than United States dollars;
|
|
|
|
provisions, if any, granting special rights to holders of the
debt securities upon the occurrence of specified events;
|
|
|
|
any deletions from, modifications of or additions to the Events
of Default or our covenants with respect to the applicable
series of debt securities;
|
|
|
|
the application, if any, of the terms of the indenture relating
to defeasance and covenant defeasance (which terms are described
below) to the debt securities and, if other than by a certified
resolution of the Board of Directors, the manner in which our
election to defease the debt securities will be evidenced;
|
|
|
|
whether the subordination provisions summarized below or
different subordination provisions will apply to the debt
securities;
|
|
|
|
the terms, if any, upon which the holders may convert or
exchange the debt securities into or for our common stock or
other securities or property;
|
|
|
|
whether any of the debt securities will be issued in global form
and, if so, the terms and conditions upon which global debt
securities may be exchanged for certificated debt securities;
|
|
|
|
any change in the right of the trustee or the requisite holders
of debt securities to declare the principal amount thereof due
and payable because of an Event of Default;
|
|
|
|
the depositary for global or certificated debt securities;
|
|
|
|
any special tax implications of the debt securities;
|
5
|
|
|
|
|
any trustees, authenticating or paying agents, transfer agents
or registrars or other agents with respect to the debt
securities; and
|
|
|
|
any other terms of the debt securities.
|
Unless otherwise specified in the applicable prospectus
supplement, the debt securities will not be listed on any
securities exchange.
Unless otherwise specified in the applicable prospectus
supplement, debt securities will be issued in fully-registered
form without coupons.
Debt securities may be sold at a substantial discount below
their stated principal amount, bearing no interest or interest
at a rate which at the time of issuance is below market rates.
The applicable prospectus supplement will describe the federal
income tax consequences and special considerations applicable to
any such debt securities. The debt securities may also be issued
as indexed securities or securities denominated in foreign
currencies, currency units or composite currencies, as described
in more detail in the prospectus supplement relating to any of
the particular debt securities. The prospectus supplement
relating to specific debt securities will also describe any
special considerations and certain additional tax considerations
applicable to such debt securities.
Subordination
The prospectus supplement relating to any offering of
subordinated debt securities will describe the specific
subordination provisions. However, unless otherwise noted in the
prospectus supplement, subordinated debt securities will be
subordinate and junior in right of payment to all of our senior
indebtedness, to the extent and in the manner set forth in the
subordinated indenture.
Under the subordinated indenture, senior
indebtedness means all obligations of ours in respect of
any of the following, whether outstanding at the date of
execution of the subordinated indenture or thereafter incurred
or created:
|
|
|
|
|
the principal of (and premium, if any) and interest due on
indebtedness of ours for borrowed money;
|
|
|
|
all obligations guaranteed by us for the repayment of borrowed
money, whether or not evidenced by bonds, debentures, notes or
other written instruments;
|
|
|
|
all obligations guaranteed by us evidenced by bonds, debentures,
notes or similar written instruments, including obligations
assumed or incurred in connection with the acquisition of
property, assets or businesses (provided that the deferred
purchase price of any other business or property or assets will
not be considered senior indebtedness if the purchase price
thereof is payable in full within 90 days from the date on
which such indebtedness was created);
|
|
|
|
all obligations of ours as lessee under leases required to be
capitalized on the balance sheet of the lessee under generally
accepted accounting principles;
|
|
|
|
all obligations of ours for the reimbursement on any letter of
credit, bankers acceptance, security purchase facility or
similar credit transaction;
|
|
|
|
all obligations of ours in respect of interest rate swap, cap or
other agreements, interest rate future or options contracts,
currency swap agreements, currency future or option contracts
and other similar agreements;
|
|
|
|
all obligations of the types referred to above of other persons
for the payment of which we are responsible or liable as
obligor, guarantor or otherwise;
|
|
|
|
all obligations of the types referred to above of other persons
secured by any lien on any property or asset of ours (whether or
not such obligation is assumed by us); and
|
|
|
|
any amendments, renewals, extensions, modifications and
refundings of any of the above.
|
Senior indebtedness does not include:
|
|
|
|
|
indebtedness or monetary obligations to trade creditors created
or assumed by us in the ordinary course of business in
connection with the obtaining of materials or services;
|
|
|
|
indebtedness that is by its terms subordinated to or ranks equal
with the subordinated debt securities; and
|
6
|
|
|
|
|
any indebtedness of ours to our affiliates (including all debt
securities and guarantees in respect of those debt securities
issued to any trust, partnership or other entity affiliated with
us that is a financing vehicle of ours in connection with the
issuance by such financing entity of preferred securities or
other securities guaranteed by us) unless otherwise expressly
provided in the terms of any such indebtedness.
|
Senior indebtedness will continue to be senior indebtedness and
be entitled to the benefits of the subordination provisions
irrespective of any amendment, modification or waiver of any
term of such senior indebtedness.
Unless otherwise noted in the accompanying prospectus
supplement, if we default in the payment of any principal of (or
premium, if any), interest or any other payment due on any
senior indebtedness when it becomes due and payable, whether at
maturity or at a date fixed for prepayment or by declaration or
otherwise, then, unless and until such default is cured or
waived or ceases to exist, we will make no direct or indirect
payment (in cash, property, securities, by set-off or otherwise)
in respect of the principal of or interest on the subordinated
debt securities or in respect of any redemption, retirement,
purchase or other acquisition of any of the subordinated debt
securities.
In the event of the acceleration of the maturity of any
subordinated debt securities, the holders of all senior debt
securities outstanding at the time of such acceleration will
first be entitled to receive payment in full of all amounts due
on the senior debt securities before the holders of the
subordinated debt securities will be entitled to receive any
payment of principal (and premium, if any) or interest on the
subordinated debt securities.
If any of the following events occurs, we will pay in full all
senior indebtedness before we make any payment or distribution
under the subordinated debt securities, whether in cash,
securities or other property, to any holder of subordinated debt
securities:
|
|
|
|
|
any dissolution or
winding-up
or liquidation or reorganization of ours, whether voluntary or
involuntary or in bankruptcy, insolvency or receivership;
|
|
|
|
any general assignment by us for the benefit of
creditors; or
|
|
|
|
any other marshaling of our assets or liabilities.
|
In such event, any payment or distribution under the
subordinated debt securities, whether in cash, securities or
other property, which would otherwise (but for the subordination
provisions) be payable or deliverable in respect of the
subordinated debt securities, will be paid or delivered directly
to the holders of senior indebtedness or their representatives
or trustees in accordance with the priorities then existing
among such holders as calculated by us until all senior
indebtedness has been paid in full. If any payment or
distribution under the subordinated debt securities is received
by the trustee of any subordinated debt securities in
contravention of any of the terms of the subordinated indenture
and before all the senior indebtedness has been paid in full,
such payment or distribution will be received in trust for the
benefit of, and paid over or delivered to, the holders of the
senior indebtedness or their representatives or trustees at the
time outstanding in accordance with the priorities then existing
among such holders as calculated by us for application to the
payment of all senior indebtedness remaining unpaid to the
extent necessary to pay all such senior indebtedness in full.
The subordinated indenture does not limit the issuance of
additional senior indebtedness.
Consolidation,
Merger, Sale of Assets and Other Transactions
Unless the accompanying prospectus supplement states otherwise,
we may not (i) merge with or into or consolidate with
another person or sell, assign, transfer, lease or convey all or
substantially all of our properties and assets to, any other
person other than a direct or indirect wholly-owned subsidiary
of ours, and (ii) no person may merge with or into or
consolidate with us or, except for any of our direct or indirect
wholly-owned subsidiaries, sell, assign, transfer, lease or
convey all or substantially all of its properties and assets to
us, unless:
|
|
|
|
|
we are the surviving corporation or the person formed by or
surviving such merger or consolidation or to which such sale,
assignment, transfer, lease or conveyance has been made, if
other than us, has expressly assumed by supplemental indenture
all our obligations under the debt securities and the indentures;
|
|
|
|
immediately after giving effect to such transaction, no default
or Event of Default has occurred and is continuing; and
|
|
|
|
we deliver to the trustee an officers certificate and an
opinion of counsel, each stating that the supplemental indenture
relating to the transaction complies with the applicable
Indenture.
|
7
Events of
Default; Notice and Waiver
Unless an accompanying prospectus supplement states otherwise,
the following constitute Events of Default under the
indentures with respect to each series of debt securities:
|
|
|
|
|
our failure to pay any interest on any debt security of such
series when due and payable, continued for 30 days;
provided, however, that a valid extension of an interest payment
period in accordance with the terms of the debt security of such
series will not constitute a default in the payment of interest
for this purpose;
|
|
|
|
our failure to pay principal (or premium, if any) on any debt
security of such series when due, regardless of whether such
payment became due because of maturity, redemption, acceleration
or otherwise, or is required by any sinking fund established
with respect to such series; provided, however, that a valid
extension of the maturity of such debt security in accordance
with the terms of the debt securities of that series will not
constitute a default in the payment of principal (or premium, if
any) for this purpose;
|
|
|
|
our failure to observe or perform any other of our covenants or
agreements with respect to such debt securities for 90 days
after we receive notice of such failure; and
|
|
|
|
certain events of bankruptcy, insolvency or reorganization.
|
If an Event of Default with respect to any debt securities of
any series outstanding under either of the indentures occurs and
is continuing, the trustee under such indenture or the holders
of at least 25% in aggregate principal amount of the debt
securities of that series outstanding may declare, by notice as
provided in the applicable indenture, the principal amount (or
such lesser amount as may be provided for in the debt securities
of that series) of all the debt securities of that series
outstanding to be due and payable immediately. In the case of an
Event of Default involving certain events in bankruptcy,
insolvency or reorganization, acceleration is automatic. In
addition, after such acceleration, but before a judgment or
decree based on acceleration, the holders of a majority in
aggregate principal amount of the outstanding debt securities of
that series may, under certain circumstances, rescind and annul
such acceleration if all Events of Default, other than the
nonpayment of accelerated principal, have been cured or waived.
Upon the acceleration of the maturity of original issue discount
securities, an amount less than the principal amount thereof
will become due and payable. Reference is made to the prospectus
supplement relating to any original issue discount securities
for the particular provisions relating to acceleration of
maturity thereof.
Any past default under either indenture with respect to debt
securities of any series, and any Event of Default arising
therefrom, may be waived by the holders of a majority in
principal amount of all debt securities of such series
outstanding under such indenture, except in the case of
(i) default in the payment of the principal of (or premium,
if any) or interest on any debt securities of such series or
(ii) default in respect of a covenant or provision which
may not be amended or modified without the consent of the holder
of each outstanding debt security of such series affected.
The trustee is required, within 90 days after the
occurrence of a default (which is known to the trustee and is
continuing), with respect to the debt securities of any series
(without regard to any grace period or notice requirements), to
give to the holders of the debt securities of such series notice
of such default; provided, however, that, except in the case of
a default in the payment of the principal of (and premium, if
any) or interest, or in the payment of any sinking fund
installment, on any debt securities of such series, the trustee
will be protected in withholding such notice if it in good faith
determines that the withholding of such notice is in the
interests of the holders of the debt securities of such series.
The trustee, subject to its duties during default to act with
the required standard of care, may require indemnification by
the holders of the debt securities of any series with respect to
which a default has occurred before proceeding to exercise any
right or power under the indenture at the request of the holders
of the debt securities of such series. Subject to such right of
indemnification and to certain other limitations, the holders of
a majority in principal amount of the outstanding debt
securities of any series under either indenture may direct the
time, method and place of conducting any proceeding for any
remedy available to the trustee, or exercising any trust or
power conferred on the trustee with respect to the debt
securities of such series.
No holder of a debt security of any series may institute any
action against us under either of the indentures (except actions
for payment of overdue principal of (and premium, if any) or
interest on such debt security or for the conversion or exchange
of such debt security in accordance with its terms) unless
(i) the holder has given to the trustee written notice of
an Event of Default and of the continuance thereof with respect
to the debt securities of such
8
series specifying an Event of Default, as required under the
applicable indenture, (ii) the holders of at least 25% in
aggregate principal amount of the debt securities of that series
then outstanding under such indenture have requested the trustee
to institute such action and offered to the trustee indemnity
reasonably satisfactory to it against the costs, expenses and
liabilities to be incurred in compliance with such request and
(iii) the trustee has not instituted such action within
60 days of such request during which time the holders of a
majority in principal amount of the debt securities of that
series do not give the trustee a direction inconsistent with
that request.
We are required to furnish annually to the trustee statements as
to our compliance with all conditions and covenants under each
indenture.
Discharge,
Defeasance and Covenant Defeasance
If indicated in the applicable prospectus supplement, we may
discharge or defease our obligations under each indenture as set
forth below.
We may discharge certain obligations to holders of any series of
debt securities issued under either the senior indenture or the
subordinated indenture which have not already been delivered to
the trustee for cancellation and which have either become due
and payable or are by their terms due and payable within one
year (or scheduled for redemption within one year) by
irrevocably depositing with the trustee cash or, in the case of
debt securities payable only in U.S. dollars,
U.S. government obligations (as defined in either
indenture), as trust funds in an amount certified to be
sufficient to pay when due, whether at maturity, upon redemption
or otherwise, the principal of (and premium, if any) and
interest on such debt securities.
If indicated in the applicable prospectus supplement, we may
elect either (i) to defease and be discharged from any and
all obligations with respect to the debt securities of or within
any series (except as otherwise provided in the relevant
indenture) (defeasance) or (ii) to be released
from its obligations with respect to certain covenants
applicable to the debt securities of or within any series
(covenant defeasance), upon the deposit with the
relevant indenture trustee, in trust for such purpose, of money
and/or
government obligations which through the payment of principal
and interest in accordance with their terms will provide money
in an amount sufficient, without reinvestment, to pay the
principal of (and premium, if any) or interest on such debt
securities to maturity or redemption, as the case may be, and
any mandatory sinking fund or analogous payments thereon. As a
condition to defeasance or covenant defeasance, we must deliver
to the trustee an opinion of counsel to the effect that the
holders of such debt securities will not recognize income, gain
or loss for federal income tax purposes as a result of such
defeasance or covenant defeasance and will be subject to federal
income tax on the same amounts and in the same manner and at the
same times as would have been the case if such defeasance or
covenant defeasance had not occurred. Such opinion of counsel,
in the case of defeasance under clause (i) above, must
refer to and be based upon a ruling of the Internal Revenue
Service or a change in applicable federal income tax law
occurring after the date of the relevant indenture. In addition,
in the case of either defeasance or covenant defeasance, we will
deliver to the trustee (i) an officers certificate to
the effect that the relevant debt securities exchange(s) have
informed it that neither such debt securities nor any other debt
securities of the same series, if then listed on any securities
exchange, will be delisted as a result of such deposit and
(ii) an officers certificate and an opinion of
counsel, each stating that all conditions precedent with respect
to such defeasance or covenant defeasance have been complied
with. Finally, the deposit may not result in (i) an Event
of Default, and no Event of Default may occur for 90 days
following the deposit, (ii) a breach or violation of, or
constitute a default under, any indenture or other agreement or
instrument for borrowed money, pursuant to which more than
$100,000,000 principal amount is then outstanding, to which we
are a party or by which we are bound or (iii) the trust
arising from such deposit constituting an investment company
within the meaning of the Investment Company Act unless such
trust will be registered under the Investment Company Act or
exempt from registration thereunder.
We may exercise our defeasance option with respect to such debt
securities notwithstanding our prior exercise of our covenant
defeasance option.
Modification
and Waiver
Under the indentures, we and the applicable trustee may
supplement the indentures for certain purposes which would not
materially adversely affect the interests or rights of the
holders of debt securities of a series without the consent of
those holders. We and the applicable trustee may also modify the
indentures or any supplemental indenture in a manner that
affects the interests or rights of the holders of debt
securities with the consent of the
9
holders of at least a majority in aggregate principal amount of
the outstanding debt securities of each affected series issued
under the indenture. However, the indentures require the consent
of each holder of debt securities that would be affected by any
modification which would:
|
|
|
|
|
extend the fixed maturity of any debt securities of any series,
or reduce the principal amount thereof, or reduce the rate or
extend the time of payment of interest thereon, or reduce any
premium payable upon the redemption thereof;
|
|
|
|
reduce the amount of principal of an original issue discount
debt security or any other debt security payable upon
acceleration of the maturity thereof;
|
|
|
|
change the currency in which any debt security or any premium or
interest is payable;
|
|
|
|
impair the right to institute suit for any payment on or with
respect to any debt security;
|
|
|
|
reduce the percentage in principal amount of outstanding debt
securities of any series, the consent of whose holders is
required for modification or amendment of the indentures or for
waiver of compliance with certain provisions of the indentures
or for waiver of certain defaults;
|
|
|
|
reduce the requirements contained in the indentures for quorum
or voting; or
|
|
|
|
modify any of the above provisions.
|
The indentures permit the holders of a majority in aggregate
principal amount of the outstanding debt securities of any
series issued under the indenture, which is affected by the
modification or amendment to waive our compliance with certain
covenants contained in the indentures.
Payment
and Paying Agents
Unless otherwise indicated in the applicable prospectus
supplement, payment of interest on a debt security on any
interest payment date will be made to the person in whose name a
debt security is registered at the close of business on the
record date for the interest.
Unless otherwise indicated in the applicable prospectus
supplement, principal, interest and premium on the debt
securities of a particular series will be payable at the office
of such paying agent or paying agents as we may designate for
such purpose from time to time. Notwithstanding the foregoing,
at our option, payment of any interest may be made by check
mailed to the address of the person entitled thereto as such
address appears in the security register.
Unless otherwise indicated in the applicable prospectus
supplement, a paying agent designated by us and located in the
Borough of Manhattan, City of New York will act as paying agent
for payments with respect to debt securities of each series. All
paying agents initially designated by us for the debt securities
of a particular series will be named in the applicable
prospectus supplement. We may at any time designate additional
paying agents or rescind the designation of any paying agent or
approve a change in the office through which any paying agent
acts, except that we will be required to maintain a paying agent
in each place of payment for the debt securities of a particular
series.
Form,
Exchange and Transfer
The debt securities of each series may be issued as registered
securities, as bearer securities (with or without coupons) or
both. Unless otherwise specified in the applicable prospectus
supplement, if any, registered securities will be issued in
denominations of $1,000 and any integral multiple thereof.
Subject to the terms of the indenture and the limitations
applicable to global securities described in the applicable
prospectus supplement, if any, registered securities will be
exchangeable for other registered securities of the same series,
in any authorized denomination and of like tenor and aggregate
principal amount.
Subject to the terms of the indenture and the limitations
applicable to global securities set forth in the applicable
prospectus supplement, debt securities issued as registered
securities may be presented for exchange or for registration of
transfer (duly endorsed or with the form of transfer duly
executed) at the office of the security registrar or at the
office of any transfer agent designated by us for that purpose.
Unless otherwise provided in the debt securities to be
transferred or exchanged, no service charge will be made for any
registration of transfer or exchange, but we may require payment
of any taxes or other governmental charges. Any transfer agent
initially
10
designated by us for any debt securities will be named in the
applicable prospectus supplement. We may at any time designate
additional transfer agents or rescind the designation of any
transfer agent or approve a change in the office through which
any transfer agent acts, except that we will be required to
maintain a transfer agent in each place of payment for the debt
securities of each series.
If the debt securities of any series are to be redeemed, we will
not be required to:
|
|
|
|
|
issue, register the transfer of, or exchange any debt securities
of that series during a period beginning at the opening of
business 15 days before any selection of debt securities
for redemption and ending at the close of business on the day of
mailing of the relevant notice of redemption; or
|
|
|
|
register the transfer of or exchange any debt securities so
selected for redemption, in whole or in part, except the
unredeemed portion of any registered security being redeemed in
part.
|
Global
Securities
The debt securities of each series may be issued in whole or in
part in global form. A debt security in global form will be
deposited with, or on behalf of, a depositary, which will be
named in an applicable prospectus supplement. A global security
may be issued in either registered or bearer form and in either
temporary or definitive form. A global debt security may not be
transferred, except as a whole, among the depositary for that
debt security
and/or
its
nominees
and/or
successors. If any debt securities of a series are issuable as
global securities, the applicable prospectus supplement will
describe any circumstances when beneficial owners of interest in
that global security may exchange their interests for definitive
debt securities of like series and tenor and principal amount in
any authorized form and denomination, the manner of payment of
principal of and interest, if any, on that global debt security
and the specific terms of the depositary arrangement with
respect to that global debt security.
Governing
Law
The indentures and debt securities will be governed by, and
construed in accordance with, the internal laws of the State of
New York.
Concerning
the Trustee
We anticipate appointing the trustee under the indenture as the
paying agent, conversion agent, registrar and custodian with
regard to the debt securities. The trustee or its affiliates may
in the future provide banking and other services to us in the
ordinary course of their respective businesses.
Conversion
or Exchange Rights
The prospectus supplement will describe the terms, if any, on
which a series of debt securities may be convertible into or
exchangeable for our common stock or other debt securities.
These terms will include provisions as to whether conversion or
exchange is mandatory, at the option of the holder or at our
option. These provisions may allow or require the number of
shares of our common stock or other securities to be received by
the holders of such series of debt securities to be adjusted.
Description
of Stock Purchase Contracts and Stock Purchase Units
We may issue stock purchase contracts, including contracts
obligating holders to purchase from or sell to us, and
obligating us to sell to or purchase from the holders, a
specified number of shares of common stock at a future date or
dates, which we refer to in this prospectus as stock purchase
contracts. The price per share of the securities and the number
of shares of the securities may be fixed at the time the stock
purchase contracts are issued or may be determined by reference
to a specific formula set forth in the stock purchase contracts,
and may be subject to adjustment under anti-dilution formulas.
The stock purchase contracts may be issued separately or as part
of units consisting of a stock purchase contract and debt
securities or debt obligations of third parties, including
United States treasury securities, any other securities
described in the applicable prospectus supplement or any
combination of the foregoing, securing the holders
obligations to purchase the securities under the stock purchase
contracts, which we refer to herein as stock purchase units. The
stock purchase contracts may require holders to secure their
obligations under the stock purchase contracts in a specified
manner. The stock purchase contracts also may require us to make
periodic payments to the holders of the stock purchase contracts
or the stock purchase units, as the case may be, or vice versa,
and those payments may be unsecured or pre-funded on some basis.
11
The applicable prospectus supplement will describe the terms of
any stock purchase contracts or stock purchase units offered
thereby and will contain a discussion of any material federal
income tax considerations applicable to the stock purchase
contracts and stock purchase units. The description of the stock
purchase contracts or stock purchase units contained in this
prospectus is not complete and the description in any applicable
prospectus supplement will not necessarily be complete, and
reference will be made to the stock purchase contracts, and, if
applicable, collateral or depositary arrangements relating to
the stock purchase contracts or stock purchase units, which will
be filed with the SEC each time we issue stock purchase
contracts or stock purchase units. If any particular terms of
the stock purchase contracts or stock purchase units described
in the applicable prospectus supplement differ from any of the
terms described herein, then the terms described herein will be
deemed superseded.
PLAN OF
DISTRIBUTION
We may sell the offered securities through agents, through
underwriters or dealers, directly to one or more purchasers or
through a combination of any of these methods of sale. We will
identify the specific plan of distribution, including any
underwriters, dealers, agents or direct purchasers and their
compensation in a prospectus supplement.
USE OF
PROCEEDS
Unless we inform you otherwise in the prospectus supplement, we
intend to use the net proceeds from the sale of the securities
offered by us to fund our ongoing business operations and for
other general corporate purposes. Pending any specific
application, we may initially invest funds in short-term
marketable securities.
RATIO OF
EARNINGS TO FIXED CHARGES
The following table sets forth our ratio of earnings to fixed
charges for our five fiscal years ended June 30, 2005:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fiscal Year Ended June 30,
|
|
|
|
|
2001
|
|
2002
|
|
2003
|
|
2004
|
|
2005
|
|
Ratio of Earnings to Fixed Charges(1)
|
|
|
|
(2)
|
|
|
|
(2)
|
|
|
|
(2)
|
|
|
|
(2)
|
|
|
25.5
|
|
|
|
|
(1)
|
|
For purposes of computing the ratio of earnings to fixed
charges, earnings consist of (a) income (loss) from
continuing operations before income taxes, extraordinary item
and cumulative effect of change in accounting principle and
before adjustment for minority interests in consolidated
subsidiaries or income or loss from equity investees,
(b) distributed income of equity investees and
(c) fixed charges. Fixed charges include (a) interest
expensed and capitalized and (b) an estimate of the
interest within rental expense.
|
|
(2)
|
|
The income (loss) from continuing operations before income
taxes, extraordinary item and cumulative effect of change in
accounting principle and before adjustment for minority
interests in consolidated subsidiaries or income or loss from
equity investees for the years ended June 30, 2001, 2002,
2003 and 2004 are not sufficient to cover fixed charges by a
total of approximately $0.7 million in 2001,
$15.3 million in 2002, $26.1 million in 2003 and
$48.5 million in 2004. As a result, the ratio of earnings
to fixed charges has not been computed for any of these periods.
|
LEGAL
MATTERS
Unless otherwise indicated in the applicable prospectus
supplement, the validity of the securities offered by us will be
passed upon by Roger John Lesinski, Esq., our General
Counsel. Mr. Lesinski beneficially owns 1,200 shares
of common stock and holds presently exercisable options to
purchase an additional 25,510 shares of common stock. If
the validity of any of the securities is also passed upon by
counsel for the underwriters of an offering, that counsel will
be named in the prospectus supplement relating to that offering.
12
EXPERTS
The consolidated financial statements, the related financial
statement schedule, and managements assessment of the
effectiveness of internal control over financial reporting of
ECD as of and for the year ended June 30, 2005,
incorporated by reference in this registration statement from
our Annual Report on
Form 10-K
(the Annual Report), have been audited by Grant
Thornton LLP, our Independent Registered Public Accounting Firm,
as stated in their reports with respect thereto (which report on
managements assessment of the effectiveness of the
Companys internal control over financial reporting
expressed an unqualified opinion and an adverse opinion on the
effectiveness of the Companys internal control over
financial reporting because of a material weakness), and are
incorporated herein by reference, and have been so incorporated
in reliance upon the reports of such firm given upon their
authority as experts in accounting and auditing.
The consolidated financial statements and the related financial
statement schedule as of and for the year ended June 30,
2004 incorporated by reference from our Annual Report have been
audited by Grant Thornton LLP, our Independent Registered Public
Accounting Firm, as stated in their report included in the
Annual Report (which report expresses an unqualified opinion and
contains an explanatory paragraph relating to substantial doubt
about our ability to continue as a going concern), which is
incorporated herein by reference, and have been so incorporated
in reliance upon the report of such firm given upon their
authority as experts in accounting and auditing.
The consolidated statements of operations, stockholders
equity and cash flows for the fiscal year ended June 30,
2003 and the related financial statement schedule, prior to the
reclassification for discontinued operations and not presented
separately herein or therein, have been audited by
Deloitte & Touche LLP, an Independent Registered
Public Accounting Firm, as stated in their report which is
incorporated herein by reference from the Companys Annual
Report on
Form 10-K
for the fiscal year ended June 30, 2005, which report dated
October 21, 2003 expresses an unqualified opinion and
contains explanatory paragraphs relating to (i) our change
in method of accounting for goodwill and other intangible assets
in fiscal year 2003, and (ii) substantial doubt about our
ability to continue as a going concern.
WHERE YOU
CAN FIND MORE INFORMATION
We have filed with the SEC a registration statement on
Form S-3
under the Securities Act with respect to the securities offered
by this prospectus. This prospectus, which is part of the
registration statement, omits certain information, exhibits,
schedules and undertakings set forth in the registration
statement. For further information pertaining to us and our
common stock, reference is made to such registration statement
and the exhibits and schedules to the registration statement.
Statements contained in this prospectus as to the contents or
provisions of any documents referred to in this prospectus are
not necessarily complete, and in each instance where a copy of
the document has been filed as an exhibit to the registration
statement, reference is made to the exhibit for a more complete
description of the matters involved.
We file annual, quarterly and current reports, proxy statements
and other information with the SEC. Our SEC filings can be read
and copied at the SECs Public Reference Room at
100 F Street, N.E., Washington, D.C. 20549. The
public may obtain information on the operation of the public
reference room by calling the SEC at
1-800-SEC-0330.
Also, the SEC maintains an Internet website at www.sec.gov that
contains reports, proxy and information statements and other
information regarding issuers that file electronically with the
SEC, including us. Our common stock is quoted on the Nasdaq
Stock Markets National Market System under the symbol
ENER. General information about our company,
including our Annual Report on
Form 10-K,
Quarterly Reports on
Form 10-Q
and Current Reports on
Form 8-K,
as well as any amendments and exhibits to those reports, are
available free of charge through our website at www.ovonic.com
as soon as reasonably practicable after we file them with, or
furnish them to, the SEC. Information on our website is not
incorporated into this prospectus or other securities filings
and is not a part of these filings.
INCORPORATION
OF CERTAIN INFORMATION BY REFERENCE
The SEC allows us to incorporate by reference in
this prospectus the information we file with it, which means
that we can disclose important information to you by referring
you to those documents. The information we incorporate by
reference is an important part of this prospectus, and later
information that we file with the SEC will automatically update
and supersede some of this information. We incorporate by
reference the documents listed
13
below and any future filings we make with the SEC under
Section 13(a), 13(c), 14 or 15(d) of the Exchange Act until
we sell all of the securities covered by this prospectus. The
documents we incorporate by reference are:
|
|
|
|
|
our Current Report on
Form 8-K
filed with the SEC on August 31, 2005;
|
|
|
|
our Quarterly Report on
Form 10-Q
for the quarter ended December 31, 2005 filed with the SEC
on February 9, 2006;
|
|
|
|
our Quarterly Report on
Form 10-Q
for the quarter ended September 30, 2005 as amended by
Form 10-Q/A
filed with the SEC on January 4, 2006;
|
|
|
|
our Annual Report on
Form 10-K
for the year ended June 30, 2005 as amended by
Form 10-K/A
filed with the SEC on January 4, 2006; and
|
|
|
|
the description of our common stock included in our Registration
Statement on
Form 8-A,
as filed with the SEC on November 27, 1968, including any
amendments or reports filed for the purpose of updating such
description.
|
Information in Current Reports on
Form 8-K
furnished to the SEC, including under Item 9 or 12 of
Form 8-K
(prior to August 23, 2004) or Item 2.02 or 7.01
of
Form 8-K
(on or subsequent to August 23, 2004) prior to, on or
subsequent to the date hereof is not being and will not be
incorporated herein by reference.
You may request a copy of these filings (other than an exhibit
to the filings unless we have specifically incorporated that
exhibit by reference into the filing), at no cost, by writing or
telephoning us at the following address:
Energy Conversion Devices, Inc.
2956 Waterview Drive
Rochester Hills, Michigan 48309
Attention: Corporate Secretary
(248) 293-0440
14
$225,000,000
% Convertible Senior Notes due
2013
PROSPECTUS SUPPLEMENT
June ,
2008
Joint
Book-Running Managers
CREDIT
SUISSE
UBS
INVESTMENT BANK
JPMORGAN
DEUTSCHE
BANK SECURITIES
LAZARD
CAPITAL MARKETS
Accretion Acquisition (NASDAQ:ENER)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
Accretion Acquisition (NASDAQ:ENER)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024